900 922 300

Congresses and Courses

By giving the gift of knowledge we empower individuals.

Congresses

  • Cacabelos R. E-PodoFavalin-15999: Biological Properties and Pharmacogenetics in Parkinson's Disease. DDTWC, Boston, 2016.
    Carrera I, Fernandez-Novoa L, Vigo C, Cacabelos R. (2016) The dual effect of EB101 vaccine: A promising strategy for preventing and treating Alzheimer's disease. DDTWC - P 9; Boston, USA.
  • Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. (2016) Neuroprotective Effects of Atremorine in MPTP Mouse Model of Parkinson's Disease. DDTWC - P 37; Boston, USA.
  • Carrera I, Cacabelos R. (2016) In vitro and in vivo anti-tumor effects of E-Congerine-10423®. DDTWC - P 38; Boston, USA.
  • Teijido O, Carril JC, Cacabelos R. Risk polymorphisms associated with Dementia in the Spanish population. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Teijido O, Carril JC, Cacabelos. Risk polymorphisms associated with lipid metabolism and vascular risk in the Spanish population. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Carril JC, Teijido O, Cacabelos R. The intelligent pharmacogenetic test. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Carril JC, Teijido O, Cacabelos R. Neuro-PGxCard: A new approach to the personalized treatment of CNS disorders. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Tellado I, Carril JC, Teijido O, Fraile C, Cacabelos R. APOE-related brain hemodynamics. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Cacabelos R, Carril JC, Teijido O. Major determinants of pharmacogenetic response in Alzheimer's Disease. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Cacabelos R, Carril JC, Teijido O, Fernández-Novoa L, Carrera I. E-PodoFavalin-15999 (Atremorine®): A new modality of nutrigenomic intervention in Parkinson's Disease. 4th International Conference on Predictive, Preventive, and Personalized Medicine and Molecular Diagnosis, Phoenix, Arizona, USA. Sept. 22-23, 2016.
  • Cacabelos R. Pentagenic haplotype-related cholesterolemic phenotype in Alzheimer's disease. Human Genet Embryol 2016; 6(3):20.
  • Cacabelos R. Genotype-related vascular phenotype in dementia: Impact on the pharmacogenetic outcome. Human Genet Embryol 2016; 6(3):41.
  • Tellado I, Carril JC, Fraile C, Cacabelos R. Effect of ACE genotype on brain bioactivity in Vascular Dementia. Human Genet Embryol 2016; 6(3):49.
  • Tellado I, Carril JC, Fraile C, Cacabelos R. Influence of the APOE4 allele on brain networks in healthy elderly subjects. Human Genet Embryol 2016; 6(3):52.
  • Fernandez-Novoa L, Tellado I, Corzo L, Seoane S, Carrera I, Carril JC, Cacabelos R. A genomic approach to histamine function. Human Genet Embryol 2016; 6(3):57.
  • Carrera I, Fernandez-Novoa L, Sampedro C, Seoane S, Tellado I, Lakshmana M, Cacabelos R. Validation and characterization of 3xTg (APP/Bin1/COPS5) mice as a new neuropathological model of Alzheimer's disease. Human Genet Embryol 2016; 6(3):59.
  • Corzo L, Rodriguez S, Carril JC, Tellado I, Cacabelos R. Vascular Risk Polymorphisms and Serum Atherogenic Biomarkers. Human Genet Embryol 2016; 6(3):60.
  • Carril JC, Tellado I, Cacabelos R. Predictive Genetic Risk Test in Cerebrovascular Disorders. Human Genet Embryol 2016; 6(3):61.
  • Teijido O, Carril JC, Tellado I, Cacabelos R. Epigenomic profile in dementiarelated disorders. Human Genet Embryol 2016; 6(3):62.
  • Carrera I, Fernandez-Novoa L, Tellado I, Vigo C, Cacabelos R. EB101 vaccine as a dual immunotherapy for preventing and treating Alzheimer's disease. Human Genet Embryol 2016; 6(3):63.
  • CACABELOS R. Pharmacogenetics of Alzheimer's disease: The critical role of the APOE-TOMM40 region. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 18.
    TEIJIDO O, CARRIL JC, CACABELOS R. Risk polymorphisms associated with lipid metabolism and vascular risk in the Spanish population. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 48.
  • CARRIL JC, CACABELOS R. Neuro-PGx Card: A new approach to the personalized treatment of CNS disorders. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 49.
  • CARRIL JC, TELLADO I, FRAILE C, CACABELOS R. Impact of rs699 and rs4762 AGT SNPs on functional networks in Vascular Dementia. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 50.
  • CARRIL JC, CACABELOS R. Nutrigenomic Card: The Nutrigenetic Risk Test. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 51.
  • CARRIL JC, FERNANDEZ-NOVOA L, CORZO L, SEOANE S, CARRERA I, TEIJIDO O, CACABELOS R. A genomic approach to histamine function. J Pharmacogenomics Pharmacoproteomics 2016; 7(4): 52.
  • Cacabelos R. Pharmacogenetics of psychotropic drugs: The UCJC pharmacogenetic card for personalized treatment. WPA Regional Congress, Osaka International Convention Center, Osaka, Japan, 4-6 June, 2015.
  • Cacabelos, R. TOMM40 Poly-T variants modify the pharmacogenetic response to conventional treatment in Alzheimer's disease. 7th Santorini Conference. Biologie Prospective Systems Medicine, Personalized Health and Therapy. 25-27 September, Santorini, Greece (2014).
  • Torrellas, C., Carril, J.C., Cacabelos. Pharmacogenetics of Antidepressant drugs: Optimizing prescription. 7th Santorini Conference. Biologie Prospective Systems Medicine, Personalized Health and Therapy. 25-27 September, Santorini, Greece (2014).
  • Corzo, L., Rodríguez, S., Carril, J.C., Cacabelos, R. Relationships between Genetic Vascular Risk Polymorphisms and Serum Vascular Biomarkers. 7th Santorini Conference. Biologie Prospective Systems Medicine, Personalized Health and Therapy. 25-27 September, Santorini, Greece (2014).
  • Corzo, L., Carril, J.C., Rodríguez, S., Couceiro, V., Cacabelos, R. Vascular Risk Factors in Dementia: Influence of APOE, MTHFR, NOS3, PSEN1 and ACE Polymorphisms and Association with Cognitive Function Scores. 7th Santorini Conference. Biologie Prospective Systems Medicine, Personalized Health and Therapy. 25-27 September, Santorini, Greece (2014).
  • Carril, J.C., Cacabelos, R. Atherogenic biomarkers in vascular dementia: the role of inflammation in neurodegeneration. 7th Santorini Conference. Biologie Prospective Systems Medicine, Personalized Health and Therapy. 25-27 September, Santorini, Greece (2014).
  • Corzo, L., Rodríguez, S., Cacabelos. Novel vascular risk factor evaluation can improve the prediction and prevention of vascular risk in dementia. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-07-009 (2013).
  • Corzo, L., Rodríguez, S., Fernández-Novoa, L., Couceiro, V., Cacabelos, R. Vascular risk factors in dementia: Influence of APOE, MTHFR, NOS3, PSEN1 and ACE polymorphisms and association with cognitive function scores. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-07-015 (2013).
  • Cacabelos, R. Influence of pleiotropic genes in CNS Pharmacogenomics. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, S-048-004 (2013).
  • Fernández-Novoa, L., Seoane, S., Carril, J.C., Agúndez, J.A., Cacabelos, R. G2019S mutation in sporadic and familial Parkinson's disease. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-10-004 (2013).
  • Fernández-Novoa, L., Lombardi, V., Etcheverría, I., Cacabelos, R. The effects of acute and chronic psychological stress on immune function in a rat model. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-12-016 (2013).
  • Carril, J.C., Corzo, L., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Characterization of the genomic risk profile in cerebrovascular diseases. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-13-022 (2013).
  • Carril, J.C., Torrellas, C., Fraile, C., Fernández-Novoa, L., Cacabelos, R. Error rate in antidepressant Drug prescription: the importance of personalized medicine. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-18-005 (2013).
  • Carril, J.C., Torrellas, C., Fraile, C., Fernández-Novoa, L., Cacabelos, R. Pharmacogenetics as a predictive tool to reduce errors in the administration of anxiolytics, hypnotics and sedatives. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-18-006 (2013).
  • Carril, J.C., Fraile, C., Torrellas, C., Couceiro, V., Fernández-Novoa, L., Cacabelos, R. The importance of pharmacogenetics in the treatment of psychotic disorders. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-18-009 (2013).
  • Carril, J.C., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Characterization of CYP3A polymorphisms in the Spanish population. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-18-015 (2013).
  • Tellado, I., Corzo, L., Canuet, L., Couceiro, V., Fraile, C., Cacabelos, R. Age-related changes in brain networks: A bioelectrical source localization and functional connectivity study in resting state. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-20-003 (2013).
  • Canuet, L., Tellado, I., Couceiro, V., Fraile, C., Fernández-Novoa, L., Ishii, R., Takeda, M., Cacabelos, R. Phenotypic profile of brain functional connectivity and oscillatory activity in Alzheimer's disease. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-21-010 (2013).
  • Canuet, L., Tellado, I., Corzo, L., Fernández-Novoa, L., Fraile, C., Torrellas, C., Ishii, R., Takeda, M., Cacabelos, R. Association of APOE genotype and LDL-cholesterol levels with brain electrical activity in Alzheimer's disease. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-21-011 (2013).
  • Canuet, L., Ishii, R., Pascual-Marqui,M., Iwase, M., Takeda, M., Cacabelos, R., del Pozo, F., Maestu, F. Resting-state EEG source localization and functional connectivity in schizophrenia-like psychosis of epilepsy and Alzheimer's disease using eLORETA. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-84-002 (2013).
  • Cacabelos, R. Pharmacogenomics of lipid metabolism dysfunction in dementia. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, S-100-004 (2013).
  • Fernández-Novoa, L., Tellado, I., Canuet, L., Couceiro, V., Fraile, C., Cacabelos, R. Impact of APOE-4 allele on brain activity in aging. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-26-004 (2013).
  • Fernández-Novoa, L., Carril, J.C., Seoane, S., Cacabelos, R. An association study between histamine and polymorphisms in immune system genes in mental disorders. WFSBP Congress, 11th World Congress of Biological Psychiatry, 23-27 June, Kyoto, P-28-025 (2013).
  • Cacabelos, R. APOE-TOMM40 and CYP2D6 in the Pharmacogenomics of dementia. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portuga (2013).
  • Carril, J.C., Cacabelos, R. Characterization of CYP3A polymorphisms in the Spanish population. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Carril, J.C., Corzo, L., Fernández-Novoa, L., Seoane, S., Cacabelos. Characterization of the genomic risk profile in cerebrovascular diseases. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Torrellas, C., Fraile, C., Carril, J.C., Fernández-Novoa, L., Cacabelos, R. Error rate in antidepressant Drug prescription: the importance of personalized medicine. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Torrellas, C., Piñeiro, S., Villanueva, M.J., Solveira, C., Fraile, C., Carril, J.C., Fernández-Novoa, L., Cacabelos, R. Hypertension management: benefits of pharmacogenetics. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Torrellas, C., Fraile, C., Carril, J.C., Fernández-Novoa, L., Cacabelos, R. Pharmacogenetics as a predictive tool to reduce errors in the administration of anxiolytics, hypnotics and sedatives. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Carril, J.C., Fraile, C., Torrellas, C., Couceiro, V., Fernández-Novoa, L., Cacabelos, R. The importance of pharmacogenetics in the treatment of psychotic disorders. European Society of Pharmacogenomics and Theranostics ESPT-2013. Second Conference. Pharmacogenomics: From Cell to Clinic. Sept 26-28, Lisbon, Portugal (2013).
  • Cacabelos, R. Can Alzheimer's disease be prevented? IX Vaccine Update Conference. Vaccines for global health. Salón de Actos Casa de las Mariposas, Almería, 1-2 October (2012).
  • Cacabelos, R. Pharmacogenomics and Alzheimer's vaccine. XXXI Memorial Lecture. Critical view of cardiovascular prevention: focusing on the determinants of healthy ageing. Fernández-Cruz Foundation. Auditorium of the Hospital Clínico San Carlos, Madrid, 26 Nov (2012).
  • Cacabelos, R. Genomics and Pharmacogenomics of neurodegeneration. Longeva. Congresso Internazionale ECM. Medicina preventiva, predittiva e rigenerativa. Fiera Milano Rho, Milan, 30 Nov- 1 Dec (2012).
  • Aliev, G., Bragin, V., Cacabelos, R. Implication of integrative treatment for real-life geriatric patients with depression, dementia and multiple chronic diseases: A 60-month follow-up of a naturistic study. 5th Clinical Trial are Alzheimer's disease (CTAD) Conference. Monte Carlo, France, Oct 29-31 (2012). J Nutrition Health Ageing 16:840-841 (2012).
  • Cacabelos, R. Nutrigenomics and pharmacogenomics: from theory to practice. VII International Congress on Nutrition, Food and Dietetics. XV National Conference on Practical Nutrition. Spanish Society of Dietetics and Food Sciences. Complutense University, Madrid, 30-31 March- 1 April, 2011. Journal of Practical Nutrition 15:9-10 (2011).
  • Cacabelos, R. Functional genomics and pharmacogenomics of CNS disorders. 10th World Congress of Biological Psychiatry, pp. 100, Prague, 29 May - 2 June, 2011.
  • Fernández-Novoa, L., Cacabelos, R. APOE and CYP2D6 in CNS disorders. European Human Genetics Conference 2011, Amsterdam, 28-31 May, 2011. Eur J Hum Genet 19 (Suppl. 2):284 (2011).
  • Fernández-Novoa, L., Carril, J., Seoane, S., Cacabelos, R. Characterization of the genomic risk profile in cerebrovascular diseases. European Human Genetics Conference 2011, Amsterdam, 28-31 May, 2011. Eur J Hum Genet 19 (Suppl. 2):290 (2011).
  • Fernández-Novoa, L., Seoane, S., Carril, J., García-Agúndez, J.A., Cacabelos, R. LRRK2 mutations in sporadic and familial Parkinson disease. European Human Genetics Conference 2011, Amsterdam, 28-31 May, 2011. Eur J Hum Genet 19 (Suppl. 2):300 (2011).
  • Cacabelos, R. Pharmacogenomics of schizophrenia and lipid metabolism alterations in CNS disorders. 3rd World Congress of Asian Psychiatry 2011. Melbourne, 31 July - 4 August, 2011. Asian Journal of Psychiatry 4(Suppl. 1): 11 (2011).
  • Cacabelos, R., Sánchez, J. Introduction to the World Guide of Pharmacogenomics. VI Annual EuroEspes Conference, Gen-T 8:34-35 (2011).
  • Carril, J.C., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Characterization of the genetic profile of cerebrovascular risk. 6th Annual EuroEspes Conference, Gen-T 8:88 (2011).
  • Carril, J.C., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Polymorphic proinflammatory cytokines as genetic markers of atherosclerosis. 6th Annual EuroEspes Conference, Gen-T 8:88-89 (2011).
  • Canuet, L., Tellado, I., Couceiro, V., Fraile, C., Cacabelos, R. EEG phenotypic profile of functional connectivity and oscillatory activity in Alzheimer's disease. 6th Annual EuroEspes Conference, Gen-T 8:89-90 (2011).
  • Canuet, L., Tellado, I., Corzo, L., Fraile, C., Cacabelos, R. Relationship of APOE genotype and serum LDL-cholesterol levels with brain bioelectrical activity in patients with Alzheimer's disease. 6th Annual EuroEspes Conference, Gen-T 8:90 (2011).
  • Corzo, L., Lombardi, V., Alejo, R., Rodríguez, S., Cacabelos, R. Bioproperties and clinical effects of Juritrofin (DefenVid®). VI Annual EuroEspes Conference, Gen-T 8:91-92 (2011).
  • Corzo, L., Rodríguez, S., Alejo, R., Cacabelos, R. Biological properties of Mineraxin. VI Annual EuroEspes Conference, Gen-T 8:92 (2011).
  • Fernández-Novoa, L., Corzo, L., Seoane, S., Carril, J.C., Cacabelos, R. A genomic approach to histamine function. VI Annual EuroEspes Conference, Gen-T 8:93-94 (2011).
  • Fernández-Novoa, L., Cacabelos, R. Histamine function in brain disorders. VI Annual EuroEspes Conference, Gen-T 8:94 (2011).
  • Lombardi, V.R.M., Carrera, I., Etcheverría, I., Martínez, E., Chacón, R., Cacabelos, R. Prevention of chronic experimental colitis induced by dextran sulphate sodium (DSS) in mice treated with FR-91. VI Annual EuroEspes Conference, Gen-T 8:94-95 (2011).
  • Lombardi, V.R.M., Alejo, R., Etcheverría, I., Pablos, A., Cacabelos, R. Experimental testing of the properties of bioproducts in preparations of Alimentos Naturales, S.A. VI Annual EuroEspes Conference, Gen-T 8:95 (2011).
  • Tellado, I., Canuet, L., Couceiro, V., Fraile, C., Cacabelos, R. Changes in brain bioelectrical activity during aging and cognitive impairment. VI Annual EuroEspes Conference, Gen-T 8:95-96 (2011).
  • Tellado, I., Canuet, L., Fraile, C., Cacabelos, R. Influence of the APOE-4 allele on brain function in healthy elderly. 6th Annual EuroEspes Conference, Gen-T 8:96 (2011).
  • Cacabelos, R. Nutrigenomic component of marine biotechnology products for human Health. 239th American Chemical Society National Meeting & Exposition. San Francisco, USA, March 21-25, pp. TECH-58 (2010).
  • Cacabelos, R. Pharmacogenetics of Alzheimer's disease. XXXIII National Congress of Pharmacology for Students. Universidad Autónoma de Madrid, Madrid, 4-5 May, 2010.
  • Cacabelos, R., Avramopoulos, Baskys, A., Cai, Y. Genetic testing in neuropsychiatry: APOE and beyond. 10th Annual Meeting of the International College of Geriatric Psychoneuropharmacology. The Divani Palace Acropolis Hotel, Athens, 15-18 September, 2010.
  • Cacabelos, R. Genomics and pharmacogenomics of psychotic disorders. VII Congress of the Polish Society of Psychogeriatrics. Wroclaw, 2-3 December, 2010.
  • Álvarez, A., Cacabelos, R., Aleixandre, M., Linares, C., Granizo, E., Doppler, E., Moessler, H. Double-blind clinical trial with cerebrolysin, donepezil and a combination therapy in mild to moderate Alzheimer's disease. Second Joint Congress of GCNN and SSNNN. Vienna, 1-3 March (2009).
  • Cacabelos, R. Pharmacogenomic protocols in CNS disorders and dementia. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 18 (2009).
  • Corzo, L., Rodríguez, S., Fernández-Novoa, L., Laredo, M., Cruceiro, V., Cacabelos, R. Influence of vascular risk factors on cognitive status. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 105 (2009).
  • Fernández-Novoa, L., Seoane, S., Llovo, R., Tudoli, I., Corzo, L., Cacabelos, R. Polygenic risk factors in Alzheimer disease: Calculation of a genetic predisposition store (GPS). 9th International Conference AD/PD 2009, Prague, March 11-15, p. 147 (2009).
  • Carril, J.C., Fernández-Novoa, L., Llovo, R., Cacabelos, R. Logistic regression as a useful tool to explain genetic risk of stroke. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 154 (2009).
  • Fernández-Novoa, L., Llovo Mariño, R., Tudoli, S., Seoane, S., Cacabelos, R. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 155 (2009).
  • Álvarez, A., Sampedro, C., Corzo, L., Cacabelos, R., Aleixandre, M., Vargas, M., Linares, C., Granizo, E. Modulatory effects of cerebrolysin on TNF-alpha and IGF.I in Alzheimer's disease. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 200 (2009).
  • Fernández-Novoa, L., Etcheverría, I., Seoane, S., Cacabelos, R., Lombardi, V. Immune studies in peripheral blood of patients with Alzheimer's disease. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 206 (2009).
  • Álvarez, A., Sampedro, C., Cacabelos, R. Inflammatory biomarkers are associated with low IGF-I levels and disability in Alzheimer's disease. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 208 (2009).
  • Álvarez, A., Sampedro, C., Cruceiro, V., Cacabelos, R., Aleixandre, M., Vargas, M., Linares, C., Granizo, E., Doppler, E., Novak, P., Moessler, H. Cerebrolysin, donepezil and a combination therapy in Alzheimer's disease: Results of a double-blind clinical trial. 9th International Conference AD/PD 2009, Prague, March 11-15, p. 231 (2009).
  • Cacabelos, R. Cancer and neurodegenerative diseases (Ende) as acid-base metabolic opposites. Genetic approach and growth factors in etiopathogenesis and treatment. International Symposium. Proton transport and its inhibition (ITP) in the etiopathogenesis, diagnosis and treatment of cancer. Ramón Areces Foundation, Madrid, 28-29 April (2009).
  • Takeda, M., Shibata, N., Kim, D.K., Cacabelos, R. Pharmacogenomics and nutrigenomics in CNS disorders of the elderly. IPA 2009 International Meeting. Brain Aging and Quality of Life, Rio de Janeiro, Brazil, 4-7 May, (2009).
  • Cacabelos, R. Genomic mechanisms of neurodegeneration: implications for pharmacogenomics and nutrigenomics. The Second Annual Iberian Congress on Anti-Aging Medicine and Biomedical Technologies. Vilamoura-Algarve, Portugal, June 4-6, (2009).
  • Álvarez, A., Sampedro, C., Cacabelos, R., Novak, P., Moessler, H. Opposite effects of cerebrolysin on serum TNF-alpha and IGF-I levels in Alzheimer's disease. Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD). Vienna, 11-16 July (2009).
  • Álvarez, A., Sampedro, C., Cacabelos, R. Overexpression of inflammation markers in Alzheimer's disease: Clinical correlates. Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD). Vienna, 11-16 July (2009).
  • Cacabelos, R. Biomarkers and pharmacogenomics. Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD). Vienna, 11-16 July (2009).
  • Cacabelos, R. Inaugural Conference. III International Congress on Complementary and Alternative Treatments in Cancer. World Association for Cancer Research, Madrid, 31 Oct-1 Nov (2009).
  • Álvarez, X.A., Sampedro, C., Cacabelos, R. Clinical relevance of peripheral inflammatory biomarkers in Alzheimer's disease and vascular dementia. Sixth International Congress on Vascular Dementia, Barcelona, 19-22 Nov (2009).
  • Cacabelos, R. Personalised medicine in the clinical approach to dementia: Pharmacogenomics of Alzheimer's disease. IV Annual EuroEspes Conference. Advances in Genomic Medicine, Coruña, Dec. 19 (2009).
  • Cacabelos, R. Pharmacogenetics of Alzheimer's disease. XXXIII National Congress of Pharmacology for Students. Universidad Autónoma de Madrid, Madrid, 4-5 May, 2010.
  • Cacabelos, R., Avramopoulos, Baskys, A., Cai, Y. Genetic testing in neuropsychiatry: APOE and beyond. 10th Annual Meeting of the International College of Geriatric Psychoneuropharmacology. The Divani Palace Acropolis Hotel, Athens, 15-18 September, 2010.
  • Cacabelos, R. Genomics and pharmacogenomics of psychotic disorders. VII Congress of the Polish Society of Psychogeriatrics. Wroclaw, 2-3 December, 2010.
  • Álvarez, A., Sampedro, C., Couceiro, V., Cacabelos, R., Doppler, E., Hitzl, M., Moessler, H. Cerebrolysin in moderate to moderately severe Alzheimer's disease: Efficacy and safety analysis in a subgroup of a double-blind, placebo-controlled trial. Alzheimer's Association International Conference on Alzheimer's Disease (ICAD). Chicago, July 26-31 (2008).
  • Álvarez, A., Sampedro, C., Cacabelos, R., Linares, C., Granizo, E., Aleixandre, M., Moessler, H. Cerebrolysin reduces TNF-alpha and soluble TNF receptor-1 levels in the serum of Alzheimer disease patients. Alzheimer's Association International Conference on Alzheimer's Disease (ICAD). Chicago, July 26-31 (2008).
  • Álvarez, A., Sampedro, C., Cacabelos, R., Linares, C., Granizo, E., Aleixandre, M., García-Fantini, M. Hyperactivity of peripheral TNF-alpha system in Alzheimer's disease: Interaction with serum IGF-1. Alzheimer's Association International Conference on Alzheimer's Disease (ICAD). Chicago, July 26-31 (2008).
  • Cacabelos, R. Practical management of pharmacogenetics in children and adults. Jornadas Médicas, Hospital Español, Mexico DF, February 16 (2008).
  • Álvarez, A., Sampedro, C., Cacabelos, R., Linares, C., Granizo, E., Aleixandre, M., García-Fantini, M. Hyperactivity of peripheral TNF-alpha system in Alzheimer's disease: Interaction with serum IGF-I. Alzheimer's Association International Conference on Alzheimer's Disease. July 26-31. Alzheimer's & Dementia, 4(Suppl.2):T137 (2008).
  • Álvarez, A., Sampedro, C., Cruceiro, V., Cacabelos, R., Aleixandre, M., Doppler, E., Moessler, H. Cerebrolysin in moderate to moderately severe Alzheimer's disease: a subgroup analysis of efficacy and safety data. 12th Congress of the European Federation of Neurological Societies, Madrid, August 23-26. Eur. J. Neurol., 15(Suppl.3):24 (2008).
  • Cacabelos, R. Pharmacogenomics in CNS Disorders. 51st Annual Meeting of the Japanese Society of Neurochemistry, Sept. 11. Jap Soc Neurochem., 47: 210 (2008).
  • Cacabelos, R. Genotype-related phenotypic expression of biomarkers in dementia: Implications for pharmacogenomics. World Federation of Societies of Biological Psychiatry. 2nd WFSBP Asia-Pacific Congress and 30th Annual Meeting of JSBP. 11-13 Sept. The World Journal of Biological Psychiatry, Vol. 9(Suppl.1):82 (2008).
  • Cacabelos, R. Pharmacogenomics in neurological diseases. XXXII Annual Meeting of the Mexican Academy of Neurology. Puerto Vallarta, 25 Oct. - 1 Nov. (2008).
  • Cacabelos, R. Genomic medicine and pharmacogenomics of neuropsychiatric disorders. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:26-29 (2008).
  • Harguindey S, Díaz de Otazu, R., Arlueca, J., Catalán, J., Arranz, J.L., Orive, G., Reshkin, S.J., Cacabelos, R. Human neurodegenerative diseases (hndds) and cancer: an integral approach to the etiopathogenesis and treatment of hndds within the frame of the trophic factor withdrawal syndrome (TFWS). III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:66 (2008).
  • Martínez, E., Chacón, R., Etcheverría, I., Cacabelos, R., Lombardi, V.R.M. Cytotoxicity effects induced by FR-91 on human tumour cell lines. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:68 (2008).
  • Martínez, E., Chacon, R., Cacabelos, R., Etcheverría, I., Lombardi, V.R.M. Effects of FR-91 on immune cells from healthy individuals and patients with non-Hodgkin lymphoma. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:68 (2008).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Caspase 3 activity in PBMCs from Alzheimer's disease patients: when and why do cells die? III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:69 (2008).
  • Des, J., Pérez, R., Alcaraz, M., Nebril, L., Fernández-Novoa, L., Cacabelos, R. ACE-related blood pressure values in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:69-70 (2008).
  • Des, J., Pérez, R., Alcaraz, M., Nebril, L., Fernández-Novoa, L., Cacabelos, R. ACE-related brain hemodynamic parameters in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:70 (2008).
  • Pérez, R., Des, J., Fraile, C., Fernández-Novoa, L., Corzo, L., Cacabelos, R. FOS-related blood biochemical parameters and brain hemodynamics in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:70 (2008).
  • Pérez, R., Des, J., Fraile, C., Fernández-Novoa, L., Corzo, L., Cacabelos, R. APOE-related blood biochemical parameters and brain hemodynamics in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:71 (2008).
  • Aguilar Aldrete, M.E., Moran Moguel, M.C., Sandoval-Ramírez, L., Rosales-Gómez, R.C., Gutiérrez-Rubio, S.A., Rodríguez-Vega, M.C., Parra Bernal, M.C., Cacabelos, R. Comparative study of APOE polymorphisms in the Mexican population: Alzheimer's disease vs. Indians and mestizos. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:74 (2008).
  • Álvarez, A., Cacabelos, R., Mandler, M., Mattner, F. Mimovax: A novel approach for a safe vaccine for Alzheimer's disease. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:75 (2008).
  • Fraile, C., Martínez, R., Cacabelos-Pérez, N., Corzo, L., Fernández-Novoa, L., Cacabelos-Pérez, R., Cacabelos, R. Presenilin-related biochemical and brain hemodynamic parameters in patients with Alzheimer's disease. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:75-76 (2008).
  • Fraile, C., Llovo, R., Martínez, R., Cacabelos-Pérez, N., Corzo, L., Fernández-Novoa, L., Cacabelos-Pérez, R., Cacabelos, R. CYP2D6-related biochemical and brain hemodynamic parameters in patients with Alzheimer's disease. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:76 (2008).
  • Martínez, R., Cacabelos-Pérez, N., Cacabelos-Pérez, R., Cacabelos, R. CYP genes and drug metabolism: major substrates for antidepressants, neuroleptics and benzodiazepines. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:76-77 (2008).
  • Llovo, R., Tudoli, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Genetic polymorphisms of Cytochrome P450: CYP2D6, CYP2C19, CYP2C9 and CYP3A5 in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:77 (2008).
  • Llovo, R., Fernández-Novoa, L., Seoane, S., Tudoli, I., Cacabelos, R. Pharmacogenetic patterns of CYP2C9 and VKORC1 in the Spanish population. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:78 (2008).
  • Corzo, L., Rodríguez, S., Cacabelos, R. Important role of novel vascular risk factors to decrease vascular risk in patients with dementia. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:78-79 (2008).
  • Carril, J.C., Tudoli, I., Cacabelos, R. IL-6 and IL-6R gene polymorphisms and risk of stroke and neurodegeneration. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:79 (2008).
  • Carril, J.C., Llovo, R., Fernández-Novoa, L., Cacabelos, R. Logistic regression as a useful tool to explain genetic risk of stroke. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:79 (2008).
  • Fernández-Novoa, L., Seoane, S., Llovo, R., Tudoli, I., Cacabelos, R. Vascular genetic risk factors in Alzheimer's disease. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:80 (2008).
  • Tellado, I. Cacabelos, R. Effect of ACE genotype on brain bioelectrical activity. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:80 (2008).
  • Fernández-Novoa, L., Seoane, S., Llovo, R., Tudoli, I., Corzo, L., Cacabelos, R. Polygenic risk factors related to neurodegeneration in Alzheimer's disease: calculation of a genetic predisposition store (GPS). III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:90-81 (2008).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Chronic activation of PBMCS in Alzheimer's disease patients. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:81 (2008).
  • Corzo, L., Rodríguez, S., Fernández-Novoa, L., Laredo, M., Cruceiro, V., Cacabelos, R. Association of novel vascular risk factors and cognitive function in dementia. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:82 (2008).
  • Tellado, I., Cacabelos, R. Impact of APOE genotype on brain bioelectrical activity. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:82-83 (2008).
  • Tellado, I., Fraile, C., Cacabelos, R. Influence of APOE genotype on brain function as assessed by Optical Topography. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:83 (2008).
  • Laredo, M., Couceiro, V., Álvarez, A., Sampedro, C., Cacabelos, R. Neuropsychiatric symptoms and APOE-4 in cognitively impaired patients. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:84 (2008).
  • Álvarez, A., Sampedro, C., Corzo, L., Cacabelos, R. Immuno-trophic regulation in Alzheimer's disease: TNF-ALPHA/IGF-I interactions. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:84 (2008).
  • Martínez, R., Alejo, R., Lombardi, V., Fernández-Novoa, L., Corzo, L., Alcaraz, M., Nebril, L., Casas, A., Fraile, C., Vallejo, A., Cacabelos, R. Nutraceutical properties of E-SAR-94010 (LipoEsar®): APOE-related nutrigenomic profile. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:85 (2008).
  • Martínez, R., Fraile, C., Cacabelos-Pérez, N., Cacabelos-Pérez, R., Fernández-Novoa, L., Corzo, L., Lombardi, V., Tellado, I., Pérez, R., Laredo, M., Cruceiro, V., Álvarez, A., Des, J., Cacabelos, R. APOE-related phenotypic profile in Alzheimer's disease and vascular dementia. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:85-89 (2008).
  • Llovo, R., Fernández-Novoa, L., Tudoli, I., Vallejo, A., Cacabelos, R. Genetic polymorphisms of several genes associated with key metabolic pathways in obesity. III EuroEspes Annual Conference, 1st Meeting World Association of Genomic Medicine, Coruña, Dec. 12-13 (2008). Gen-T/The EuroEspes Journal (International Edition) 2:89-90 (2008).
  • Cacabelos, R. Pharmacogenomics and therapeutic prospects in dementia. Pharmainnovation. Pharmaceutical Innovation. Bonn, 11-12 June (2007).
  • Álvarez, X.A., Linares, C., Aleixandre, M., Cacabelos, R., Hitzl, M. Neurotrophic treatment in Alzheimer's disease: Molecular mechanisms and clinical studies. XII Pan-American Congress of Neurology. Santo Domingo, 7-11 Oct. pp. 16 (2007).
  • Álvarez, X.A., Sampedro, C., García-Fantini, M., Linares, C., Aleixandre, M., Cacabelos, R., Hitzl, M. Functional interaction between TNF-alpha and IGF-I in Alzheimer's disease: Pathogenic and therapeutic implications. XII Pan-American Congress of Neurology. Santo Domingo, 7-11 Oct. pp. 51-52 (2007).
  • Álvarez, X.A., Sampedro, C., Cacabelos, R., Moessler, H. Interaction between TNF-alpha and IGF-I in Alzheimer disease: Pathogenic and therapeutic implications. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1): 334 (2007).
  • Cacabelos, R. Influence of pharmacogenetic factors on Alzheimer's disease. Therapeutics. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1): 4 (2007).
  • Fernández-Novoa, L., Llovo, R., Seoane, S., Bello, A., Rey, P., Corzo, L., Cacabelos, R. Cholesteryl ester transfer protein (CETP) gene and cholesterol metabolism in dementia. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1): 119 (2007).
  • Isaza, C., Henao, J., Llovo, R., Fernández-Novoa, L., Cacabelos, R. Similar pharmacogenetic patterns of CYP2C19 in Spanish and Colombian populations. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1): 138 (2007).
  • Isaza, C., Henao, J., Llovo, R., Fernández-Novoa, L., Cacabelos, R. CYP2D6 in the Spanish population with dementia. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1): 138 (2007).
  • Corzo, L., Fernández-Novoa, L., Rodríguez, S., Cacabelos, R. Vascular risk factors and endothelial NOS3 polymorphism variants in Alzheimer's disease. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1):143-144 (2007).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Lymphocyte subset markers and cytokine production in peripheral blood of patients with AD. 8th International Conference AD/PD, Salzburg, Austria, March 14-18. Neurodegenerative Dis., 4(Suppl.1):229 (2007).
  • Cacabelos, R. Genomic medicine in degenerative diseases and cancer. II International Congress on Complementary and Alternative Treatments in Cancer. Madrid, 26 May (2007).
  • Cacabelos, R. Pharmacogenetics and therapeutic optimization in dementia. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):8-9 (2007).
  • Álvarez, A., Sampedro, C., Cacabelos, R., Moessler, H. Functional interaction of serum tumor necrosis factor-alpha and insulin growth factor-I in Alzheimer's disease. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):300 (2007).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. IL-1beta, IL-6 and TNF-alpha inflammatory cytokines and lymphocyte subset markers in patients with Alzheimer's disease (AD). Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):302-303 (2007).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Inflammatory and immune responses in patients with Alzheimer's disease (AD). Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):303 (2007).
  • Lombardi, V.R.M., Fernández-Novoa, L., Llovo, R., Seoane, S., Corzo, L., Cacabelos, R. Cholesteryl ester transfer protein (CETP) gene and cholesterol in Alzheimer's disease. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):303-304 (2007).
  • Lombardi, V.R.M., Llovo, R., Fernández-Novoa, L., Seoane, S., Henao, J., Cacabelos, R. CYP2D6 in the Spanish population with dementia. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):304 (2007).
  • Lombardi, V.R.M., Llovo, R., Fernández-Novoa, L., Seoane, S., Henao, J., Cacabelos, R. Similar pharmacogenetic patterns of CYP2C19 in Spanish and Colombian populations. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):304-305 (2007).
  • Lombardi, V.R.M., Llovo, R., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Genetic polymorphisms of cytochromes P450: CYP2D6, CYP2C19 and CYP2C9 in Spanish population. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):305 (2007).
  • Corzo, L., Rodríguez, S., Fernández-Novoa, L., Cacabelos, R. Alzheimer's disease-associated peripheral markers are interrelated to lipid metabolism. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):307 (2007).
  • Corzo, L., Rodríguez, S., Fernández-Novoa, L., Cacabelos, R. Endothelial NOS3 polymorphism influence on peripheral vascular markers in Alzheimer's disease. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):307-308 (2007).
  • Tellado, I., Fraile, C., Cacabelos, R. Brain optical topography in Alzheimer's disease and vascular dementia. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):308 (2007).
  • Álvarez, A., Sampedro, C., Cruceiro, V., Cacabelos, R., Aleixandre, M., Moessler, H. Neuropsychiatric symptoms and ApoE-4 in patients with cognitive impairment: Impact on functioning. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):335-336 (2007).
  • Tellado, I., Fraile, C., Cacabelos, R. Impact of ApoE genotype on brain function as assessed by optical topography. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):363 (2007).
  • Tellado, I., Fraile, C., Cacabelos, R. ACE genotype-related changes in brain optical topography. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):363-364 (2007).
  • Corzo, L., Vallejo, A.I., Antelo, A.M., Lombardi, V., Cacabelos, R. E-JUR-94013; a nutraceutical compound with immunomodulatory effects in the elderly. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):416 (2007).
  • Tellado, I., Fraile, C., Cacabelos, R. Brain optical topography patterns in stroke, vascular encephalopathy and migraine. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):426 (2007).
  • Lombardi, V.R.M., Etcheverría, J., Díaz, J., Fernández-Novoa, L., Cacabelos, R. Silver Congress of the International Psychogeriatric Association. Osaka, 14-18 Oct. International Psychogeriatrics, 19(Suppl.1):Add. 5 (2007).
  • Cacabelos, R. Dementia in Europe: Present and future challenges. Aiming for the Communities Living Together with Dementia - In Japan and the World. Aging and Dementia - the States in Japan and Abroad. Osaka International Convention Center, Osaka, 14 Oct. (2007).
  • Álvarez X.A., Sampedro, C., Corzo, L., Cacabelos, R. Alterations of serum TNF-alpha and IGF-I levels in vascular dementia. Fifth International Congress on Vascular Dementia. Budapest, Hungary, Nov 8-11 (2007).
  • Cacabelos, R. Genomic Medicine. International Congress of Biological Medicine. Vanguard Functional Medicine. Autonomous University of Guadalajara, Guadalajara, Mexico; 30 Nov., 2007.
  • Cacabelos, R. Pharmacogenomics applied to clinical neuroscience. II Annual EuroEspes Conference, Coruña, Dec. 15 (2007).
  • Cacabelos, R. Pharmacogenetic aspects of therapy with cholinesterase inhibitors. 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. 19-22 April, Geneva, Neurobiol. Aging, 27 (S1): S4 (2006).
  • Álvarez, A., Laredo, M., Varela, M., Cacabelos, R., Sampedro, C., Aleixandre, M., Linares, C., Moessler, H. Double-blind, placebo-controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease. Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders. Madrid, 15-20 July. Alzheimer's & Dementia, 2(Suppl.1):S364 (2006).
  • Álvarez, A., Corzo, L., Couceiro, V., Sampedro, C., Cacabelos, R. Cerebrolysin reduces the increased levels of serum tumor necrosis factor-alpha in Alzheimer's disease. Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders. Madrid, 15-20 July. Alzheimer's & Dementia, 2(Suppl.1): S370 (2006).
  • Cacabelos, R. Introduction to Genomic Medicine in Neuroscience. I Annual EuroEspes Conference, Coruña, 15 Dec (2006).
  • Fernández-Novoa, L., Seoane, S., Lombardi, V., Cacabelos, R. The influence of genotype on blood lipid parameters in Alzheimer's disease and control subjects. 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 25 (2005).
  • Álvarez, X.A., Cacabelos, R., Moessler, H. Cerebrolysin: Efficacy and safety in moderate to moderately severe Alzheimer's disease- A subgroup analysis of a randomized, double-blind, placebo-controlled trial. 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 46 (2005).
  • Cacabelos, R. Functional genomics and pharmacogenomics of Alzheimer's disease. 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 56 (2005).
  • Álvarez, X.A., Corzo, L., Zas, R., Sampedro, C., Cacabelos, R. Serum TNF-alpha in Alzheimer's disease: Increased levels and negative correlations with IGF-1. 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 120 (2005).
  • Álvarez, X.A., Sampedro, C., Cruceiro, V., Corzo, L., Cacabelos, R., Aleixandre, M., Vargas, M., Linares, C., Granizo, E., Moessler, H. Double-blind, placebo-controlled study of three doses of cerebrolysin in mild to moderate Alzheimer's disease. 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 136 (2005).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Alterations of immune functions and lymphocyte apoptosis in patients with Alzheimer's disease (AD). 7th International Conference AD/PD 2005. Alzheimer's and Parkinson's diseases: Insights, Progress and Perspectives. Sorrento, March 9-13, pp. 170 (2005).
  • Cacabelos, R. Pharmacogenomics studies in Alzheimer's disease: Genotype-related therapeutic response. Joint Meeting of the 27th Annual Meeting of the Japanese Society of Biological Psychiatry (JSBP) and the 35th Annual Meeting of the Japanese Society of Neuropsychopharmacology (JSNP). Osaka, July 6-8, pp. 15, 2005.
  • Cacabelos, R. Pharmacogenetics and pharmacogenomics of CNS disorders. Joint Meeting of the 27th Annual Meeting of the Japanese Society of Biological Psychiatry (JSBP) and the 35th Annual Meeting of the Japanese Society of Neuropsychopharmacology (JSNP). Osaka, July 6-8, pp. 93, 2005.
  • Álvarez, A., Laredo, M., Couceiro, V., Sampedro, C., Cacabelos, R., Illescas, E., Vargas, M. Neuropsychiatric symptoms in Alzheimer's disease versus mild cognitive impairment. XIII World Congress of Psychiatry, Cairo, Egypt, 10-15 Sept. PO1.P259 (2005).
  • Álvarez, A., Cacabelos, R., Laredo, M., Varela, M., Sampedro, C., Aleixandre, M., Illescas, E., Linares, C., Granizo, E., Moessler, H. Cerebrolysin in Alzheimer's disease: a double-blind, placebo-controlled study. XIII World Congress of Psychiatry, Cairo, Egypt, 10-15 Sept. OR22.6 (2005).
  • Álvarez, A., Laredo, M., Couceiro, V., Sampedro, C., Cacabelos, R., Illescas, E., Aleixandre, M. Neuropsychiatric symptoms in vascular dementia: Comparison with AD and mild cognitive impairment. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Álvarez, X.A., Sampedro, C., Cruceiro, V., García, C., Vargas, M., Cuesta, I., Cacabelos, R., Moessler, H. Cognitive improvement and EEG activation by cerebrolysin in vascular dementia: an exploratory study. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Cacabelos, R., Fernández-Novoa, L., Lombardi, V., Tellado, I., Nebril, L., Casas, A., Alcaraz, M., Pichel, V. Structural genomics studies in vascular dementia (VD) and Alzheimer disease (AD): Differential genomic patterns and genetic variation. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Fernández-Novoa, L., Seoane, S., Corzo, L., Lombardi, V.R.M., Cacabelos, R. Genetic risk factors and lipid parameters in dementia. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Corzo, L., Fernández-Novoa, L., Rodríguez, S., Cacabelos, R. Decreased serum nitric oxide levels in vascular dementia. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Peripheral increases in IL-6, lymphocyte apoptosis and immune activation in patients with dementia. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Pichel, V., Tellado, I., Nebril, L., Casas, A., Alcaraz, M., Varela, M., Cacabelos, R. Disease-specific differences in brain hemodynamics in patients with vascular dementia, Alzheimer's disease and Parkinson's disease. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Tellado, I., Pichel, V., Nebril, L., Casas, A., Alcaraz, M., Varela, M., Cacabelos, R. Influence of blood pressure on brain hemodynamics and bioelectrical activity spectral power in vascular dementia, Alzheimer's disease and Parkinson's disease. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Tellado, I., Pichel, V., Cacabelos, R. Brain bioelectrical activity spectral power in vascular dementia, Alzheimer's disease and Parkinson's disease. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Pichel, V., Tellado, I., Nebril, L., Casas, A., Alcaraz, M., Varela, M., Cacabelos, R. Age-related brain hemodynamics in vascular dementia, Alzheimer's disease and Parkinson's disease. Fourth International Congress on Vascular Dementia, Porto, Portugal, 20-23 Oct (2005).
  • Cacabelos, R., Lombardi, V., Kubota, Y., Pichel, V., Fernández-Novoa, L. Increased genetic variation in Alzheimer disease (AD) and no apparent influence of the prion M129V polymorphism on AD pharmacogenomics. Human Genome Meeting (HGM-2004). Berlin, April 4-7, 2004; pp. 63.
  • Fernández-Novoa, L., Corzo, L., Zas, R., Seoane, S., Cacabelos, R. Influence of ACE indel polymorphism on ACE activity and plasma beta-amyloid in dementia. Human Genome Meeting (HGM-2004). Berlin, April 4-7, 2004; pp. 65.
  • Isaza, C., Henao, J., Fernández-Novoa, L., Cacabelos, R. The drug metabolizer CYP2D6 gene in Alzheimer disease. Human Genome Meeting (HGM-2004). Berlin, April 4-7, 2004; pp. 67.
  • Lombardi, V.R.M., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Probable Alzheimer disease and alpha-2-macroglobulin polymorphism. Human Genome Meeting (HGM-2004). Berlin, April 4-7, 2004; pp. 70.
  • Tellado, I., Fernández-Novoa, L., Lombardi, V., Pichel, V., Cacabelos, R. APOE-related phenotypic variation in brain function. Human Genome Meeting (HGM-2004). Berlin, April 4-7, 2004; pp. 75.
  • Cacabelos, R. Genetic variation, functional genomics and pharmacogenomics in Alzheimer disease. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004. Neurobiol. Aging, 25:S4 (2004).
  • Álvarez, A., Corzo, L., Sampedro, C., Cacabelos, R. FERUM insulin-like growth factor I (IGF-I), growth hormone (GH), tumor necrosis factor-alpha (TNF) and interleukin-6 (IL6) in Alzheimer disease (AD) and mild cognitive impairment (MCI) patients. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 36.
  • Álvarez, A., Laredo, M., Sampedro, C., Cacabelos, R. Vargas, M., Illescas, I. Prevalence of neuropsychiatric symptoms (NPS) in a clinical population of APOE-genotyped patients: Alzheimer disease (AD) versus mild cognitive impairment. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 37.
  • Álvarez, A., Varela, M., Sampedro, C., Cruceiro, V., Cacabelos, R., Moessler, H. Positive effects of cerebrolysin in Alzheimer disease (AD): a randomized, double-blind, placebo-controlled trial (RCT). 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 38.
  • Álvarez, A., Cacabelos, R., Moessler, H., Doppler, E. Cerebrolysin in moderate to moderately severe Alzheimer disease (AD): Subgroup analysis of a randomized, double-blind, placebo-controlled trial (RCT). 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 39.
  • Fernández-Novoa, L., Lombardi, V., Seoane, S., Cacabelos, R. Alpha-2-macroglobulin polymorphisms in probable Alzheimer disease. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 58.
  • Fernández-Novoa, L., Corzo, L., Zas, R., Seoane, S., Cacabelos, R. ACE InDel polymorphism, serum ACE activity and plasma beta-amyloid in dementia. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 59.
  • Lombardi, V., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Cellular immune changes in peripheral blood of Alzheimer disease patients. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 85.
  • Lombardi, V., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Activation of immune cells in peripheral blood of Alzheimer disease patients. 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-17, 2004; pp. 86.
  • Cacabelos, R. The pathogenic role of histamine in Alzheimer disease. 33rd Annual Meeting European Histamine Research Society. Düsseldorf/Köln, April 28-May 2, 2004; pp. 30.
  • Álvarez, X.A., Cacabelos, R., Vargas, M., Aleixandre, M., Linares, C., Granizo, E., Moessler, H. Dose-response effects of cerebrolysin in Alzheimer's disease patients: A randomized, double-blind, placebo-controlled trial. XXIV CINP Congress, June 2004. Int. J. Neuropsychopharmacol., 7(Suppl.1): S383 (2004).
  • Lombardi, V., Álvarez, X.A., Echeverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Alterations in percentages of lymphocyte subpopulations in peripheral blood of Alzheimer's disease patients. XXIV CINP Congress, June 2004. Int. J. Neuropsychopharmacol., 7(Suppl.1 : S383 (2004).
  • Álvarez, X.A., Laredo, M., Cruceiro, V., Sampedro, C., Cacabelos, R., Illescas, E., Vargas, M., Moessler, H. Frequency and severity of neuropsychiatric symptoms in Alzheimer's disease and mild cognitive impairment: influence of the APOE genotype. XXIV CINP Congress, June 2004. Int. J. Neuropsychopharmacol., 7(Suppl.1): S384 (2004).
  • Cacabelos, R. Genetics and ageing. International Congress. The Challenge of Ageing 1979-2004. 25 Years of Gerontological Care in Mexico. Mexico DF, 16-18 June, 2004.
  • Cacabelos, R. Pharmacogenomics and ageing. Galisenior. 4th Galician Exhibition of Our Elderly. I European Forum on Ageing. Orense, 21-23 October, 2004.
  • Cacabelos, R. Forum for new bioenterprises. EBIOTEC. BioSpain/Asebio-2003. Madrid, 23-28 Feb. (2003).
  • Cacabelos, R. Genetic variation and pharmacogenomic profiles in Alzheimer disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 3.
  • Álvarez, X.A., Sampedro, C., Cacabelos, R. Central amyloid-beta impairs learning and induces glial activation, neuronal loss and apoptosis in rats. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 16.
  • Álvarez, X.A., Sampedro, C., Cacabelos, R., Windisch, M. AF64A-induced neuronal apoptosis in the septohippocampal area. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 17.
  • Álvarez, X.A., Sampedro, C., Cacabelos, R., Sempere, J.M., Díaz, J. Anapsos reverses beta-amyloid-induced learning impairment, neuronal loss and apoptosis. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 17.
  • Amado, L., Etcheverría, I., Pichel, V., Moreno, A., Cacabelos, R. Age-dependent changes in brain atrophy parameters. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 17.
  • Amado, L., Etcheverría, I., Pichel, V., Moreno, A., Corzo, L., Zas, R., Lombardi, V., Cacabelos, R. Influence of vascular risk factors on brain atrophy. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 17.
  • Lombardi, V.R.M., Díaz, J., Fernández-Novoa, L., Etcheverría, I., Seoane, S., Blanco, A., Cacabelos, R. Regulation of MHC class-I and class-II expression on primary microglial cells by natural compounds. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 28.
  • Pichel, V., Amado, L., Etcheverría, I., Cacabelos, R. Age-dependent cerebrovascular hemodynamic changes. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 33.
  • Pichel, V., Amado, L., Etcheverría, I., Corzo, L., Zas, R., Alcaraz, M., Mulet, E., Rodríguez, S., Cacabelos, R. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 33.
  • Pichel, V., Figueroa, J., Cornes, J.M., Álvarez, X.A., Etcheverría, I., Fernández-Novoa, L., Amado, L., Hernández, A., Varela, M., Cacabelos, R. Cervico-arthrosis is associated with occipital EEG slowing and a poor brain perfusion in women. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 34.
  • Aguilar-Aldrete, M.E., Cacabelos, R., Rosales-Gómez, R.C., Rodríguez-Vera, M.C., Silva-Lepe, Y., Moran-Moguel, M.C. The apolipoprotein E genotype in western Mexican population with Alzheimer disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 54.
  • Álvarez, X.A., Lombardi, V., Sampedro, C., Corzo, L., Zas, R., Pérez, P., Laredo, M., Cruceiro, V., Astoreka, I., Varela, M., Fernández-Novoa, L., Cacabelos, R., Stoeffler, A., Moebius, H.J. Genotype-related reduction of apoptosis in Alzheimer's disease patients treated with memantine. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 54.
  • Isaza, C., Henao, J., Fernández-Novoa, L., Cacabelos, R. The drug metabolizer CYP2D6 gene in Alzheimer disease therapy. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 56.
  • Etcheverría, I., Pichel, V., Amado, L., Fernández-Novoa, L., Lombardi, V., Cacabelos, R. APOE genotype-related brain atrophy in the Spanish population. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 57.
  • Etcheverría, I., Pichel, V., Amado, L., Fernández-Novoa, L., Alcaraz, M., Mulet, E., Rodríguez, S., Cacabelos, R. APOE-related cerebrovascular haemodynamics in the Spanish population. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 57.
  • Fernández-Novoa, L., Lombardi, V.R.M., Corzo, L., Laredo, M., Cruceiro, V., Álvarez, X.A., Cacabelos, R. Association study between DCPI genotype and Alzheimer's disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 58.
  • Kubota, Y., Pichel, V., Fernández-Novoa, L., Lombardi, V., Álvarez, A., Mollet, E., Alcaraz, M., Rodríguez, S., Laredo, M., Cruceiro, V., Amado, L., Etcheverría, I., Cacabelos, R. Combination therapy in Alzheimer disease: A pharmacogenomic study. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 64.
  • Laredo, M., Couceiro, V., Fraile, C., Álvarez, X.A., Sampedro, C., Cacabelos, R. Neuropsychological evaluation of mild degenerative dementia patients: improving the screening capacity of the MMSE. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 65.
  • Pichel, V., Etcheverría, I., Amado, L., Cacabelos, R. Effect of cerebrovascular risk factors on brain haemodynamics in dementia. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 73.
  • Lombardi, V.R.M., Fernández-Novoa, L., Etcheverría, I., Seoane, S., Cacabelos, R. Regulating factors for pathological activation of microglia in Alzheimer's disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 121.
  • Álvarez, X.A., Sampedro, C., Corzo, L., Zas, R., Pérez, P., Pichel, V., Laredo, M., Cruceiro, V., Hernández, A., Varela, M., Figueroa, J., Lombardi, V., Fernández-Novoa, L., Cacabelos, R., Moessler, H. Cerebrolysin improves cognition and brain bioelectrical activity in senile dementia and in traumatic brain injury patients. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 126.
  • Cacabelos, R., Kubota, Y., Pichel, V., Lombardi, V., Mollet, E., Alcaraz, M., Rodríguez, S., Amado, L., Corzo, L., Zas, R., Fernández-Novoa, L., Suárez, J., Pardo, R. E-SAR-94010: A novel pleiotropic compound with age-dependent regulatory activity on lipid metabolism. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 127.
  • Corzo, L., Zas, R., Fernández-Novoa, L., Cacabelos, R. FERUM nitric oxide study in Alzheimer disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 128.
  • Corzo, L., Zas, R., Fernández-Novoa, L., Álvarez, X.A., Laredo, M., Cruceiro, V., Sampedro, C., Rodríguez, S., Cacabelos, R. Study of serum apolipoprotein E in Alzheimer disease. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 128.
  • Fernández-Novoa, L., Corzo, L., Seoane, S., Zas, R., Sampedro, C., Álvarez, X.A., Lombardi, V.R.M., Cacabelos, R. ACE serum activity and I/D genetic polymorphism in elderly subjects. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 129.
  • Lombardi, V.R.M., Fernández-Novoa, L., Etcheverría, I., Seoane, S., Cacabelos, R. Flow cytometry analysis of supressor cell precursor and memory T lymphocytes in the peripheral blood of Alzheimer's disease patients. 6th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD-2003), Seville, May 8-12, 2003; pp. 131.
  • Takeda, M., Cacabelos, R. (Co-chairmen), Yamada, T., Maelick, A., Kurz, A. Roundtable Discussion Meeting on Treatment for Patients with Dementia. Lebrija Room. Hotel Meliá Sevilla, May 12, 2003.
  • Álvarez, X.A., Sampedro, C., Laredo, M., Cruceiro, V., Fernández-Novoa, L., Kubota, Y., Cacabelos, R., Vargas, M. Differential influence of neuropsychiatric symptoms on functional and cognitive decline in mild-moderate Alzheimer's disease. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 41.
  • Isaza, C., Henao, J., Fernández-Novoa, L., Kubota, Y., Cacabelos, R. The drug metabolizer CYP2D6 in Alzheimer's disease. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 42.
  • Lombardi, V., Fernández-Novoa, L., Etcheverría, I., Seoane, S., Kubota, Y., Cacabelos, R. Peripheral blood analysis of CD28-/CD8+ supressor cell precursor and CD45RO+/CD4+ memory T-lymphocytes in patients with Alzheimer's disease. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 42.
  • Fernández-Novoa, L., Corzo, L., Seoane, S., Lombardi, V., Kubota, Y., Cacabelos, R. ACE serum activity and ACE genetic polymorphisms in elderly subjects. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 42.
  • Amado, L., Etcheverría, I., Pichel, V., Kubota, Y., Cacabelos, R. Age-dependent brain atrophy in CNS disorders: A CT-Scan study. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 42-43.
  • Etcheverría, I., Pichel, V., Amado, L., Fernández-Novoa, L., Kubota, Y., Cacabelos, R. Differential brain atrophy profile associated with APOE genotype in CNS disorders. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 43.
  • Pichel, V., Amado, L., Etcheverría, I., Fernández-Novoa, L., Kubota, Y., Cacabelos, R. APOE-related cerebrovascular risk factors and hemodynamics in CNS disorders. World Psychiatric Association. International Thematic Conference. Diagnosis in Psychiatry: Integrating the sciences. Vienna, 19-22 June, 2003; pp. 43.
  • Etcheverría, I., Amado, L., Pichel, V., Cacabelos, R. Age- and APOE-dependent cerebrovascular changes in the Spanish population. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 32.
  • Pichel, V., Amado, L., Etcheverría, I., Cacabelos, R. Age-dependent changes in brain hemodynamic parameters. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 38.
  • Etcheverría, I., Amado, L., Pichel, V., Cacabelos, R. Age-dependent brain atrophy: A CT-Scan study. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 47.
  • Etcheverría, I., Amado, L., Pichel, V., Cacabelos, R. Differential brain atrophy profile associated with the APOE genotype in the Spanish population. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 47.
  • Pichel, V., Amado, L., Etcheverría, I., Cacabelos, R. Vascular risk factors and brain atrophy: A correlation analysis in the Spanish population. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 55.
  • Pichel, V., Amado, L., Etcheverría, I., Fernández-Novoa, L., Laredo, M., Cruceiro, V., Alcaraz, M., Rodríguez, S., Mulet, E., Cacabelos, R. APOE-related cerebrovascular risk factors and hemodynamics in dementia. 6th International Conference on Stroke and 3rd Conference on the Mediterranean Stroke Society. Monte Carlo, March 12-15, 2003; pp. 55.
  • Amado, L., Etcheverría, I., Pichel, V., Fernández-Novoa, L., Lombardi, V.R.M., Cacabelos, R. APOE genotype-related brain atrophy in the Spanish population. First Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG 2003). Göteborg, 2003; pp. 33.
  • Etcheverría, I., Pichel, V., Amado, L., Fernández-Novoa, L., Alcaraz, M., Mulet, E., Rodríguez, S., Cacabelos, R. APOE-related cerebrovascular haemodynamics in the Spanish population. First Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG 2003). Göteborg, 2003; pp. 55.
  • Cacabelos, R., Fernández-Novoa, L., Etcheverría, I., Tellado, I., Kubota, Y., Lombardi, V., Pichel, V.M. APOE-related phenotypic variation in brain bioelectrical activity mapping. First Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG 2003). Göteborg, 2003; pp. 58-59.
  • Pichel, V., Amado, L., Etcheverría, I., Corzo, L., Zas, R., Alcaraz, M., Mulet, E., Rodríguez, S., Cacabelos, R. Vascular risk factor-associated brain hemodynamics. First Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG 2003). Göteborg, 2003; pp. 60-61.
  • Cacabelos, R. Potential role of histamine and cytokine networks in Alzheimer disease and neurodegeneration. 1st International Symposium of Neurobehavioral Pharmacology. Okayama, September 13-15, 2003; pp. 72.
  • Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L., Seoane, S., Cacabelos, R. Chronic activation of immune/inflammatory cells in Alzheimer's disease. VI European Meeting on Glial Cell Function in Health and Disease. Berlin, September 3-6, 2003; P-104.
  • Álvarez, X.A., Laredo, M., Cruceiro, V., Fernández-Novoa, L., Sampedro, C., Cacabelos, R., Vargas, M., Aleixandre, M. Neuropsychiatric symptoms in APOE-genotyped Alzheimer's disease patients: Contributions to diagnosis and prognosis of the disease. 16th Congress of the European College of Neuropsychopharmacology. Prague, September 20-24, 2003. European Neuropsychopharmacology, 13(Suppl.4):S399-S400 (2003).
  • Álvarez, X.A., Sampedro, C., Laredo, M., Cruceiro, V., Pérez, P., Cacabelos, R., Moessler, H., Doppler, E. Effects of cerebrolysin on quantitative EEG activity in elderly controls and in patients with brain damage. 16th Congress of the European College of Neuropsychopharmacology. Prague, September 20-24, 2003. European Neuropsychopharmacology, 13(Suppl.4):S400 (2003).
  • Álvarez, X.A., Sampedro, C., Cacabelos, R. Memory deficits and neuropathology induced by central amyloid-beta injections in rats. 16th Congress of the European College of Neuropsychopharmacology. Prague, September 20-24, 2003. European Neuropsychopharmacology, 13(Suppl.4):S405 (2003).
  • Álvarez, X.A., Lombardi, V., Fernández-Novoa, L., Etcheverría, I., Seoane, S., Cacabelos, R. CD28-/CD8+ supressor cell precursor and CD45RO+/CD4+ memory T lymphocyte expressions in the peripheral blood of Alzheimer's disease patients. 16th Congress of the European College of Neuropsychopharmacology. Prague, September 20-24, 2003. European Neuropsychopharmacology, 13(Suppl.4):S406 (2003).
  • Pichel, V., Etcheverría, I., Amado, L., Kubota, Y., Cacabelos, R. Phenotypic profiles of vascular dementia and Alzheimer disease associated with brain atrophy and cerebrovascular hemodynamics. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 38.
  • Corzo, L., Zas, R., Fernández-Novoa, L., Cacabelos, R. Oxidative and vascular blood markers in dementia. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 43.
  • Etcheverría, I., Pichel, V., Amado, L., Moreno, A., Cacabelos, R. Brain atrophy-associated vascular risk factors. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 47.
  • Etcheverría, I., Pichel, V., Fernández-Novoa, L., Cacabelos, R. Association between different APOE genotypes and cerebrovascular parameters assessed by transcranial Doppler ultrasonography in the Spanish population. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 47.
  • Pichel, V., Etcheverría, I., Corzo, L., Zas, R., Cacabelos, R. Effects of vascular risk factors on brain hemodynamic parameters. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 51.
  • Pichel, V., Etcheverría, I., Cacabelos, R. Age-related cerebrovascular changes in haemodynamic parameters. 3rd International Congress on Vascular Dementia. Prague, October 23-26, 2003; pp. 51.
  • Etcheverría, I., Vallejo, A.I., Lombardi, V.R.M., Corzo, L., Zas, R., Cacabelos, R. Effect of BioKin on biochemical parameters in the blood of rats with dietary supplementation. IX Congress of the Spanish Society of Nutrition. Tenerife, November 26-29, 2003. Nutrición Hospitalaria, XVIII/5:296 (2003).
  • Vallejo, A.I., Etcheverría, I., Lombardi, V.R.M., Cacabelos, R. Effect of BioKin on growth in rats. IX Congress of the Spanish Society of Nutrition. Tenerife, November 26-29, 2003. Nutrición Hospitalaria, XVIII/5:297 (2003).
  • Vallejo, A.I., Lombardi, V., Fernández-Novoa, L., Pichel, V., Amado, L., Cacabelos, R. E-SAR-94010 (LipoEsar): A pleiotropic lipoprotein compound with a potent anti-atheromatous and lipid-lowering effect. IX Congress of the Spanish Society of Nutrition. Tenerife, November 26-29, 2003. Nutrición Hospitalaria, XVIII/5:318 (2003).
  • Etcheverría, I., Vallejo, A.I., Lombardi, V., Corzo, L., Zas, R., Cacabelos, R. BioKin effects on the blood biochemical parameters of rats with a supplemented diet. Nutrition, 19:1052-1053 (2003).
  • Vallejo, A.I., Lombardi, V., Fernández-Novoa, L., Pichel, V., Amado, L., Cacabelos, R. E-SAR-94010 (LipoEsar): A pleiotropic lipoprotein compound with powerful anti-atheromatous and lipid-lowering effects. Nutrition, 19:1066 (2003).
  • Cacabelos, R. Family, work and health. First CEDE International Congress of Directors. Enterpreneurs with values: Directors and the new Europe-America partnership. Madrid Nov. 29-30 (2002).
  • Cacabelos, R. Genomics: Implications for diagnosis and treatment. Aging at XXI century. Thinking the future. Coimbra University Hospitals, Coimbra, 21-23 March, 2002.
  • Cacabelos, R. Workshop "Mild Cognitive Impairment: Concept and Realities". Divonne-les-Bains, France, April 1-2, 2002.
  • Cacabelos, R. Pharmacogenomics and treatment of Alzheimer disease. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 39, 2002.
  • Álvarez, X.A., Sampedro, C., Sempere, J.M., Díaz, J., Cacabelos, R. Antiapoptotic and neuroprotective effects of anapsos in rats with beta-amyloid injections into the hippocampus. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 161, 2002.
  • Álvarez, X.A., Sampedro, C., Pérez, P., Pichel, V., Hernández, A., Varela, M., Figueroa, J., Laredo, M., Couceiro, V., Corzo, L., Moessler, H., Cacabelos, R. Positive effects of cerebrolysin on brain bioelectrical activity and cognitive performance in traumatic brain injury and in senile dementia patients. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 162, 2002.
  • Fernández-Novoa, L., Lombardi, V.R.M., Fondevila, M., Seoane, S., Cacabelos, R. Prion protein gene (PRNP) polymorphisms in Alzheimer disease. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 183, 2002.
  • Lombardi, V.R.M., Fernández-Novoa, L., Etcheverría, I., Cacabelos, R. Cytokine production by human peripheral blood mononuclear cells in Alzheimer disease. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 212, 2002.
  • Pichel, V., Pérez, P., Fernández-Novoa, L., Laredo, M., Couceiro, V., Alcaraz, M., Rodríguez, S., Mulet, E., Cacabelos, R. Cerebrovascular risk factors and hemodynamics in dementia. 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 3-6, pp. 228, 2002.
  • Cacabelos, R., Fernández-Novoa, L., Lombardi, P., Laredo, M., Couceiro, V., Pichel, V., Álvarez, A. Alzheimer Disease-Associated Genes: Genomic Screening in the Spanish Population. Proceedings ELSO 2002, Nice, France, June 29-July 3, pp. 20 (2002).
  • Lombardi, V., Fernández-Novoa, L., Cacabelos, R. Evaluation of TNF-alpha and IL-10 levels in peripheral blood mononuclear cells of Alzheimer patients measured by a cytometric bead array system. Proceedings ELSO 2002, Nice, France, June 29-July 3, pp. 281 (2002).
  • Fernández-Novoa, L., Lombardi, V., Cacabelos, R. Association studies of polymorphisms in the angiotensin converting enzyme gene (ACE) and Alzheimer's disease (AD) in the Spanish population. Proceedings ELSO 2002, Nice, France, June 29-July 3, pp. 294 (2002).
  • Álvarez, A., Sampedro, C., Fernández-Novoa, L., Lombardi, V., Cacabelos, R. Amyloid beta-induced neurodegeneration in vivo: An experimental model to test potential anti-dementia drugs. Proceedings ELSO 2002, Nice, France, June 29-July 3, pp. 308 (2002).
  • Álvarez, A., Cacabelos, R., Fernández-Novoa, L., Lombardi, V. Pharmacogenomics and treatment of Alzheimer's disease. XXIIIrd CINP Congress, June 23-27, Montréal, Canada, P.1. Intern. J. Neuropsychopharmacol., 5(Suppl.1):S90 (2002).
  • Álvarez, A., Fernández-Novoa, L., Lombardi, V.R.M., Fondevila, M., Seoane, S., Cacabelos, R. M129V polymorphism at the PRNP gene and Alzheimer's disease in the Spanish population. XXIIIrd CINP Congress, June 23-27, Montréal, Canada, P.2. J. Neuropsychopharmacol., 5(Suppl.1):S118 (2002).
  • Álvarez, A., Cacabelos, R., Fernández-Novoa, L., Lombardi, V., Pérez, P., Laredo, M., Couceiro, V., Alcaraz, M., Rodríguez, S., Sampedro, C., Pichel, V. Genomic screening of Alzheimer's disease-associated genes in the Spanish population. XXIIIrd CINP Congress, June 23-27, Montréal, Canada, P.2. J. Neuropsychopharmacol., 5(Suppl.1):S117 (2002).
  • Álvarez, A., Cacabelos, R., Pichel, V., Pérez, P., Fernández-Novoa, L., Laredo, M., Couceiro, V., Alcaraz, M., Rodríguez, S., Mulet, E., Sampedro, C., Lombardi, V. Cerebrovascular risk factors and hemodynamics in dementia. XXIIIrd CINP Congress, June 23-27, Montréal, Canada, P.1. Intern. J. Neuropsychopharmacol., 5(Suppl.1):S89 (2002).
  • Álvarez, A., Sampedro, C., Pérez, P., Pichel, V., Hernández, A., Varela, M., Figueroa, J., Laredo, M., Couceiro, V., Corzo, L., Moessler, H., Cacabelos, R. Cerebrolysin improves brain bioelectrical activity pattern and cognitive functioning in traumatic brain injury and in senile dementia. XXIIIrd CINP Congress, June 23-27, Montreal, Canada, P.1. J. Neuropsychopharmacol., 5(Suppl.1):S92 (2002).
  • Álvarez, A., Sampedro, C., Sempere, J.M., Díaz, J., Cacabelos, R. Central beta-amyloid impairs learning and induces neuronal degeneration and apoptosis in rats: Neuroprotective effects of Anapsos. XXIIIrd CINP Congress, June 23-27, Montreal, Canada, P.3. Intern. J. Neuropsychopharmacol., 5(Suppl.1):S177 (2002).
  • Cacabelos, R. Advances in molecular biology, genetics and neurochemistry of schizophrenia. II International Congress ARAPDIS & IX Congress Mediterranean Social Psychiatrie (MESPA), Barcelona, May 26-30 (2002).
  • Cacabelos, R., Artigas, F., Fañanas, L., Bulbena, A., Taboada, A. Aetiopathogenic bases of schizophrenia: Genetics, molecular biology, neurochemistry and neuropharmacology. II International Congress ARAPDIS & IX Congress Mediterranean Social Psychiatrie (MESPA), Barcelona, May 26-30 (2002).
  • Álvarez, A., Sampedro, C., Sempere, J.M., Díaz, J., Cacabelos, R. Anapsos reverses the neurotoxic effects of central beta-amyloid injections in rats: Behavioral and morphological evaluations. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S97 (2002).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R., Quack, G. Memantine prevents beta-amyloid-induced neurotoxicity and learning impairment in rats. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S102 (2002).
  • Cacabelos, R., Álvarez, A., Pérez, P., Laredo, M., Couceiro, V., Alcaraz, M., Rodríguez, S., Pichel, V. Multifactorial therapy in vascular dementia and Alzheimer disease. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S121 (2002).
  • Lombardi, V., Fernández-Novoa, L., Cacabelos, R. Increased TNF-alpha and IL-10 production by human peripheral blood mononuclear cells in Alzheimer's disease measured by a cytometric bead array system. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S229 (2002).
  • Cacabelos, R., Fernández-Novoa, L., Lombardi, V., Pérez, P., Laredo, M., Couceiro, V., Alcaraz, M., Rodríguez, S., Pichel, V., Álvarez, A. Genomic screening of Alzheimer's disease-associated genes in the Spanish population. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S318 (2002).
  • Fernández-Novoa, L., Lombardi, V., Seoane, S., Cacabelos, R. M129V polymorphism at the PRNP gene in Alzheimer's disease. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S320 (2002).
  • Fernández-Novoa, L., Lombardi, V., Seoane, S., Cacabelos, R. Angiotensin converting enzyme gene polymorphism (ACE) and Alzheimer's disease (AD) in the Spanish population. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002. Neurobiol. Aging, 23(Suppl.1):S346 (2002).
  • Cacabelos, R., Fernández-Novoa, L., Lombardi, V., Takeda, M. Genomic variation and pharmacogenomic studies in Alzheimer disease. XII World Congress of Psychiatry. Yokohama, August 24-29, pp. 111 (2002).
  • Takeda, M., Cacabelos, R., Ray, O., Forstl, H., Hoon Oh, B. International situation of diagnosing dementia and the direction of future study. Cognition and Dementia. Round Table Discussion. Yokohama, August 27 (2002).
  • Cacabelos, R. Genomic screening, genetic variation and pharmacogenomics in Alzheimer disease. International Symposium "Molecular Neurobiology of Alzheimer Disease and Related Disorders". Osaka Sun Palace Hotel, Osaka, October 5; Dementia Japan 16:83 (2002).
  • Fernández-Novoa, L., Lombardi, V., Seoane, S., Cacabelos, R. Distribution of APOE genotypes in CNS disorders in the Spanish population. Am. J. Med. Genet., 114/7:789 (2002).
  • Cacabelos, R., Lombardi, V., Fernández-Novoa, L. Genomic variation in Alzheimer disease. Am. J. Med. Genet., 114/7:829 (2002).
  • Fernández-Novoa, L., Lombardi, V.R.M., Fondevila, M., Seoane, S., Cacabelos, R. Association study of M129V polymorphism at the PRNP gene in Alzheimer disease. Am. J. Med. Genet., 114/7:829-830 (2002).
  • Álvarez, A., Sampedro, C., Cacabelos, R. Effects of central beta-amyloid on learning, glial activation, neuronal degeneration and apoptosis in rats. 6th Congress of the European Federation of Neurological Societies. Vienna, October 26-29, 2002. Eur. J. Neurol., 9(Suppl.2):158-159 (2002).
  • Álvarez, A., Sampedro, C., Corzo, L., Pérez, P., Pichel, V., Laredo, M., Hernández, A., Varela, M., Figueroa, J., Cacabelos, R., Windisch, M., Moessler, H. . 6th Congress of the European Federation of Neurological Societies. Vienna, October 26-29, 2002. Eur. J. Neurol., 9(Suppl.2):198 (2002).
  • Cacabelos, R., Fernández-Novoa, L., Álvarez, X.A., Lombardi, V. Distribution of polygenic genotypes in Alzheimer disease (AD): Genomic screening of AD-associated genes. Eur. Neuropsychopharmacol., 11(Suppl.1):S15 (2001).
  • Cacabelos, R., Fernández-Novoa, L., Álvarez, X.A., Lombardi, V. Pharmacogenomic studies in Alzheimer disease with a multifactorial treatment. Eur. Neuropsychopharmacol., 11(Suppl.1):S15 (2001).
  • Fernández-Novoa, L., Lombardi, V., Pérez-Herrera, S., Cacabelos, R. Angiotensin-converting enzyme I/D polymorphism in polygenic disorders. Eur. Neuropsychopharmacol., 11(Suppl.1):S16 (2001).
  • Izasa, C., Henao, J., López, A.M., Cacabelos, R. CYP2D6 allelic variants in the Colombian population. Eur. Neuropsychopharmacol., 11(Suppl.1):S16 (2001).
  • Cacabelos, R. Biotechnological innovation and business initiative. GALIEMPREGO 2001. III Training and Employment Fair. Xunta de Galicia, Santiago de Compostela, 15-17 May, 2001.
  • Cacabelos, R. Immune function, cytokines and apoptosis in Alzheimer disease: Implications for drug monitoring and pharmacogenomics. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; A-5-4, pp. 13 (2001).
  • Fernández-Novoa, L., Lombardi, V., Álvarez, X.A., Corzo, L., Pérez-Herrera, S., Sampedro, C., Zas, R., Cacabelos, R. Alpha 2-macroglobulin polymorphisms in early- and late-onset Alzheimer's disease. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-15, pp. 39 (2001).
  • Fernández-Novoa, L., Lombardi, V., Álvarez, X.A., Corzo, L., Pérez-Herrera, S., Sampedro, C., Zas, C., Cacabelos, R. Angiotensin-converting enzyme I/D polymorphism in multifactorial human diseases. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-16, pp. 39 (2001).
  • Laredo, M., Couceiro, V., Pérez, P., Álvarez, X.A., Cacabelos, R. Senile Dementia-Associated Sleep Disorders Scale (SDASDS). New data on the validation of the Sleep-Related Subscale. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-31, pp. 43 (2001).
  • Pérez, P., Laredo, M., Álvarez, X.A., Cacabelos, R. Fronto-temporal brain bioelectrical activity theta correlates with hallucinations in Alzheimer disease. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-32, pp. 43 (2001).
  • Álvarez, X.A., Sampedro, C., Lozano, R., Secades, J., Cacabelos, R. Citicoline reduces neuronal degeneration and apoptosis induced by -amyloid and hypoperfusion in rats. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-51, pp. 48 (2001).
  • Álvarez, X.A., Sampedro, C., Lombardi, V., Fernández-Novoa, L., Cacabelos, R., Moessler, H., Windisch, M. Procognitive, immunomodulatory and neurotrophic activities of Cerebrolysin in an animal model of hippocampal degeneration. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; III-AD-55, pp. 49 (2001).
  • Corzo, L., Zas, R., Fernández-Novoa, L., Álvarez, X.A., Lombardi, V., Cacabelos, R. Vitamin B12 and folate deficiency in dementia. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-06, pp. 93 (2001).
  • Corzo, L., Zas, R., Fernández-Novoa, L., Álvarez, X.A., Lombardi, V., Cacabelos, R. Thyroid function study in dementia. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-07, pp. 93 (2001).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Fernández-Novoa, L., Corzo, L., Zas, R., Alcaraz, M., Sampedro, C., Cacabelos, R., Secades, J., Lozano, R. Citicoline improves cognitive performance, brain bioelectrical activity and cerebral perfusion in APOE-genotyped Alzheimer disease patients. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-26, pp. 98 (2001).
  • Álvarez, X.A., Lombardi, V., Corzo, L., Pérez, P., Pichel, V., Laredo, M., Hernández, A., Freixeiro, F., Varela, M., Sampedro, C., Alcaraz, M., Rodríguez, S., Cacabelos, R., Windisch, M., Moessler, H. Oral Cerebrolysin in elderly humans: Effects on memory and brain bioelctrical activity. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-27, pp. 98 (2001).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Corzo, D., Sampedro, C., Zas, R., Fernández-Novoa, L., Cacabelos, R., Sempere, J.M., Díaz, J. Procognitive and neurobiological effects of anapsos in senile dementia: A double-blind and placebo-controlled study. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-28, pp. 98 (2001).
  • Lombardi, V.R.M., Fernández-Novoa, L., Álvarez, X.A., Corzo, L., Zas, R., Cacabelos, R. Peripheral immune dysfunction in Alzheimer disease. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-37, pp. 100 (2001).
  • Cacabelos, R., Fernández-Novoa, L., Álvarez, X.A., Corzo, L., Laredo, M., Pérez, P., Pichel, V., Lombardi, V. Multifactorial treatment and pharmacogenomics in Alzheimer disease. The 5th International Conference on Progress in Alzheimer's and Parkinson's disease. Kyoto, March 31-April 5, 2001; V-AD-46, pp. 103 (2001).
  • Cacabelos, R. Psychogeriatric research: Strategies and development. 16th Jap. Congr. Psychogeriatrics. Osaka, 13-15 June, 2001.
  • Cacabelos, R. Prospective treatments in Alzheimer disease. 16th Jap. Congr. Psychogeriatrics. Osaka, 13-15 June, 2001.
  • Cacabelos, R. Acetylcholinesterase inhibitors as a factor of hope in the treatment of Alzheimer's disease. The Elderly in the Year 2000. Old are the Rags. Auditorium of the Hospitals of the University of Coimbra. Portuguese Association of Gerontopsychiatry. Coimbra, 20-22 January (2000).
  • Cacabelos, R. Genetics of Alzheimer's disease. Workshop University of Coimbra. 22 January (2000).
  • Cacabelos, R. Advances in the aetiology of dementias. VII National Congress. Colombian Association of Biological Psychiatry. Pereira, Colombia, 18-19 March (2000).
  • Cacabelos, R. Pharmacogenetics of dementias. VII National Congress. Colombian Association of Biological Psychiatry. Pereira, Colombia, 18-19 March (2000).
  • Cacabelos, R., Fernández-Novoa, L., Lombardi, V., Álvarez, X.A. Genotype-specific apoptosis and therapeutic response in Alzheimer disease: Implications for drug design and clinical trials. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 41 (2000).
  • Álvarez, X.A., Fernández-Novoa, L., De Olano, M., Sampedro, C., Lombardi, V., Windisch, M., Cacabelos, R. Cerebrolysin exerts neuroimmunotrophic and neuroprotective effects in an animal model of hippocampal neurodegeneration. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 197 (2000).
  • Álvarez, X.A., Lombardi, V.R.M., Corzo, L., Pérez, P., Pichel, V., Laredo, M., Hernández, A., Freixeiro, F., Sampedro, C., Lorenzo, R., Alcaraz, M., Windisch, M., Cacabelos, R. Oral Cerebrolysin potentiates brain alpha activity and improves memory in elderly humans. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 197 (2000).
  • Álvarez, X.A., Sampedro, C., Lozano, R., Secades, J., Cacabelos, R. Citicoline protects hippocampal neurons against apoptosis induced by brain -amyloid deposits plus cerebral hypoperfusion in rats. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 198 (2000).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Corzo, L., Zas, R., Fernández-Novoa, L., Sempere, J.M., Díaz, J., Cacabelos, R. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: Effects on cognition, brain electrical activity and cerebral hemodynamics. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 198 (2000).
  • Cacabelos, R., Álvarez, X.A., Laredo, M., Couceiro, V., Anido, R., Pérez, P., Pichel, V., Corzo, L., Zas, R., Alcaraz, M., García, M., Rodríguez, S., Freixeiro, F., Figueroa, J., Hernández, M.A., Lombardi, V., Fernández-Novoa, L. Cognitive performance in dementia patients during a 4-year follow-up with a neuroprotective multifactorial treatment: Comparative effects for prevention in subjects at risk. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 201 (2000).
  • Cacabelos, R., Moreno, A., Caamaño, J.M., López, S., Pérez, P., Pichel, V., Laredo, M., Couceiro, V., Anido, R., Corzo, L., Zas, R., Alcaraz, M., Rodríguez, S., Hernández, M.A., Álvarez, X.A., Lombardi, V., Fernández-Novoa, L. Cognitive function and brain atrophy in dementia: A psychomorphometric correlation analysis. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 202 (2000).
  • de Olano, M., Fernández-Novoa, L., Mesa, M.D., Corzo, L., Cacabelos, R. Different allele frequency distribution in angiotensin-converting enzyme I/D polymorphism and angiotensinogen M235T polymorphism in dementia. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 205 (2000).
  • Fernández-Novoa, L., De Olano, M., Mesa, M.D., Cacabelos, R. Alpha-2 macroglobulin V1000I and insertion-deletion polymorphisms in Alzheimer's disease. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 208 (2000).
  • Fernández-Novoa, L., de Olano, M., Mesa, M.D., Corzo, L., Lombardi, V., Álvarez, X.A., Cacabelos, R. Identification of two novel mutations in the amyloid precursor protein (APP) gene. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 208 (2000).
  • Lombardi, V.R.M., Fernández-Novoa, L., Sampedro, C., De Olano, M., Álvarez, X.A., Cacabelos, R. Overexpression of FAS/CD95 in spontaneous and induced apoptosis in lymphocytes from Alzheimer's disease patients. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, April 5-8, pp. 217 (2000).
  • Cacabelos, R. Review of research in geriatric psychiatry. American Society of Hispanic Psychiatry and University of Chicago of Illinois at Chicago. Hispanic American Day at the APA Annual Meeting. May 13 (2000).
  • Álvarez, X.A., Lombardi, V.R.M., Fernández-Novoa, L., García, M., Sampedro, C., Cagiao, A., Windisch, M., Moessler, H., Cacabelos, R. Cerebrolysin reduces microglia activation in vivo and in vitro: A potential neuroprotection mechanism. Neuroinflammation in Alzheimer's Disease. A Neurobiology of Aging Conference. Washington DC, 7-8 July, pp. 2.06 (2000).
  • Lombardi, V.R.M., Álvarez, X.A., Fernández-Novoa, L., García, M., Sampedro, C., de Olano, M., Cacabelos, R. Regulation of brain immunity: A central role played by -amyloid and IL-1 in microglial cells. Neuroinflammation in Alzheimer's Disease. A Neurobiology of Aging Conference. Washington DC, 7-8 July, pp. 2.07 (2000).
  • Lombardi, V.R.M., Álvarez, X.A., Fernández-Novoa, L., de Olano, M., Corzo, L., Sampedro, C., Cacabelos, R. One year "plateau-phase" in microglial cell cultures. Neuroinflammation in Alzheimer's Disease. A Neurobiology of Aging Conference. Washington DC, 7-8 July, pp. 2.08 (2000).
  • Cacabelos, R., Sampedro, C., Álvarez, X.A. Citicoline exerts antiapoptotic effects in an animal model of hippocampal neurodegeneration. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S87 (2000).
  • Lombardi, V., Cacabelos, R., Pérez, P., Laredo, M., Moessler, H., Hernández, A., Windisch, M., Álvarez, X.A. Cerebrolysin improves memory performance and the brain bioelectrical activity pattern in elderly humans. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S157 (2000).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Corzo, L., Zas, R., Fernández-Novoa, L., Cacabelos, R. Dose-dependent effects of Anapsos in senile dementia patients: A double-blind, randomized, placebo-controlled study. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S218 (2000).
  • Mesa, M.D., Fernández-Novoa, L., de Olano, M., Cacabelos, R. Allele frequency of alpha-2 macroglobulin V1000I and insertion-deletion polymorphism in Alzheimer's disease patients. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S250 (2000).
  • Fernández-Novoa, L., Mesa, M.D., Corzo, L., de Olano, M., Cacabelos, R. Two novel mutations in the amyloid precursor protein (APP) gene. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S250 (2000).
  • De Olano, M., Fernández-Novoa, L., Mesa, M.D., Corzo, L., Cacabelos, R. Angiotensin-converting enzyme I/D polymorphism and ansiotensinogen M235T polymorphism in dementia: A genetic study. World Alzheimer Congress 2000. Washington DC, July 9-13, pp. S250 (2000).
  • Lombardi, V.R.M., Álvarez, X.A., Fernández-Novoa, L., de Olano, M., Perea, L., Daniele, D., Cacabelos, R. Regulation of MHC class-I and class-II expression and neuronal death by citicoline. IV European Meeting on Glial Cell Function in Health and Disease. Barcelona, 24-27 May, pp. 100 (2000).
  • Lombardi, V.R.M., Álvarez, X.A., Sampedro, C., Miguel-Hidalgo, J.J., Quack, G., Cacabelos, R. Modulation of A(1-40)-induced neurodegeneration in the CA1 subfield by memantine. IV European Meeting on Glial Cell Function in Health and Disease. Barcelona, 24-27 May, pp. 100 (2000).
  • Lombardi, V.R.M., Álvarez, X.A., Sampedro, C., Cacabelos, R. Cerebrolysin-regulated microglial function through the modulation of proinflammatory cytokines. IV European Meeting on Glial Cell Function in Health and Disease. Barcelona, 24-27 May, pp. 107 (2000).
  • Álvarez, X.A., de Olano, M., Sampedro, C., Lombardi, V., Moessler, H., Windisch, M., Cacabelos, R. Cerebrolysin protects against neurodegeneration induced by -amyloid in rats. XXIInd CINP Congress, Brussels, 9-13 July, pp. S359 (2000).
  • Álvarez, X.A., Lombardi, V.R.M., Corzo, L., Zas, R., Pérez, P., Pichel, V., Laredo, M., Hernández, A., Freixeiro, F., Sampedro, C., Lorenzo, R., Alcaraz, M., Moessler, H., Windisch, M., Cacabelos, R. Oral Cerebrolysin accelerates the brain bioelectrical activity pattern and enhances memory performance in elderly humans. XXIInd CINP Congress, Brussels, 9-13 July, pp. S359 (2000).
  • Álvarez, X.A., Sampedro, C., Lozano, R., Secades, J., Cacabelos, R. Citicoline protects neurons against apoptosis induced by deposits of -amyloid into the hippocampus plus cerebral hypoperfusion in rats. XXIInd CINP Congress, Brussels, 9-13 July, pp. S359 (2000).
  • Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L., Mesa, M., Olano, M., Laredo, M., Pichel, V., Pérez, P., Corzo, L., Lombardi, V. Genotype-related therapeutic response in Alzheimer's disease: A pharmacogenomic approach. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 31 (2000).
  • Álvarez, X.A., Lombardi, V.R.M., Fernández-Novoa, L., García, M., Sampedro, C., Cagiao, A., Windisch, M., Moessler, H., Cacabelos, R. Cerebrolysin reduces microglia activation in vivo and in vitro. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 177 (2000).
  • Álvarez, X.A., Lombardi, V., Corzo, L., Pérez, P., Pichel, V., Laredo, M., Hernández, A., Freixeiro, F., Sampedro, C., Lorenzo, R., Alcaraz, M., Windisch, M., Moessler, H., Cacabelos, R. Cerebrolysin improves memory and induces brain bioelectrical activation in elderly humans after a single oral administration. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 177 (2000).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Corzo, D., Zas, R., Fernández-Novoa, L., Sempere, J.M., Díaz, J., Cacabelos, R. Effects of anapsos on cognition, brain bioelectrical activity and cerebral hemodynamics in senile dementia: A double-blind, randomized, placebo-controlled study. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 125 (2000).
  • Álvarez, X.A., Mouzo, R., Pichel, V., Pérez, P., Laredo, M., Fernández-Novoa, L., Corzo, L., Zas, R., Alcaraz, M., Secades, J.J., Lozano, R., Cacabelos, R. Effects of citicoline on cognitive performance, brain bioelectrical activity and cerebral perfusion in APOE-genotyped Alzheimer's disease patients. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 176 (2000).
  • Álvarez, X.A., Sampedro, C., Lozano, R., Secades, J., Cacabelos, R. Neuroprotective and antiapoptotic effects of citicoline in rats with hippocampal degeneration induced by -amyloid and hypoperfusion. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 176 (2000).
  • Álvarez, X.A., Miguel-Hidalgo, J.J., Quack, G., Cacabelos, R. Memantine protects against neuronal degeneration induced by A(1-40) in the CA1 subfield of the rat hippocampus. VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Florence, 15-20 July, 2000. British J. Clin. Pharmacol., pp. 176 (2000).
  • Fernández-Novoa, L., de Olano, M., Mesa, M.D., Cacabelos, R. Alpha-2 macroglobulin polymorphism in Alzheimer's disease. Eighth World Congress of Psychiatric Genetics. Versailles, 27-31 August, pp. 522 (2000).
  • de Olano, M., Fernández-Novoa, L., Mesa, M.D., Corzo, L., Cacabelos, R. Association between ACE I/D and APOE polymorphisms in different kinds of dementia. Eighth World Congress of Psychiatric Genetics. Versailles, 27-31 August, pp. 522 (2000).
  • Fernández-Novoa, L., de Olano, M., Mesa, M.D., Corzo, L., Cacabelos, R. Identification of two novel mutations in the amyloid precursor protein (APP) gene. Eighth World Congress of Psychiatric Genetics. Versailles, 27-31 August, pp. 522 (2000).
  • Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L., Mesa, M.D., Olano, M., Laredo, M., Pichel, V., Pérez, P., Corzo, L., Lombardi, V. A pharmacogenomic approach to Alzheimer disease treatment. Eighth World Congress of Psychiatric Genetics. Versailles, 27-31 August, pp. 541 (2000).
  • Cacabelos, R. Hypertension and dementia. VII Congress of the Galician Society of Arterial Hypertension. Sada, La Coruña, Sept. 8-9 (2000).
  • Corzo, L., Álvarez, X.A., Zas, R., Rodríguez, S., Pérez, P., Cacabelos, R. Blood pressure, lipid and glucose levels in patients with senile dementia: Correlation study. VII Congress of the Galician Society of Arterial Hypertension. Sada, La Coruña, Sept. 8-9, pp. 596 (2000).
  • Álvarez, X.A., Mouzo, R., Pichel, V., Laredo, M., Pérez, P., Couceiro, V., Corzo, L., Zas, R., Varela, M., Sampedro, C., Fernández-Novoa, L., Mesa, M.D., De Olano, M., Cacabelos, R. Blood pressure and apolipoprotein E (APOE) genotype in senile dementia. VII Congress of the Galician Society of Arterial Hypertension. Sada, La Coruña, Sept. 8-9, pp. 600 (2000).
  • Fernández-Novoa, L., Corzo, L., de Olano, M., Cacabelos, R. Study of ACE and AGT gene polymorphisms in dementia and arterial hypertension. VII Congress of the Galician Society of Arterial Hypertension. Sada, La Coruña, Sept. 8-9, pp. 600 (2000).
  • Cacabelos, R. Update in Alzheimer therapeutics. Pfizer CNS Symposium. Dementia hoje... o olhar no futuro. Funchal, Madeira, Portugal. 23 Sept. (2000).
  • Cacabelos, R. Genetics of schizophrenia and psychotic syndrome. XVIII Venezuelan Congress of Psychiatry "Dr. Mauro Villegas". Psychiatry of the New Millennium. Hotel Radisson Plaza Eurobuilding, Caracas, 18-21 October 2000.
  • Cacabelos, R. Pharmacogenetics of Alzheimer's disease. XVIII Venezuelan Congress of Psychiatry "Dr. Mauro Villegas". Psychiatry of the New Millennium. Hotel Radisson Plaza Eurobuilding, Caracas, 18-21 October 2000.
  • Cacabelos, R. Genomics: Diagnostic and therapeutic implications. International Symposium. Towards a Gerontological Society. University of Oviedo and Ramón Areces Foundation, Oviedo, 21-22 November, 2000.
  • Fernández-Novoa, L., Mesa, M.D., Álvarez, X.A., Cacabelos, R. Genetic associations and risk factors in Alzheimer's disease. Neurological Restoration '99, CIREN, Havana, 23-25 Feb., pp. 60 (1999).
  • Álvarez, X.A., Sampedro, C., Cacabelos, R. Antiapoptotic effects of CDP-choline in a combined (hypoperfusion + -amyloid) animal model of hippocampal neurodegeneration. Neurological Restoration '99, CIREN, Havana, 23-25 Feb., pp. 58 (1999).
  • Álvarez, X.A., Fernández-Novoa, L., Sampedro, C., Lombardi, V., Cacabelos, R., Windisch, M. Neuroimmunotrophic effects of cerebrolysin in an animal model of neurodegeneration induced by -amyloid. Neurological Restoration '99, CIREN, Havana, 23-25 Feb., pp. 58-59 (1999).
  • Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L., Lombardi, V. Basic mechanisms of neuroprotection and genotype-related therapeutic response in Alzheimer's disease: Implications for active treatment and prevention in dementia. Neurological Restoration '99, CIREN, Havana, 23-25 Feb., pp. 56 (1999).
  • Álvarez, X.A., Fernández-Novoa, L., Sampedro, C., Lombardi, V., Cacabelos, R., Windisch, M. Cerebrolysin reverses learning impairment and brain neuroimmune activation in an animal model of neurodegeneration induced by -amyloid. Keystone Symposia on Molecular & Cellular Biology. Molecular Mechanisms in Alzheimer's Disease. Taos, New Mexico, March 3-9, pp. 48 (1999).
  • Lombardi, V.R.M., García, M., Rey, L., Cacabelos, R. Peripheral immunological abnormalities and lymphocyte dysfunction in Alzheimer disease. Keystone Symposia on Molecular & Cellular Biology. Molecular Mechanisms in Alzheimer's Disease. Taos, New Mexico, March 3-9, pp. 52 (1999).
  • Fernández-Novoa, L., Lombardi, V., Mesa, M.D., Cacabelos, R. Genetic risk factors in Alzheimer disease and vascular dementia in the Spanish population. Keystone Symposia on Molecular & Cellular Biology. Molecular Mechanisms in Alzheimer's Disease. Taos, New Mexico, March 3-9, pp. 35 (1999).
  • Cacabelos, R., Mesa, M.D., Fernández-Novoa, L. Association between genotypes and risk factors in Alzheimer's disease. Keystone Symposia on Molecular & Cellular Biology. Molecular Mechanisms in Alzheimer's Disease. Taos, New Mexico, March 3-9, pp. 35 (1999).
  • Cacabelos, R. Genetics of Alzheimer's disease. Molecular and Predictive Diagnosis of Familial Risk. APAL North-South Regional Symposium. Psychiatric Association of Latin America. Margarita Island, Venezuela. Nov. 23-27, pp. 54-55 (1999).
  • Cacabelos, R. Pharmacological treatment of senile dementia. APAL North-South Regional Symposium. Psychiatric Association of Latin America. Margarita Island, Venezuela. Nov. 23-27, pp. 70-71 (1999).
  • Laredo, M., Couceiro, V., Pérez, P., Anido, R., Figueroa, J., García, E., Mantiñán, N.P., Álvarez, X., Cacabelos, R. Neurorehabilitation in cranioencephalic traumatisms. I National Congress of Clinical and Health Psychology. Orense, 23-27 Nov., pp. 140-141 (1999).
  • Laredo, M., Gómez, E., Gallo, E., Corzo, L., Couceiro, V., Anido, R., Pérez, P., Álvarez, X.A., Cacabelos, R. Evaluation of language functions in senile dementia. I National Congress of Clinical and Health Psychology. Orense, 23-27 Nov., pp. 114-115 (1999).
  • Cacabelos, R. Cerebrolysin enhances brain bioelectrical activity alpha and improves memory performance in humans. Internal Meeting Research Initiative EBEWE. Graz, Austria. Sept. 23 (1999).
  • Cacabelos, R., Mesa, M.D., Fernández-Novoa, L. Genetic epidemiology of risk factors in Alzheimer's disease. Human Genome Meeting. Brisbane, Australia, 27-30 March, pp. 26 (1999).
  • Mesa, M.D., Fernández-Novoa, L., Lombardi, V.R., Álvarez, X.A., Cacabelos, R. ADGT-Kit: A diagnostic aid for the analysis of genetic risk factors involved in the etiopathogenesis of Alzheimer's disease and vascular dementia. Human Genome Meeting. Brisbane, Australia, 27-30 March, pp. 26 (1999).
  • Álvarez, X.A., Pichel, V., Pérez, P., Laredo, M., Corzo, L., Zas, R., Fernández-Novoa, L., Alcaraz, M., Sempere, J.M., Díaz, J., Cacabelos, R. A double-blind placebo-controlled study with anapsos in vascular dementia and Alzheimer disease. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 23 (1999).
  • Pérez, P., Corzo, L., Álvarez, X.A., Laredo, M., Cacabelos, R. Changes in brain bioelectrical activity associated with cognitive and behavioral function in dementia. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 27 (1999).
  • Corzo, L., Zas, R., Fernández-Novoa, L., Álvarez, X.A., Olano, M., Mesa, D., Cacabelos, R. Serum apolipoprotein E and lipid levels in vascular dementia and Alzheimer disease. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 30 (1999).
  • Laredo, M., Gómez, E., Gallo, E., Corzo, L., Álvarez, X.A., Cacabelos, R. Evaluation of language functions in senile dementia. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 35 (1999).
  • Laredo, M., Pérez, P., Couceiro, V., Anido, R., Corzo, L., Álvarez, X.A., Cacabelos, R. Sleep disorders in vascular dementia and Alzheimer disease. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 35 (1999).
  • Fernández-Novoa, L., Mesa, M.D., Olano, M., Lombardi, V., Álvarez, X.A., Cacabelos, R. Evaluation of the genetic profile in Alzheimer's disease and vascular dementia. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 41 (1999).
  • Fernández-Novoa, L., Mesa, M.D., de Olano, M., Lombardi, V., Álvarez, X.A., Cacabelos, R. Genotype characterization in Alzheimer disease according to gender, disease expression and age at onset. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 41 (1999).
  • de Olano, M., Mesa, M.D., Blanco, A., Fernández-Novoa, L., Corzo, L., Cacabelos, R. Angiotensin-converting enzyme I/D polymorphism in cerebrovascular pathology. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 41 (1999).
  • Álvarez, X.A., Fernández-Novoa, L., Sampedro, C., Lombardi, V., Windisch, M., Cacabelos, R. Neuroimmunotrophic effects of Cerebrolysin in an animal model of hippocampal degeneration induced by -amyloid. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 43 (1999).
  • Álvarez, X.A., Sampedro, C., Cacabelos, R. CDP-Choline reduces neuronal apoptosis in rats with brain hypoperfusion and hippocampal -amyloid implants. 1st Int. Cong. Vascular Dementia. Geneva, 3-6 Oct., pp. 43 (1999).
  • Cacabelos, R. Bioethics of care for the elderly with neurodegenerative diseases. Genetic prevention of dementia. VI National and II International Bioethics Conference. Aging when a century is born. Granada, Sept. 25-26, pp. 20-23 (1998).
  • Cacabelos, R. Alzheimer's disease. Aetiopathogenesis and treatment. International Symposium. Alzheimer's disease, From diagnosis to a comprehensive therapeutic approach. Wyeth, Mexico, Feb. 28, pp. 35-52 (1998).
  • Cacabelos, R., Lao, J.I., Beyer, K., Sellers, M.A., Laredo, M., Alcaraz, M., Álvarez, X.A. Genotype-specific therapeutic response in Alzheimer disease with novel compounds: New designs in drug clinical trials and preventive strategies. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 24 (1998).
  • Khachaturian, Z., Radebaugh, T., Thal, L., Gauthier, S., Cacabelos, R, Sano, M., Leber, P. International Working Group on Prevention of Alzheimer's Disease. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 60 (1998).
  • Álvarez, X.A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Cacabelos, R. Intrahippocampal injections of -amyloid fragments impair learning and memory in rats. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 134 (1998).
  • Álvarez, X.A., Fernández-Novoa, L., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline reverses learning impairment induced by -amyloid injections into the rat hippocampus. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 134 (1998).
  • Álvarez, X.A., Laredo, M., Corzo, L., Zas, R., Mouzo, R., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline enhances memory performance in elderly subjects. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 135 (1998).
  • Álvarez, X.A., Sellers, M.A., Mouzo, R., Pichel, V., Pérez, P., Laredo, M., Caamaño, J.M., Corzo, L., Zas, R., Fernández-Novoa, L., Lao, J.l., Beyer, K., Alcaraz, M., Cacabelos, R. Effects of CDP-choline on cognitive function and brain bioelectrical activity and hemodynamic parameters in Alzheimer disease patients: A double-blind placebo-controlled study. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 135 (1998).
  • Álvarez, X.A., Sellers, M.A., Mouzo, R., Pichel, V., Pérez, P., Laredo, M., Caamaño, J.M., Corzo, L., Zas, R., Fernández-Novoa, L., Lao, J.I., Beyer, K., Alcaraz, M., Sempere, J.M., Díaz, J., Cacabelos, R. Double-blind randomized placebo-controlled study with anapsos in senile dementia. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 136 (1998).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Cacabelos, R. V1481: A novel mutation in the predicted TM2 domain of the presenilin-2 gene in a Spanish patient with late-onset Alzheimer's disease. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April l 5-18, pp. 139 (1998).
  • Cacabelos, R. Protocol for preventive intervention in dementia: Gene-specific therapeutic responses with multifactorial strategies (combined treatment). Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp, 140 (1998).
  • Corzo, L., Fernández-Novoa, L., Zas, R., Beyer, K., Lao, J.I., Laredo, M., Álvarez, X.A., Cacabelos, R. Serum ApoE and lipid levels according to APOE genotype in Alzheimer disease. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 141 (1998).
  • Fernández-Novoa, L., Corzo, L., Beyer, K., Zas, R., Lao, J.I., Laredo, M., Álvarez, X.A., Cacabelos, R. Histamine levels in Alzheimer's disease and vascular dementia according to GDS staging. APOE genetic profile evaluation. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 142 (1998).
  • Lao, J.I., Beyer, K., Fernández-Novoa, L., Cacabelos, R. A possible epistasia between presenilin-l gene and APOE-E4 allele on Alzheimer disease in the Spanish population. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 149 (1998).
  • Laredo, M., Pichel, V., Álvarez, X.A., Mouzo, R., Pérez, P., Lao, J.I., Beyer, K., Novo, B., Alcaraz, M., Cacabelos, R. Influence of diagnosis and APOE genotype on cognitive performance in senile dementia: a prospective study. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 150 (1998).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Quack, G., Cacabelos, R. Protection by memantine against A(1-40)-induced neurodegeneration in the CA1 subfield. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 153 (1998).
  • Pérez, P., Pichel, V., Álvarez, X.A., Laredo, M., Mouzo, R., Lao, J.I., Beyer, K., Novo, B., Alcaraz, M., Cacabelos, R. Changes in brain bioelectrical activity associated with disease stage and APOE genotype in senile dementia. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 155 (1998).
  • Pichel, V., Caamaño, J.M., Mouzo, R., Álvarez, X.A., Pérez, P., Laredo, M., Alcaraz, M., Lao, J.I., Beyer, K., Sellers, A., Cacabelos, R. Changes in cerebral blood flow associated with disease staging and APOE genotype in patients with senile dementia. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 15-18, pp. 156 (1998).
  • Cacabelos, R. Etiopathogenia da doença de Alzheimer e suas implicaçoes no tratamento. Simposium Envelhecimiento e Demencias. Coimbra, Portugal, June 26-27 (1998).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Cacabelos, R. Identification of a novel mutation (V1481) in the TM2 domain of the presenilin-2 gene in a patient with late-onset Alzheimer's disease. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July l 8-23. Neurobiol. Aging, 19/4S:S87 (1998).
  • Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Lombardi, V. An animal model of neurodegeneration induced by injections of -amyloid into the rat hippocampus: Behavioral characterization. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18-23. Neurobiol. Aging, 19/4S:S126 (1998).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Quack, G., Cacabelos, R. Protection of memantine against A(1-40)-induced neurodegeneration in the CA1 subfield. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18-23. Neurobiol. Aging, 19/4S:S129 (1998).
  • Álvarez, X.A., Laredo, M., Corzo, L., Zas, R., Mouzo, R., Fernández-Novoa, L., Perea, J.E., Daniele, D., Cacabelos, R. Memory-enhancing effects of citicoline in elderly nondemented people. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18- 23. Neurobiol. Aging, 19/4S:S184 (1998).
  • Mouzo, R., Álvarez, X.A., Sellers, M.A., Pichel, V.M., Pérez, P., Laredo, M., Caamaño, J.M., Corzo, L., Zas, R., Fernández-Novoa, L., Lao, J.I., Beyer, K., Alcaraz, M., Sempere, J.M., Díaz, J., Cacabelos, R. Treatment with anapsos in senile dementia: A double-blind placebo-controlled study. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18- 23. Neurobiol. Aging, 19/4S:S184 (1998).
  • Lombardi, V., García, M., Cacabelos, R. Neuroimmunomodulation induced by cerebrolysin, a brain-derived peptide preparation, on primary microglial cell cultures. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18-23. Neurobiol. Aging, 19/4S:S200 (1998).
  • Vigo-Pelfrey, C., Cacabelos, R., Álvarez, X.A., Allison, C. Neurostrol, a potent anti-inflammatory drug to treat Alzheimer's disease. 6th International Conference on Alzheimer's Disease and Related Disorders. Amsterdam, July 18-23. Neurobiol. Aging, 19/4S:S262 (1998).
  • Álvarez, X.A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Cacabelos, R. Beta-amyloid injections into the rat hippocampus impair learning and memory. XXlst CINP Congress, Glasgow, July 12-16, pp. 391 (1998).
  • Álvarez, X.A., Fernández-Novoa, L., Perea, J.E., Cacabelos, R. Citicoline reverses learning impairment in rats with hippocampal neurodegeneration induced by beta-amyloid. XXlst CINP Congress, Glasgow, July 12-16, pp. 391 (1998).
  • Cacabelos, R., Miguel-Hidalgo, J.J., Álvarez, X.A., Quack, G. Protection of memantine against A(1-40)-induced neurodegeneration in the CA1 subfield. XXIst CNIP Congress, Glasgow, July 12- 16, pp. 392 (1998).
  • Cacabelos, R., Miguel-Hidalgo, J.J., Álvarez, X.A. Beta-amyloid-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. XXlst CNIP Congress, Glasgow, July 12-16, pp. 392 (1998).
  • Cacabelos, R., Fernández-Novoa, L., Álvarez, X.A., Miguel-Hidalgo, J.J. Effects of hippocampal beta-amyloid injections on histamine levels, SOD, and AchE activities in the rat brain. XXlst CNIP Congress, Glasgow, July 12-16, pp. 392 (1998).
  • Álvarez, X.A., Fernández-Novoa, L., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline antagonizes bromazepam-induced amnesia in rats. XXlst CMP Congress, Glasgow, July 12-16, pp. 396 (1998).
  • Cacabelos, R., Lombardi, V., García, M., Álvarez, X.A. Neuroimmunotrophic compounds from marine organisms. XXIst CNIP Congress, Glasgow, July 12-16, pp. 433 (1998).
  • Beyer, K., Lao, J.I., Sellers, M.A., Álvarez, X.A., Cacabelos, R. Association between presenilin-l (S182) gene polymorphism and Alzheimer's disease in the Spanish population. 4th Joint Clinical Genetics Meeting of the 28th Annual March of Dimes Clinical Genetics Conference and the American College of Medical Genetics 4th Annual Meeting. Ft. Lauderdale, Florida, pp. A50. Feb. 28-March 2 (1997).
  • Lao, J.I., Beyer, K., Cacabelos, R., De la Fuente, R. Three new mutations in the GTP-CHI gene in Spanish families with hereditary progressive and dopa-responsive dystonia. 4th Joint Clinical Genetics Conference of the 28th Annual March of Dimes Clinical Genetics Conference and the American College of Medical Genetics 4th Annual Meeting. Ft. Lauderdale, Florida, pp. A53 (1997).
  • A large GAA expanded allele in a family with Friedreich's ataxia: A case report. 4th Joint Clinical Genetics Meeting of the 28th Annual March of Dimes Clinical Genetics Conference and the American College of Medical Genetics 4th Annual Meeting. Ft. Lauderdale, Florida, pp. A54. (1997).
  • Cacabelos, R. Aetiopathogenesis and therapeutic strategy in Alzheimer's disease. I Alzheimer Symposium. Nuestra Señora del Carmen Residence, Valencia (17.3.1997).
  • Cacabelos, R. Preventive strategies in Alzheimer's Disease and Related Disorders: Genotyping and drug monitoring. International Workshop. The role of the glutamatergic system in neurodegeneration and dementia. Osaka. April 5 (1997).
  • Cacabelos, R. Therapeutic strategies in Alzheimer's disease: Novel compounds with neuroimmunotrophic activity. International Workshop. Brain Aging and Alzheimer's Disease. From Molecular to Clinical Approaches. Havana, April 10-12, pp. 14-15 (1997).
  • Cacabelos, R. Neuroimmune dysfunction in Alzheimer's disease. International Workshop. Brain Aging and Alzheimer's Disease. From Molecular to Clinical Approaches. Havana, April 10-12, pp. 15 (1997).
  • Cacabelos, R. Advances in brain histamine research. XXVI Annual Meeting. European Histamine Research Society, Seville, May 14-14 (1997).
  • Cacabelos, R., Lao, J.I., Beyer, K., Álvarez, X.A., Fernández-Novoa, L. Central and peripheral histamine in neurodegenerative and psychiatric disorders: genetic markers and histamine levels. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 10 (1997).
  • Fernández-Novoa, L., Álvarez, X.A., Miguel-Hidalgo, J.J., Cacabelos, R. Brain histamine in an animal model of neuronal degeneration. XXVI Annual Meeting. European Histamine Research Society, Seville, May 14-17, pp. 104 (1997).
  • Maneiro, E., Fernández-Novoa, L., Lombardi, V., Cacabelos, R. Effects of histamine on lactate dehydrogenase (LDH) release in cultured rat endothelial cells. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 105 (1997).
  • Fernández-Novoa, L., Corzo, L., Zas, R., Álvarez, X.A., Cacabelos, R. Whole blood and serum histamine in healthy subjects and in schizophrenic patients: Correlation analysis with transcranial Doppler ultrasonography. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 106 (1997).
  • Fernández-Novoa, L., Corzo, L., Zas, R., Álvarez, X.A., Cacabelos, R. Histamine levels in Alzheimer's disease and vascular dementia patients according to Global Deterioration Scale Staging: Correlation studies with brain hemodynamic parameters. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 107 (1997).
  • Fernández-Novoa, L., Álvarez, X.A., Cacabelos, R. Effects of famotidine on the levels of blood histamine in healthy subjects: Correlation studies with brain mapping. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 108 (1997).
  • Fernández-Novoa, L., Álvarez, X.A., Cacabelos, R. Blood histamine levels in depression. XXVI Annual Meeting. European Histamine Research Society. Seville, May 14-17, pp. 109 (1997).
  • Mouzo, R., Álvarez, X.A., Sellers, A., Pichel, V., Lao, J.I., Caamaño, J.M., Laredo, M., Pérez, P., Beyer, K., Alcaraz, M., Rúa, M.C., Fernández-Novoa, L., Fernández, R., Carrera, C., Cacabelos, R. Blood pressure and apolipoprotein-E (APOE) in senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May l 8-23, pp. 6 (1997).
  • Laredo, M., Álvarez, X.A., Mouzo, R., Pérez, P., Lao, J.I., Beyer, K., Sellers, A., Pichel, V., Caamaño, J.M., Rodríguez, S., Iglesias, E., Varela, B., Cacabelos, R. Psychometric evaluation and APOE genotyping in senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 8 (1997).
  • Maneiro, E., Lombardi, V., Díaz, J., Cacabelos, R. Effects of anapsos on adult rat microglial cell cultures. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 10 (1997).
  • Sellers, A., Pérez, P., Rodríguez, B., Pichel, V.M., Caamaño, J.M., Laredo, M., Alcaraz, M., Álvarez, X.A., Cacabelos, R. Dementia-associated sleep disorders. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 12 (1997).
  • Pérez, L., Sellers, A., Caamaño, J.M., Lao, J.I., Beyer, K., Bustos, J.C., Cacabelos, R. Clinical evaluation at the onset of senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 13 (1997).
  • Sellers, A., Carrera, C., Bustos, J.C., Caamaño, J.M., Rodríguez, B., Mouzo, R., Pérez, P., Lao, J.I., Beyer, K., Álvarez, X.A., Cacabelos, R. Cognitive and non-cognitive symptoms in senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 13 (1997).
  • Maneiro, E., Lombardi, V., Cacabelos, R. Adult rat microglial cell cultures: An in vitro cellular model to study the effect of IL-1 and -amyloid on microglial activation. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 41 (1997).
  • Maneiro, E., Lombardi, V., Cacabelos, R. Rat endothelial cell cultures: An in vitro cellular model to study the cytotoxic effect of -amyloid, LPS, histamine and serum from AD patients on endothelial cell cultures. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 41 (1997).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. -Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 42 (1997).
  • Álvarez, X.A., Fernández-Novoa, L., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline reverses learning impairment in rats with hippocampal injections of -amyloid (1-40). Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 42 (1997).
  • Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Hippocampal implants of -amyloid induce memory deficits in rats. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 43 (1997).
  • Cacabelos, R. Therapeutic strategies in Alzheimer's disease: pleiotropic versus etiopathogenic treatment. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 48 (1997).
  • Beyer, K., Lao, J.I., Cacabelos, R. Allele differences in the presenilin-2 gene in Alzheimer's disease. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 56 (1997).
  • Beyer, K., Lao, J.I., Cacabelos, R. A rapid and easy method for presenilin-1 gene screening. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 57 (1997).
  • Corzo, L., Fernández-Novoa, L., Zas, R., Beyer, K., Lao, J.I., Álvarez, X.A., Cacabelos, R. Influence of the APOE genotype on serum ApoE levels from Alzheimer's disease patients in the Spanish population. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 59 (1997).
  • Pichel, V.M., Caamaño, J.M., Mouzo, R., Álvarez, X.A., Pérez, P., Laredo, M., Alcaraz, M., Lao, J.I., Beyer, K., Sellers, A., Cacabelos, R. Changes in cerebral blood flow associated with disease staging and APOE genotyping in patients with senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 62 (1997).
  • Pérez, P., Álvarez, X.A., Laredo, M., Mouzo, R., Sellers, A., Pichel, V.M., Caamaño, J.M., Lao. J.I., Beyer, K., Novo, B., Alcaraz, M., Cacabelos, R. Brain activity mapping and APOE genotyping in senile dementia. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 62 (1997).
  • Lao, J.I., Beyer, K., Cacabelos, R. Centromere disturbances affecting Alzheimer's disease lymphocyte metaphases. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 62 (1997).
  • Álvarez, X.A., Fernández-Novoa, L., Díaz, J., Sempere, J.M., Cacabelos, R. Anapsos improves learning and memory in rats with -amyloid(1-28) deposits into the hippocampus. Oholo 41st Conference. Progress in Alzheimer's and Parkinson's diseases. Fourth International Conference. Eilat, Israel, May 18-23, pp. 64 (1997).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Neuroprotection by CDP-choline in a model of hippocampal degeneration after deposits of fragment 1-40 of -amyloid. 6th World Congress Biological Psychiatry, June 22-27, Nice. Biol. Psychiatry, 42(1S):39S (1997).
  • Maneiro, E., Lombardi, V., Cacabelos, R. Cytotoxicity induced by -amyloid, histamine, LPS and serum from AD patients on rat endothelial cells. 6th World Congress Biological Psychiatry, June 22- 27, Nice. Biol. Psychiatry, 42(1S):90-91S (1997).
  • Maneiro, E., Lombardi, V., Cacabelos, R. -Amyloid and IL-1 effects on rat microglial cell cultures. 6th World Congress Biological Psychiatry. June 22-27, Nice. Biol. Psychiatry, 42(1S):91S (1997).
  • Sellers, A., Álvarez, X.A., Carrera, C., Bustos, J.C., Caamaño, J.M., Mouzo, R., Pérez, P., Lao, J.I., Beyer, K., Cacabelos, R. Cognitive and non-cognitive symptoms in patients with senile dementia. 6th World Congress Biological Psychiatry, June 22-27, Nice. Biol. Psychiatry 42(1S):93S (1997).
  • Álvarez, X.A., Fernández-Novoa, L., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline antagonizes bromazepam-induced amnesia in rats. 6th World Congress Biological Psychiatry June 22-27, Nice. Biol. Psychiatry, 42(1S):95S (1997).
  • Álvarez, X.A., Laredo, M., Corzo, L., Perea, J.E., Daniele, D., Cacabelos, R. Citicoline improves memory in elderly subjects. 6th World Congress Biological Psychiatry, June 22-27, Nice. Biol. Psychiatry 42(1 S):95S (1997).
  • Lao, J.I., Beyer, K., Álvarez, X.A., Cacabelos, R. Analysis of a polymorphic tetranucleotide repeat in the TH gene in Spanish psychiatric patients. 6th World Congress Biological Psychiatry, June 22- 27, Nice. Biol. Psychiatry 42(1S):101S (1997).
  • Sellers, A., Álvarez, X.A., Rodríguez, B., Caamaño, J.M., Laredo, M., Pichel, V.M., Alcaraz, M., Cacabelos, R. Sleep disorders in patients with senile dementia. 6th World Congress Biological Psychiatry. June 22-27, Nice. Biol. Psychiatry, 42(1S): 115S (1997).
  • Beyer, K., Lao, J.I., Sellers, M.A., Álvarez, X.A., Cacabelos, R. Association between presenilin-l (S182) gene polymorphism and Alzheimer's disease in the Spanish population. 6th World Congress Biological Psychiatry. June 22-27, Nice. Biol. Psychiatry 42(1S):120S (1997).
  • Fernández-Novoa, L., Corzo, L., Álvarez, X.A., Cacabelos, R. Whole blood and serum histamine in healthy subjects and schizophrenic patients: Correlation analysis with transcranial Doppler ultrasonography. 6th World Congress Biological Psychiatry. June 22-27, Nice. Biol. Psychiatry, 42(1S):176-177S (1997).
  • Pichel, V.M., Caamaño, J.M., Mouzo, R., Álvarez, X.A., Pérez, P., Laredo, M., Alcaraz, M., Lao, J.I., Beyer, K., Sellers, A., Cacabelos, R. Cerebral blood flow in senile dementia: Changes associated with disease staging and APOE genotyping. 6th World Congress Biological Psychiatry. June 22-27, Nice. Biol. Psychiatry, 42(1S):211S (1997).
  • Cacabelos, R. Alzheimer's disease: present and future. Symposium II. New views on CNS pharmacology. Innsbruck University, Innsbruck, Austria, Sept. 12 (1997).
  • Cacabelos, R. Etiopathogenesis of Alzheimer's disease. XVII Venezuelan Congress of Psychiatry. Nov. 5-8, Maracaibo (1997).
  • Cacabelos, R. Controversies in the treatment of dementia. XVII Venezuelan Congress of Psychiatry. Nov. 5-8, Maracaibo (1997).
  • Cacabelos, R. Pharmacological treatment of dementias: genotypic specificity of therapeutic responses in Alzheimer's disease. XVII Venezuelan Congress of Psychiatry. Nov. 5-8, Maracaibo (1997).
  • Lombardi, V., Cacabelos, R. Primary microglial cell cultures in the study of novel marine-derived compounds. 1st EuroConference on Marine Natural Products. Athens, Nov. 2-6, pp. 52 (1997).
  • Lombardi, V., Cacabelos, R. Biological effects of the fish extract E-CAB-9401l in rats. lst EuroConference on Marine Natural products. Athens, Nov. 2-6, pp. 120 (1997).
  • Lombardi, V., Cacabelos, R. E-JUR-94013 Marine fish extract: Neuroimmunological studies in adult Sprague-Dawley rats. lst EuroConference on Marine Natural Products. Athens, Nov. 2-6, pp. 121 (1997).
  • Lombardi, V., Reguera, R., Cacabelos, R. Neuroimmunological properties of Atlantic starfish-derived compounds. lst EuroConference on Marine Natural Products. Athens, Nov. 2-6, pp. 122 (1997).
  • Lombardi, V., Cacabelos, R. Neuroimmunological studies with the fish extract E-SAR-94010 in rats. lst EuroConference on Marine Natural Products. Athens, Nov. 2-6, pp. 123 (1997).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Franco-Maside, A., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Allelic frequency of ApoE in the Spanish population. HGM'96. HUGO's Human Genome Meeting, Heidelberg, March 22-24, pp. 11 (1996).
  • Lao, J.I., Beyer, K., Fernández-Novoa, L., Franco-Maside, A., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Cytogenetic findings in Alzheimer's disease. HGM'96. HUGO's Human Genome Meeting, Heidelberg, 22-24 March, pp. 57 (1996).
  • Allain, H., Guez, D., Cacabelos, R., Derouesné, C., Jolles, J., Lenzi, G.L., Levy, R., Bruno, J., Neuman, E., Lepagnol, J. Safety and efficacy of S-12024 in patients with mild to moderate Alzheimer's disease. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 74 (1996).
  • Cacabelos, R., Lagares, R., Fernández-Novoa, L., Franco-Maside, A., Miguel-Hidalgo, J.J., Álvarez, X.A. Anapsos: New therapeutic strategies for neurodegeneration and brain aging with natural neuroimmunotrophic factors. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 83 (1996).
  • Cacabelos, R., Vinagre, D., Caamaño, J., Lao, J.I., Beyer, K., Álvarez, X.A. Brain mapping and transcranial Doppler ultrasonography in Alzheimer disease drug monitoring. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 95 (1996).
  • Álvarez, X.A., Miguel-Hidalgo, J.J., Lagares, R., Franco, A., Fernández-Novoa, L., Lao, J.I., Díaz, J., Sempere, J.M., Cacabelos, R. Neuroprotective activity of anapsos in rats with hippocampal degeneration. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 130 (1996).
  • Álvarez, X.A., Franco, A., Fernández, L., Beyer, K., García, M., Polo, E., Desche, P., Guez, D., Cacabelos, R. Behavioral and neurochemical effects of S12024 in rats with implants of -amyloid into the hippocampus. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 130 (1996).
  • Álvarez, X.A., Zas, R., García, M., Polo, E., Desche, P., Guez, D., Cacabelos, R. Comparative effects of S9977-2 vs Tacrine in learning and locomotion. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 131 (1996).
  • Álvarez, X.A., Lagares, R., Franco, A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Beyer, K., Cacabelos, R. Effects of CDP-choline in rats with brain neurotoxic lesions. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 131 (1996).
  • Beyer, K., Lao, J.I., Maneiro, E., Cacabelos, R, Alzheimer soluble factor (ASF): A potential peripheral marker for genetic Alzheimer disease. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 135 (1996).
  • Cacabelos, R., Caamaño, J., Gómez, M.J., Franco-Maside, A., Vinagre, D., Novo, B., Zas, R., Álvarez, X.A., Polo, E., García, M., Neuman, E., Guez, D. S-12024-2: A double-blind randomized placebo-controlled study in patients with Alzheimer disease. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 138 (1996).
  • Fernández-Novoa, L., Franco-Maside, A., Álvarez, X.A., Vecino, B., Díaz, J., Sempere, J.M., Cacabelos, R. Effects of anapsos on the activity of superoxide dismutase (SOD) in an animal model of neurodegeneration. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 143 (1996).
  • Fernández-Novoa, L., Vinagre, D., Franco-Maside, A., Caamaño, J., Álvarez, X.A., Cacabelos, R. Effects of famotidine on the levels of blood histamine in healthy subjects: Correlation studies with brain electrical activity mapping. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 143 (1996).
  • Lao, J.I., Beyer, K., Cacabelos, R. Senile dementia-associated FOS gene mutation in the Spanish population. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 156 (1996).
  • Maneiro, E., Lao, J.I., Beyer, K., Cacabelos, R. Microglia activation by an AD-associated 19kDa soluble factor. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 160 (1996).
  • Winblad, B., Ravizza, L., Rossor, M., Cacabelos, R. Research priorities in Alzheimer disease treatment- An international perspective. A European response. Fourth International Nice/Springfield Symposium on Advances in Alzheimer Therapy, Nice, April 10-14, pp. 16 (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Allelic frequency of ApoE in the Spanish population. The Lancet Conference 1996. The challenge of the dementias, Edinburgh, April 25-26, pp. 38 (1996).
  • Cacabelos, R. Endocrinological variations in psychic disorders in the elderly. XXI Nat. Congr. Soc. Esp. Geriatrics and Gerontology. V Castilian-Leonese Soc. Castellano-Leonesa, Salamanca, June 5-8, 1996.
  • Cacabelos, R. Etiopathogenesis and therapeutic prospects of Alzheimer's disease. Actualidad científica y sociosanitaria de la enfermedad de Alzheimer. Fundación Ramón Areces, Madrid, June 6, 1996.
  • Cacabelos, R. Neuroimmunological and endocrine function in neurogeriatric disorders. Rev. Esp. Geriatrics and Gerontology, 31: Suppl. I (1996).
  • Sellers, A., Rodríguez, B., Cacabelos, R., Caamaño, J.M. Psychometric evaluation of sleep disorders in senile dementia. Rev. Esp. Geriatrics and Gerontology, 31:Suppl. l (1996).
  • Fernández-Novoa, L., Corzo, L., Caamaño, J., Zas, R., Gómez, M.J., Álvarez, X.A., Cacabelos, R. Cerebral haemodynamics and histamine levels in Alzheimer's disease and vascular dementia. Rev. Esp. Geriatrics and Gerontology, 31:Suppl. l (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Miguel-Hidalgo, J., Álvarez, X.A., Cacabelos, R. The allele frequency of ApoE in the Galician population. Rev. Esp. Geriatrics and Gerontology, 31:Suppl. I (1996).
  • Maneiro, E., Cacabelos, R. Modification of microglia by a soluble factor from the serum of patients with Alzheimer's disease. Rev. Esp. Geriatrics and Gerontology, 31:Suppl. I (1996).
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Lagares, R., Franco, A., Beyer, K., Maneiro, E., Cacabelos, R. Effects of anapsos on brain function in old mice. Rev. Esp. Geriatrics and Gerontology, 31: Suppl. I (1996).
  • Álvarez, X.A., Miguel-Hidalgo, J.J., Lagares, R., Franco, A., Fernández-Novoa, L., Beyer, K., Lao, J.l., Vecino, B., Díaz, J., Sempere, J.M., Cacabelos, R. Protective effects of anapsos in rats with hippocampal neurodegeneration. XXth CINP Congress, Melbourne, Melbourne, June 23-27, 1996. Eur. Neuropharmacol., 6(Suppl. 3):75 (1996),
  • Fernández-Novoa, L., Franco-Maside, A., Álvarez, X.A., Vecino, B., Díaz, J., Sempere, J,M., Cacabelos, R. Effects of anapsos on the activity of SOD in an animal model of neurodegeneration. XXth CINP Congress, Melbourne, Melbourne, June 23-27, 1996. Eur. Neuropharmacol., 6 (Supp1.3):193 (1996).
  • Franco-Maside, A., Fernández-Novoa, L., Álvarez, X.A., Vecino, B., Díaz, J., Sempere, J.M., Cacabelos, R. Effects of anapsos on brain histamine and 1L-1 levels in an animal model of neurodegeneration. XXth CINP Congress, Melbourne, Melbourne, June 23-27, l996. Eur. Neuropharmacol., 6 (Suppl.3):193 (1996).
  • Álvarez, X.A., Zas, R., Lagares, R., Franco, A., Fernández-Novoa, L., Díaz, J., Sempere, J.M., Cacabelos, R. Effects of anapsos on longevity, behavior and brain neurochemistry in mice. XXth CINP Congress, Melbourne, Melbourne, June 23-27, 1996. Eur. Neuropharmacol., 6(Suppl.3):193 (1996).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Lagares, R., Franco, A., Fernández. L., Cacabelos, R. Brain neurotoxic lesions in rats: Study of the neuroprotective effects of CDP-choline. XXth CINP Congress, Melbourne, Melbourne, June 23-27, 1996. Eur. Neuropharmacol., 6(Suppl.3): 193-194 (1996).
  • Álvarez, X.A., Zas, R., García, M., Polo, E., Guez, D., Cacabelos, R. Comparative effects of S- 9977-2 vs Tacrine on passive avoidance learning. XXth CINP Congress, Melbourne, Melbourne, June 23-27, 1996. Eur. Neuropharmacol., 6(Supp1.3):189-190 (1996).
  • Maneiro, E., Lao, J.l., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Microglia activation by an AD-associated 19kDa soluble factor. Neurobiol. Aging, 17:S22 (1996).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., García, M., Polo, E., Desche, P., Cacabelos, R. Neuroprotective effects of S12024 in rats with implants of -amyloid into the hippocampus. Neurobiol. Aging, 17:S28-29 (1996).
  • Cacabelos, R. Behavioral changes and biological markers associated with different genotypes in Alzheimer's disease. Neurobiol. Aging, 17:S47 (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Vecino, B., Álvarez, X.A., Cacabelos, R. A molecular genetic approach to Alzheimer's disease from different genomic sites in the Spanish population. Neurobiol. Aging, 17:S60 (1996).
  • Lao, J.I., Beyer, K., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Vecino, B., Álvarez, X.A., Cacabelos, R. Cytogenetic signs of genomic instability in Alzheimer's disease. Neurobiol. Aging, 17:S62-63 (1996).
  • Miguel-Hidalgo, J.J., Cacabelos, R. Subpopulations of rat Congo Red-staining neurons display distinct morphological features and altered distribution of -amyloid precursor protein immunoreactivity. Neurobiol. Aging, 17:S67 (1996).
  • Lagares, R., Álvarez, X.A., Franco, A., Fernández-Novoa, L., Beyer, K., Lao, J.I., Cacabelos, R. Behavioral deficits induced by stereotaxic -amyloid implants into the rat hippocampus. Neurobiol. Aging, 17:S68 (1996).
  • Cacabelos, R., Maneiro, E., Lagares, R., Lao, J.I., Beyer, K., Miguel-Hidalgo, J.J., Fernández-Novoa, L., Álvarez, X.A. Neuroimmunotrophic strategies in neurodegeneration and Alzheimer's disease. Neurobiol. Aging, 17:S139-140 (1996).
  • Miguel-Hidalgo, J.J., Fernández-Novoa, L., Álvarez, X.A., Franco, A., Cacabelos, R. Characterization of a model of neuronal degeneration in the gyrus dentatus of the rat: Neuroprotective effects of anapsos. Neurobiol. Aging, 17:S140 (1996).
  • Álvarez, X.A., Fernández-Novoa, L., Caamaño, J., Vinagre, D., Gómez, M.J., Cacabelos, R. Effects of' anapsos on brain function: Preclinical and clinical neuropharmacological studies. Neurobiol. Aging, 17:S140-141 (1996).
  • Fernández-Novoa, L., Corzo, L., Caamaño, J., Zas, R., Gómez, M.J., Álvarez, X.A., Cacabelos, R. Histamine and brain hemodynamics in Alzheimer disease and vascular dementia patients according to global deterioration scale staging. Neurobiol. Aging, 17:S184 (1996).
  • Cacabelos, R. Novel therapeutic strategies in Alzheimer's disease. X World Congress of Psychiatry, Madrid, August 23-28, pp. 120 (1996).
  • Lao, J.I., Beyer, K., Álvarez, X.A., Cacabelos, R. Apo-E allelic frequency analysis in psychiatric disorders. X World Congress of Psychiatry, Madrid, August 23-28, pp. 195 (1996).
  • Beyer, K., Lao, J.I., Álvarez, X.A., Cacabelos, R. Rapid molecular detection of the fragile X gene trinucleotide repeat. X World Congress of Psychiatry, Madrid, August 23-28, pp. 197 (1996).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Fernández-Novoa, L., Díaz, J., Sempere, J.M., Cacabelos, R. Anapsos exerts neuroprotective effects in an animal model of neurodegeneration. X World Congress of Psychiatry, Madrid, August 23-28, pp. 211 (1996).
  • Cacabelos, R., Vinagre, D., Caamaño, J., Lao, J.I., Beyer, K., Álvarez, X.A. Brain mapping and transcranial Doppler ultrasonography in Alzheimer's disease drug monitoring. X World Congress of Psychiatry, Madrid, August 23-28, pp. 212 (1996).
  • Cacabelos, R., Maneiro, E., Beyer, K., Lao, J.l., Miguel-Hidalgo, J.J., Álvarez, X.A. Effects of Alzheimer Apo-E-related ASF in microglia cell culture. X World Congress of Psychiatry, Madrid, August 23-28, pp. 213 (1996).
  • Miguel-Hidalgo, J.J., Vecino, B., Fernández-Novoa, L., Franco, A., Álvarez, X.A., Cacabelos, R. Neuroprotection by S-12024 in a model of neuronal degeneration in the rat hippocampus. X World Congress of Psychiatry, Madrid, August 23-28, pp. 216 (1996).
  • Miguel-Hidalgo, J.J., Álvarez, X.A., Lagares, R., Franco, A., Fernández, L., Cacabelos, R. Protective effects of CDP-choline against neurotoxic lesions in rat brain. X World Congress of Psychiatry, Madrid, August 23-28, pp. 216-217 (1996).
  • Lagares, R., Álvarez, X.A., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Franco, A., Cacabelos, R. Stereotaxic -amyloid implants into the hippocampus induce behavioral deficits in rats. X World Congress of Psychiatry, Madrid, August 23-28, pp. 217 (1996).
  • Lao, J.I., Beyer, K., Miguel-Hidalgo, J.J., Fernández-Novoa, L., Álvarez, X.A., Cacabelos, R. Apo-E allelic frequency and genetic risk calculation in Alzheimer's disease. X World Congress of Psychiatry, Madrid, August 23-28, pp. 247 (1996).
  • Lagares, R., Álvarez, X.A., Zas, R., Franco, A., Fernández-Novoa, L., Cacabelos, R. Behavior and brain neuroimmune function in old mice treated chronically with anapsos. X World Congress of Psychiatry, Madrid, August 23-28, pp. 247 (1996).
  • Fernández-Novoa, L., Caamaño, J., Álvarez, X.A., Cacabelos, R. Correlation analysis between whole blood and serum histamine levels and transcranial Doppler ultrasonography parameters in healthy subjects and schizophrenic patients. X World Congress of Psychiatry, Madrid August 23-28, pp. 248 (1996).
  • Fernández-Novoa, L., Álvarez, X.A., Franco-Maside, A., Miguel-Hidalgo, J.J., Polo, E., Cacabelos, R. Effects of S-12024 in rats with hippocampal neurodegeneration. X World Congress of Psychiatry, Madrid, August 23-28, pp. 249 (1996).
  • Álvarez, X.A., Vara, E., Ayuso, J.L., Cacabelos, R. Effects of GHRP-6 on brain somatostatin levels in naive and cysteamine-treated rats. X World Congress of Psychiatry, Madrid, August 23- 28, pp. 249 (1996).
  • Lao, J.I., Beyer, K., Miguel-Hidalgo, J.J., Fernández-Novoa, L., Álvarez, X.A., Cacabelos, R Karyotypic figures found in Alzheimer's disease patients. X World Congress of Psychiatry, Madrid, August 23-28, pp. 250 (1996).
  • Álvarez, X.A., Diéguez, C., Ayuso, J.L., Cacabelos, R. Learning impairment in rats with vitamin A-free diet: Influence on the testicular function. X World Congress of Psychiatry, Madrid, August 23-28, pp. 250-251 (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Molecular genetic analysis of Alzheimer's disease patients at Apo-E locus. X World Congress of Psychiatry, Madrid, August 23-28, pp. 251 (1996).
  • Álvarez, X.A., Ayuso, J.L., Cacabelos, R. The hexapeptide GHRP-6 improves passive avoidance learning in rats. X World Congress of Psychiatry, Madrid, August 23-28, pp. 253 (1996).
  • Cacabelos, R., Lagares, R., Fernández-Novoa, L., Franco-Maside, A., Miguel-Hidalgo, J.J., Álvarez, X.A. Anapsos: New therapeutic strategies for neurodegeneration and brain aging with natural neuroimmunotrophic factors. X World Congress of Psychiatry, Madrid, August 23-28, pp. 286 (1996).
  • Cacabelos, R., Caamaño, J., Gómez, M.J., Franco-Maside, A., Vinagre, D., Novo, B. S-12024-2: A double-blind randomized placebo-controlled study in patients with Alzheimer disease. X World Congress of Psychiatry, Madrid, August 23-28, pp. 315 (1996).
  • Sastre, I., Álvarez, X.A., Arauxo, A., Cacabelos, R. Standard operating procedures for filing documents in clinical trials. X World Congress of Psychiatry, Madrid, August 23-28, pp. 331 (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Miguel-Hidalgo, J.J., Álvarez, X.A., Cacabelos, R. Molecular identification of trinucleotide expansion causing Huntington's disease without labelling with radionucleotides. X World Congress of Psychiatry, Madrid, August 23-28, pp. 342 (1996).
  • Cacabelos, R. Alzheimer's disease and other dementias. Round Table. Ibero-American Master's Degree in Social Gerontology. Santiago de Chile. 10 Oct., (1996).
  • Cacabelos, R. Alzheimer's Disease: Genetics and Therapeutic Alternatives. World Alzheimer's Day commemorative conference. Association of Relatives of Alzheimer's patients. Tenerife, 21 Sept., (1996).
  • Cacabelos, R. Alzheimer's disease: Preventive possibilities and treatment. IV Information Conference. "Alzheimer's disease". International Alzheimer's Day. Palencia, 17 Sept., (1996).
  • Cacabelos, R. Epidemiology and diagnosis of dementias. Round Table: Senile Dementia. Alzheimer's disease. Alzheimer's disease: etiopathogenic factors and clinical-molecular diagnosis. Book of Papers and Communications. III Congress of Spanish General Medicine. La Coruña, 17 Oct., pp. 28 (1996).
  • Sellers, M.A., Carrera, C., Bustos, J.C., Cacabelos, R. Evolution of senile dementia according to clinical criteria. Book of Papers and Communications. III Congress of Spanish General Medicine, La Coruña, pp. 302 (1996).
  • Sellers, M.A., Rodríguez, B., Caamaño, J.M., Cacabelos, R. Psychometric evaluation of sleep disorders in 231 patients with senile dementia. Book of Papers and Communications. 111th Congress of Spanish General Medicine, La Coruña. pp. 304 (1996).
  • Sellers, M.A., Bustos, J.C., Pérez, L., Cacabelos, R. Role of the general practitioner in the care of the dementia patient. Book of Papers and Communications. III Congress of Spanish General Medicine, La Coruña. pp. 306 (1996).
  • Álvarez, X.A., Fernández-Novoa, L., Corzo, L., Zas, R., Cacabelos, R. Cerebrovascular changes associated with interleukin-1 (IL-1) and histamine (HA) levels in Alzheimer's disease. In: Cerebrovascular Pathology in Alzheimer's disease. A New York Academy of Sciences Conference. New Jersey, 12-15 Nov., pp. 22 (1996).
  • Fernández-Novoa, L., Corzo, L., Zas, R., Álvarez, X.A., Cacabelos, R. Global Deterioration Scale-related brain haemodynamics and histamine levels in Alzheimer disease and vascular dementia. In: Cerebrovascular Pathology in Alzheimer's disease. A New York Academy of Sciences Conference. New Jersey, 12-15 Nov., pp. 24 (1996).
  • Beyer, K., Lao, J.I., Fernández-Novoa, L., Álvarez, X.A., Sellers, M.A., Cacabelos, R. APOE E-4 allelic frequency in Alzheimer disease and vascular dementia in the Spanish population. In: Cerebrovascular Pathology in Alzheimer's disease. A New York Academy of Sciences Conference. New Jersey, 12-15 Nov., pp. 31 (1996).
  • Cacabelos, R. Etiopathogenesis and therapeutic prospects of Alzheimer's disease. Actualidad Científica y Sociosanitaria de la enfermedad de Alzheimer. Fundación Ramón Areces, Madrid, l0 Jun. (1996).
  • Cacabelos, R. (Representing the Ministry of Health to the EU) Alzheimer's Disease and Related Disorders. European Conference. Limerick, Ireland, Nov. 20-22 (1996).
  • Cacabelos, R, Alzheimer's disease. Aetiopathogenic factors and genetic evaluation. Lifelong Learning Programme. Valencian Pharmaceutical Federation. 10 Jun., (1996).
  • Cacabelos, R. Alzheimer's disease: Aetiopathogenic bases and therapeutic strategies. Symposium. Mental Health and Psychiatry on the threshold of the new millennium, I Caribbean and Bolivarian Countries Regional Meeting "Carlos Alberto Seguín". XIV National Congress of Psychiatry "Honorio Delgado". Lima 28 Nov.-1 Dec. (1996).
  • Cacabelos, R. Advances in Dementia (Part I). Symposium. Mental Health and Psychiatry on the threshold of the new millennium. I Caribbean and Bolivarian Countries Regional Meeting "Carlos Alberto Seguín". XIV National Congress of Psychiatry "Honorio Delgado". Lima, 28 Nov.-1 Dec. (1996).
  • Cacabelos, R. Advances in Dementia (Part II). Symposium. Mental Health and Psychiatry on the threshold of the new millennium. I Caribbean and Bolivarian Countries Regional Meeting "Carlos Alberto Seguín". XIV National Congress of Psychiatry "Honorio Delgado". Lima, 28 Nov.-1 Dec. (1996).
  • Cacabelos, R. Alzheimer's disease: Etiopathogenic treatments. III Meeting. Mapfre Medicine Foundation. Brain Damage and Quality of Life. Dementias. Madrid, 14-15 Nov (1996).
  • Cacabelos, R. Alzheimer's disease today. Treatment and prevention. Aula Magna Tirso de Molina Programme. Caja Rural Foundation. Soria. 11 Nov. (1996).
  • Cacabelos, R. Aetiopathogenic bases of Alzheimer's disease. II Spanish-American Symposium. Advances in Psychiatry. Faculty of Medicine. University of Salamanca. Salamanca, 28-30 March, 1995.
  • Cacabelos, R. Alzheimer's disease. Round Table. V Congress of the Valencian Community for Rural and General Practitioners. Benicasim, 27-29 April, 1995.
  • Cacabelos, R. Alzheimer's disease. Predictors of an etiopathogenic treatment. IV Meeting of the Psychiatry Society of the Valencian Community. Hotel Castilla, Alicante 28-29 April, 1995,
  • Álvarez, X.A., Fernández-Novoa, L., Franco, A., Zas, R., Lagares, R., Sastre, I., Beyer, K., Lao, J.I., Miguel-Hidalgo, J.J., García, M., Guez, D., Cacabelos, R. Effects of S-9977-2 on learning and brain vasopressin in rats. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July, 1995. Alzheimer's Res., 1(Suppl. 1):120P (1995)
  • Miguel-Hidalgo, J.J., Maneiro, E., Franco, A., Álvarez, X.A., Cacabelos, R. Plastic effects of 1-28 amyloid -protein fragment deposits in the hippocampus with and without CDP-choline treatment. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1(Suppl. 1) :28 (1995).
  • Beyer, K., Lao, J.l., Álvarez, X.A., Franco, A., Cacabelos, R. Alzheimer's disease genotyping in families at risk. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1(Suppl. 1):47 (1995).
  • Fernández-Novoa, L., Franco-Maside, A., Álvarez, X.A., Maneiro, E., Lagares, R., Miguel-Hidalgo, J.J., Beyer, K., Bullido, M.J., Valdivieso, F., Caamaño, J., Gómez, M.J., Vinagre, D., Cacabelos, R. APO-E genotyped patients with senile dementia: Correlations between plasma interleukin-1 and whole blood histamine. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1(Suppl. 1):50 (1995).
  • Cacabelos, R., Franco, A., Bullido, M.J., Recuero, M., Sastre, L., Zas, R., Álvarez, X.A., Lao, J.I., Beyer, K., Valdivieso, F. APO-E genotypes in Alzheimer's disease and vascular dementia. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1(Suppl. 1):50 (1995).
  • Cacabelos, R., Vigo-Pelfrey, C., Franco-Maside, A., Lao, J.l., Beyer, K., Zas, R., Álvarez, X.A. Serum -amyloid levels in demented patients with different APO-E genotypes. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1 (Suppl. 1):51 (1995).
  • Álvarez, X.A., Zas, R., Lagares, R., Franco-Maside, A., Fernández-Novoa, L., Díaz, J., Cacabelos. R. Effects of the chronic administration of Anapsos on behavior in old mice. Int. Symp. Alzheimer's Res., Cambridge, UK, 4-7 July 1995. Alzheimer's Res., 1(Suppl. 1):53 (1995).
  • Álvarez, X.A., Fernández-Novoa, L., Franco, A., Zas, R., Lagares, R., Beyer, K., Lao, J.I., Miguel- Hidalgo, J.J., García, M., Guez, D., Cacabelos, R. Effects of S-9977-2 on learning and brain vasopressin levels in rats. Fourth IBRO World Congr. Neurosci., Kyoto, Japan, 9-14 July, pp. 376 (1995).
  • Miguel-Hidalgo, J.J., Lagares, R., Franco, A., Beyer, K., Lao, J.I., Álvarez, X.A., Cacabelos, R. Detection of bilateral neuronal degeneration after multiple lesions into the rat brain. Fourth IBRO World Neurosci. congr., Kyoto, Japan, 9-14 July, pp. 246 (1995).
  • Álvarez, X.A., Fernández-Novoa, L., Franco, A., Zas, R., Lagares, R., Beyer, K., Lao, J.I., Miguel-Hidalgo, J.J., García, M., Guez, D., Cacabelos, R. Effects of S-12024-2 on brain vasopressin levels in rats. Fourth IBRO World Congr. Neurosci., Kyoto, Japan, 9-14 July, pp. 122 (1995).
  • Cacabelos, R. Dementia. Aetiopathogenesis. V Castilian-Leonese Congress of Geriatrics and Gerontology. Benavente, 29-30 Sept., 1995.
  • Cacabelos, R. Senile cognitive decline: Characterization of genotypic-phenotypic correlations in Alzheimer's disease. Congr. Spanish Soc. Physiological Sciences & The Physiological Society, Salamanca, 2-5 Oct., 1995.
  • Cacabelos, R. CDP-Choline. Clinical experience. XI International Conference. Alzheimer's Disease International. Buenos Aires, 12-15 Sept., 1995.
  • Cacabelos, R., Franco-Maside, A., Bullido, M.J., Recuero, M., Sastre, I., Zas, R., Álvarez, X.A., Lao, J.I., Beyer, K., Valdivieso, F. Age- and sex-related APO-E genotypes in Alzheimer's disease and vascular dementia. 1995 World Congress on Psychiatric Genetics. Psychiatric Genetics 5:S70 (1995).
  • Beyer, K., Lao, J.I., Álvarez, X.A., Cacabelos, R. Rapid molecular detection of the fragile X gene trinucleotide repeat. 1995 World Congress on Psychiatric Genetics. Psychiatric Genetics 5:S85 (1995).
  • Álvarez, X.A., Zas, R., Lagares, R., Franco-Maside, A., Fernández-Novoa, L., Díaz, J., Cacabelos, R. Chronic Anapsos administration improves psychomotor functioning in old mice. 7th IPA Congress, Sydney, 29 Oct.-3 Nov., 1995.
  • Miguel-Hidalgo, J.J., Maneiro, E., Álvarez, X.A., Lagares, R., Franco, A., Fernández-Novoa, L., Lao, J.I., Beyer, K., Cacabelos, R. Effects of 1-28 AP deposits in the hippocampus with and without CDP-choline treatment. 7th IPA Congress, Sydney, 29 Oct.-3 Nov., 1995.
  • Beyer, K., Lao-Villadóniga, J.I., Zas, R., Franco-Maside, A., Lagares, R., Miguel-Hidalgo, J.J., Maneiro, E., Álvarez, X.A., Cacabelos, R. A rapid molecular characterization of Alzheimer's disease. 7th IPA Congress, Sydney, 29 Oct.-3 Nov., 1995.
  • Cacabelos, R., Franco, A., Bullido, M.J., Recuero, M., Sastres, I., Zas, R., Álvarez, X.A., Lao, J.I., Beyer, K., Valdivieso, F. APO-E genotypes in Alzheimer's disease and vascular dementia. 7th IPA Congress, Sydney, 29 Oct.-3 Nov., 1995.
  • Vigo-Pelfrey, C., Álvarez, X.A., Franco-Maside, A., Cacabelos, R. Serum -Amyloid levels in Alzheimer's disease and vascular dementia. 7th IPA Congress, Sydney, 29 Oct.-3 Nov., 1995.
  • Cacabelos, R. Pharmacological treatment of memory disorders. International Conference in Neuropsychiatry. Restoring Brain Function. A Multidisciplinary Approach. The University of Illinois, Chicago, 1-2 Dec., 1995.
  • Cacabelos, R. New therapeutic alternatives in dementias. III International Symposium-Workshop. Psychiatry, Schizophrenia and Dementias. Year 2000. Tenerife, 28-30 April, 1994.
  • Cacabelos, R. Conventional psychopharmaceuticals in psychogeriatrics. III International Symposium-Workshop. Psychiatry, Schizophrenia and Dementias. Year 2000. Tenerife 28-30 April, 1994.
  • Cacabelos, R. New strategies for Alzheimer's disease treatment: Pleiotropic drugs and multifactorial intervention. Third International Springfield Symposium on Advances in Alzheimer therapy. May 11-15, Springfield, Illinois, pp. 103 (1994).
  • Caamaño, J., Gómez, M.J., Franco, A., Álvarez, X.A., Fernández-Novoa, L., Novo, B., Vinagre, D., Cacabelos, R. Cerebrovascular and cognitive effects of CDP-choline in patients with Alzheimer's disease. Third International Springfield Symposium on Advances in Alzheimer Therapy. May 11-15, Springfield, Illinois, pp. 119 (1994).
  • Franco-Maside, A., Caamaño, J., Gómez, M.J., Vinagre, D., Álvarez, X.A., Fernández-Novoa, L., Novo, B., Zas, R., Cacabelos, R. Effects of CDP-choline in brain electrical activity mapping and cerebral blood flow velocities in Alzheimer's disease. Third International Springfield Symposium on Advances in Alzheimer Therapy. May 11-l5, Springfield, Illinois, pp. 120 (1994).
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Caamaño, J., Novo, B., Diaz, J., Sempere, J.M., Cacabelos, R. Effects of Anapsos on behavior and brain neuroimmune factors in rats with neurotoxic lesions in the nucleus basalis of Meynert. Third International Springfield Symposium on Advances in Alzheimer Therapy. May 11-l5, Springfield, Illinois, pp. 122 (1994).
  • Fernández-Novoa, L., Álvarez, X.A., Zas, R., Gómez, M.J., Vinagre, D., Sada. G., Cacabelos, R. Effects of Polypodium leucotomos (Difur) on behavior and the hippocampal levels of interleukin-1, histamine and tumor necrosis factor in nbM-lesioned rats. Third International Springfield Symposium on Advances in Alzheimer Therapy. May 11-15, Springfield, Illinois, pp. 122 (1994).
  • Cacabelos, R., Fernández-Novoa, L., Álvarez, X.A. Brain histamine in aging and senile dementia. XXIIIrd Annual Meeting European Histamine Res. Soc., Budapest, May 18-21, pp. 4 (1994).
  • Fernández-Novoa, L., Zas, R., Deslandes, A., Polo, E., Álvarez, X.A., Cacabelos, R. Time- and dose-dependent changes induced by S-9977-2 in brain histamine. XXIIIrd Ann. Meet. Eur. Histamine Res. Soc., Budapest, May 18-21, 1994.
  • Cacabelos, R., Franco-Maside, A., Caamaño, J., Zas, R., Novo, B., Fernández-Novoa, L., Álvarez, X.A. CDP-choline reduces blood histamine levels in Alzheimer's disease patients. XXIIIrd Ann. Meet. Eur. Histamine Res. Soc., Budapest, May 18-21, 1994.
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Cacabelos, R. Effects of neurotoxic lesions in the nucleus basalis of Meynert on brain histamine. XXIIIrd Ann. Meet Eur. Histamine Res. Soc., Budapest, May 18-21, 1994.
  • Caamaño, J., Franco-Maside, A., Cacabelos, R. Blood histamine correlates with cerebrovascular parameters and quantitative EEG in Alzheimer's disease. XXIIIrd Ann. Meet. Eur. Histamine Res. Soc., Budapest, May 18-21, 1994.
  • Cacabelos, R. Alzheimer's disease. V International Symposium. Sagrado Corazón" Neuropsychiatric Centre. Martorell, Barcelona, 16-18 June, 1994.
  • Cacabelos, R., Sempere, J.M. Etiopathogenic factors in Alzheimer's disease. Immune function. Biomedical Training Day. Introduction to neuroimmune and neurotrophic treatment in Alzheimer's disease. Medical College, Alicante, 10 June, 1994.
  • Cacabelos, R. Therapeutic strategies in Alzheimer's disease. Biomedical Training Day. Introduction to neuroimmune and neurotrophic treatment in Alzheimer's disease. Colegio Médicos, Alicante, 10 June, 1994.
  • Cacabelos, R. Biological markers and the cholinergic hypothesis in Alzheimer's disease. Putative mechanisms of action of Tacrine. Advances in the management of Alzheimer's disease. The role of Tacrine. Satellite Symposium. Fourth Meet. Eur. Neurol. Soc., Barcelona, 29 June, 1994.
  • Fernández-Novoa, L., Caamaño, J., Franco-Maside, A., Álvarez, X.A., Cacabelos, R. Blood histamine correlates with cerebrovascular parameters and brain electrical activity mapping in Alzheimer's disease. XIXth CINP, Washington DC, June 27-July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, pp. 215S (1994).
  • Fernández-Novoa, L., Álvarez, X,A., Cacabelos, R. CDP-choline-induced blood histamine changes in Alzheimer's disease. XIXth CINP, Washingon DC, June 27-July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, pp. 131S (1994).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Zas, R., Cacabelos, R. Effects of Anapsos on behavior and brain interleukin-1. XIXth CINP, Washingon DC, June 27-July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, pp. 38S (1994).
  • Cacabelos, R., Fernández-Novoa, L., Zas, R., Deslandes, A., García, M., Álvarez, X.A. Time- and dose-dependent effects of S-9977-2 on brain histamine. XIXth CINP, Washingon DC, June 27- July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, 147S (1994).
  • Franco-Maside, A., Caamaño, J., Gómez, M.J., Cacabelos, R. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease. XIX CINP, Washingon DC, June 27-July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, 216S (1994).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Zas, R., Kamoun, A., Polo, E., García, M., Cacabelos, R. Behavioral and neuroimmune effects of S-9977-2. XIXth CINP, Washingon DC, June 27-July 1, 1994. Neuropsychopharmacology, 10/3S/Part 2/May, 39S (1994).
  • Cacabelos, R. Therapy for two symptoms of Alzheimer's disease. Roundtable: Treating Alzheimer's disease: present potential and future prospects. University of Minnesota. Accreditation Council for Continuing Medical Education. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 20-August 3, 1994.
  • Álvarez, X.A., Franco-Maside, A., Fernández-Novoa, L., Caamaño, J., Gómez, M.J., Novo, B., Zas, R., Cacabelos, R. Blood levels of histamine, interleukin-1 and tumor necrosis factor in Alzheimer's disease. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 20-August 3, 1994. Neurobiol. Aging, 15(Suppl.1):S93 (1994).
  • Caamaño, J., Gómez, M.J., Vinagre, D., Franco, A., Fernández-Novoa, L., Álvarez, X.A., Zas, R., Novo, B., Cacabelos, R. Hemodynamic parameters of the middle cerebral artery in cerebrovascular disorders and senile dementia: A transcranial Doppler study. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 29-August 3, 1994. Neurobiol. Aging, 15 (Suppl.1):S96 (1994).
  • Franco-Maside, A., Caamaño, J., Vinagre, D., Gómez. M.J., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Brain electrical activity mapping correlates with cerebral blood flow velocity in Alzheimer's disease. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 29-August 3, 1994. Neurobiol. Aging, 15(Suppl.1):S98 (1994).
  • Gómez, M.J., Caamaño, J., Vinagre, D., Franco, A., Fernández-Novoa, L., Álvarez, X., Zas, R., Novo, B., Cacabelos, R. Cognitive and non-cognitive profiles in cerebrovascular disorders and senile dementia: A neuropsychological study. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 29-August 3, 1994. Neurobiol. Aging, 15(Suppl.1);S106 (1994)
  • Fernández-Novoa, L., Franco-Maside, A., Álvarez, X.A., Caamaño, J., Gómez, M.J., Zas, R., Cacabelos, R. Histamine, interleukin- IO and tumor necrosis factor correlate with brain electrical activity mapping in Alzheimer's disease. 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 29-August 3, 1994. Neurobiol. Aging, 15 (Suppl.l):S l21 (1994).
  • Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L. Brain tumour necrosis factor alpha (TNF) in Alzheimer's disease (AD). 4th Int. Conf. Alzheimer's Disease and Related Disorders. Minneapolis, July 29-August 3, 1994. Neurobiol. Aging, 15(Suppl.1):S152 (1994).
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Vinagre, D., Gómez, M.J., Sada, G., Cacabelos, R. Effects of polipodium leucotomos (Difur) on behavioral parameters and brain neuroimmune factors in nbm-lesioned rats. ECNP, Jerusalem, Oct. 16-21, 1994.
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Franco, A., Kamoun, A., Deslandes, A., Polo, E., Gorostiaga, C., Cacabelos, R. S-9977-2 normalizes behavior and brain interleukin-1 levels in rats with lesions in the nucleus basalis of Meynert. ECNP, Jerusalem, Oct. 16-21, 1994.
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Caamaño, J., Novo, B., Díaz, J., Sempere, J.M., Cacabelos, R. Behavioral and neuroimmune effects of anapsos in cognitively-impaired rats. ECNP. Jerusalem, Oct. 16-21, 1994.
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Cacabelos, R. Effects of scopolamine on behavior and brain neuroimmune factors in rats. 17th Ann. Meet. Eur. Neurosci. Assoc., Vienna, 4-8 Sept., pp. 95 (1994).
  • Álvarez, X.A., Fernández-Novoa, L., Zas, R., Vinagre, D., Sada, G., Cacabelos, R. Effects of polypodium leucotomos (Difur) on behavior and brain neuroimmune factors in nbM-lesioned rats. 17th Ann. Meet. Eur. Neurosci. Assoc., Vienna, 4-8 Sept., pp. 99 (1994).
  • Caamaño, J., Gómez, M.J., Vinagre, D., Franco, A., Fernández-Novoa, L., Álvarez, X.A., Zas, R., Novo, B., Cacabelos, R. Hemodynamic parameters of the middle cerebral artery in cerebrovascular disorders and senile dementia. 17th Ann. Meet. Eur. Neurosci. Assoc., Vienna, 4-8 Sept., pp. l l0 (1994).
  • Vinagre, D., Franco-Maside, A., Caamaño, J., Gómez, M.J., Álvarez, X.A., Fernández-Novoa, L., Novo, B., Zas, R., Cacabelos, R. Brain electrical activity mapping in senile dementia and cerebrovascular disorders. 17th Ann. Meet. Eur. Neurosci. Assoc., Vienna, 4-8 Sept., pp. 110 (1994).
  • Cacabelos, R., Franco, A., Fernández-Novoa, L., Zas, R., Díaz, J., Sempere, J.M., Álvarez, X.A. Behavioral and neuroimmune effects of Anapsos in intact and nbM-lesioned rats. IBC's Third Annual Alzheimer's Disease. Advances in Understanding and treatment. Philadelphia, 22-23 Sept. (1994).
  • Cacabelos, R., Fernández-Novoa, L., Zas, R., Franco-Maside, A., Deslandes, A., García, M., Kamoun, A., Álvarez, X.A. Effects of S-9977-2 on behavior and brain neuroimmune factors in rats. IBC's Third Annual Alzheimer's Disease. Advances in Understanding and Treatment. Philadelphia, 22-23 Sept. (1994).
  • Cacabelos, R., Caamaño, J., Gómez, M.J., Álvarez, X.A., Novo, B., Zas, R., García, M., Polo, E., Malbezin, M., Neuman, E., Guez, D. Effects of S-I2024-2 on cognition, brain mapping and cerebrovascular parameters in Alzheimer's disease. IBC's Third Annual Alzheimer's Disease. Advances in Understanding and Treatment. Philadelphia, 22-23 Sept. (1994).
  • Cacabelos, R., Álvarez, X.A., Franco-Maside, A., Fernández- Novoa, L., Caamaño, J., Valle-lnclán, F. Effect of CDP-Choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Proc. 7th Meeting International Study Group on the Pharmacology of memory disorders associated with aging. Alzheimer's disease: Amyloid precursor proteins, signal transduction, and neural transplantation. Nitsch, R.M., Growdon, J.H., Corkin, S., Wurtman, R.J., Zürich, Switzerland, Feb. 12-14; pp. 391-393 (1993).
  • Cacabelos, R. Biomedical aspects of Alzheimer's disease: Introductory remarks. International Workshop on Alzheimer's disease: Progress for the next decade. Fundación Ramón Areces, March 22-23, 1993.
  • Cacabelos, R. New trends for an etiopathogenic therapy in Alzheimer's disease. International Workshop on Alzheimer's disease: Progress for the next decade. Ramón Areces Foundation. March 22-23, l993.
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Novo, B., Rettori, M.C., García, M., Cacabelos, R. Effects of S-9977-2 on learning and behavior in rats with neurotoxic lesions in the nucleus basalis of Meynert (NBM). Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. Collegium Internationale Neuro-Psychopharmacologicum (CINP) President's Workshop. Capri (Italy), May 1-3, 1993. pp. 125 (1993).
  • Gómez, M.J., Cacabelos, R. Alzheimer's Disease Assessment Scale in control elderly subjects and in patients with Alzheimer's disease or multi-infarct dementia. Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. CINP. President's Workshop. Capri (Italy), May 1-3, pp. 141 (1993).
  • Franco-Maside, A., Caamaño, J., Gómez, M.J., Álvarez, A., Fernández-Novoa, L., Novo, B., Cacabelos, R. CDP-Choline-induced brain mapping changes in patients with Alzheimer's disease. Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. CINP. President's Workshop. Capri (Italy), May 1-3, pp. 154 (1993).
  • Caamaño, J., Franco, A., Gómez, M.J., Novo, B., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Acute effects of CDP-Choline on middle cerebral artery blood flow velocities in Alzheimer's disease: A transcranial Doppler study. Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. CINP. President's Workshop. Capri (Italy), May 1-3, pp. 155 (1993).
  • Cacabelos, R, Perspectivas actuais do tratamento da demencia de Alzheimer. Demencias: Avanços recentes. Actualizaçao nos aspectos bioquímicos, clínicos e terapéuticos. Hospital de Universidade de Coimbra. Coimbra, Portugal, May 8, 1993.
  • Cacabelos, R. Alzheimer's disease: Diagnostic and therapeutic strategies. VIII Congr. Soc. Castellano-leonesa Cantabria de Medicina Interna. Zamora, May 14-15, 1993. Anales Medicina Interna, Extra II, May, pp. 19 (1993).
  • Cacabelos, R. Role of histamine and interleukin-1 in the neuroimmune dysregulation occurring in Alzheimer's disease. Eur. Histamine Res. Soc., Cologne, Germany, May 19-22, pp. 7 (1993).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of neurotoxic lesions in histaminergic neurons on psychomotor activity and learning. Eur. Histamine Res. Soc., Cologne, Germany, May 19-22, pp. 70 (1993).
  • Fernández-Novoa, L., Franco, A., Álvarez, X.A., Cacabelos, R. Changes in serum histamine and tumor necrosis factor (TNF) from patients with Alzheimer's disease and multi-infarct dementia. Eur. Histamine Res. Soc., Cologne, Germany, May 19- 22, pp. 89 (1993).
  • Fernández-Novoa, L., Franco, A., Lodeiro, C., Álvarez, X.A., Cacabelos, R. Effects of histamine and alpha-fluoromethylhistidine on brain tumor necrosis factor levels. Eur. Histamine Res. Soc., Cologne, Germany, May 19-22, pp. 90 (1993).
  • Franco, A., Fernández-Novoa, L., Lodeiro, C., Álvarez, X.A., Cacabelos, R. Effects of histamine and antihistaminics on the hippocampal levels of interleukin-1 in rats. Eur. Histamine Res. Soc., Cologne, Germany, May 19-22, pp. 91 (1993).
  • Fernández-Novoa, L., Franco, A., Álvarez, X.A., Cacabelos, R. Effects of neurotoxic lesions in histaminergic neurons on brain tumor necrosis factor. Eur. Histamine Res. Soc., Cologne, Germany, May 19-22, pp. P-86 (1993).
  • Caamaño, J., Valle-lnclán, F., Cacabelos, R. Blood flow velocity in multi-infarct dementia and Alzheimer's disease studied by transcranial Doppler ultrasonography. World Congr. Gerontology. XVth Congr. Intern. Assoc. Gerontology, Budapest, July 4-9, pp. 301 (1993).
  • Álvarez, X.A., Franco, A., Novo, B., Fernández-Novoa, L., Cacabelos, R. Age-dependent serum interleukin-1 beta levels in healthy control subjects. World Congr. Gerontology. XVth Congr. Intern. Assoc. Gerontology, Budapest, July 4-9, pp. 302 (1993).
  • Cacabelos, R., Fernández-Novoa, L., Pérez-Trullén, J.M., Franco, A., Álvarez, X.A. Serum tumor necrosis factor (TNF) in Alzheimer's disease (AD) and multi-infarct dementia (MID). World Congr. Gerontology. XVth Congr. Intern. Assoc. Gerontology, Budapest, July 4-9, pp. 302 (1993).
  • Gómez, M.J., Álvarez, X.A., Cacabelos, R. Dementia mood assessment scale in elderly controls and in patients with depression and/or dementia. World Congr. Gerontology. XVth Congr. Intern. Assoc. Gerontology, Budapest, July 4-9, pp. 302 (1993).
  • Cacabelos, R. Biochemical basis of bipolar affective disorder. XVII Reunión Nacional Soc. Esp. Biol., Salamanca, June 16-19 (1993).
  • Caamaño, J., Franco, A., Gómez, M.J., Novo, B., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Cerebrovascular effects of CDP-choline in patients with Alzheimer's disease: A transcranial Doppler study. Sixth Congr. Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Gómez, M.J., Cacabelos, R. Alzheimer's disease assessment scale in control elderly subjects and in patients with senile dementia. Sixth Congr. Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Franco-Maside, A., Caamaño, J., Cacabelos, R. Brain electrical activity mapping correlates with cerebral blood flow velocity in Alzheimer's disease. Sixth Congr. Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Cacabelos, R., Miller, D., Álvarez, X.A., Fernández-Novoa, L., Franco-Maside, A., Nishimura, T., Pearson, J. Brain interleukin-1 in Alzheimer's disease and vascular dementia. Sixth Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of Anapsos on psychomotor activity, passive avoidance behavior and brain interleukin-1 levels. Sixth Congr. Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Álvarez, X.A., Franco, A., Rettori, M.C., Polo, E., García, M., Cacabelos, R. Effects of S9977-2 on behavior and brain interleukin-1 levels in an animal model of cognitive impairment. Sixth Congr. Intern. Psychogeriat. Assoc. (IPA), Berlin, Sept. 5-10, 1993.
  • Caamaño, J., Franco, A., Gómez, M.J., Novo, B., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Cerebrovascular effects of CDP-choline in patients with Alzheimer's disease: Hemodynamic parameters measured by transcranial Doppler ultrasonography. 16th Ann. Meeting Eur. Neurosci. Assoc., Madrid, Sept. 18-21, pp. 88, 1993.
  • Franco-Maside, A., Caamaño, J., Cacabelos, R. Brain electrical activity mapping correlates with cerebral blood flow velocity in Alzheimer's disease. 16th Ann. Meeting Eur. Neurosci. Assoc., Madrid, Sept. 18-21, pp. 89, 1993.
  • Álvarez, X.A., Fernández-Novoa, L., Franco, A., Cacabelos, R. Influence of brain histamine on interleukin-1 production in the hypothalamus and hippocampus. 16th Ann. Meeting Eur. Neurosci. Assoc., Madrid, Sept. 18-21, pp. 169, 1993.
  • Fernández-Novoa, L., Álvarez, X.A., Franco-Maside, A., Caamaño, J., Cacabelos, R. CDP-choline-induced changes in blood histamine in patients with Alzheimer's disease. 16th Ann. Meeting Eur. Neurosci. Assoc., Madrid, Sep. 18-21, pp. l l8, 1993.
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Rettori, M.C., García, M., Cacabelos, R. Time- and dose-dependent effects of S9977 on behavior and brain interleukin-1. First Int. Congr. on Hormones, Brain and Neuropharmacology, Rhodes, Sept. 13-17, 1993. Neuropsychopharmacology 9/2S:78S (1993).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of Anapsos on behavior and brain neuroimmune factors. First Int. Congr. on Hormones, Brain and Neuropsychopharmacology, Rhodes, Sept. 13-17, 1993. Neuropsychopharmacology, 9/2S:164S (1993).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of neurotoxic lesions in histaminergic neurons on behavior and brain cytokines. First Int. Congr. on Hormones, Brain and Neuropsychopharmacology, Rhodes, Sept. 13-17, 1993. Neuropsychopharmacology 9/2S:164S (1993).
  • Cacabelos, R. Present and future of research on Alzheimer's disease. III Congr. Soc. Gallega Gerontología y Geriatría, La Coruña, Sep. 23-25, 1993.
  • Cacabelos, R. Alzheimer's disease: Perspectives for a decade. Primeres Jornades Geriàtriques, Malatia d'Alzheimer, Universitat Ramon Llull, Barcelona, Oct. 22-23, 1993.
  • Cacabelos, R. Neurobiology and molecular genetics of Alzheimer's disease. International symposium: Current perspectives in human genetics. Fundación Ramón Areces, Madrid, Oct. 25-27, 1993.
  • Franco-Maside, A., Caamaño, J., Gómez, M.J., Álvarez, X.A., Fernández-Novoa, L., Novo, B., Cacabelos, R. CDP-choline-induced brain mapping changes in patients with Alzheimer's disease. 6th Congr. ECNP, Budapest, Oct. l l-l4, 1993.
  • Caamaño, J., Franco, A., Gómez, M.J., Novo, B., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Acute effects of CDP-choline on middle cerebral artery blood flow velocities in Alzheimer's disease: A transcranial Doppler study. 6th Congr. ECNP, Budapest, Oct. 11-l4, 1993.
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Age-related changes in serum interleukin-1 and tumor necrosis factor-alpha levels in healthy control subjects. 6th Congr. ECNP, Budapest, Oct. 11-14, 1993.
  • Álvarez, X.A., Franco, A., Kamoun, A., Polo, E., Cacabelos, R., Rettori, M.C. S9977-2 reduces learning impairment and brain interleukin-1 overproduction in rats with neurotoxic lesions in the nucleus basalis of Meynert. 6th Congr. ECNP, Budapest, Oct. 11-14, 1993.
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of Anapsos on behavior and brain neuroimmune function. 6th Congr. ECNP, Budapest, Oct. 11-14, 1993.
  • Cacabelos, R. Tratamento farmacologico da Doença de Alzheimer: Bases moleculares. Psiquiatría: das suas raices aos seus elos de ligaçao. Figueira da Foz, Oct. 28-30, 1993.
  • Cacabelos, R. Ageing and dementia in the framework of primary care. Bayer Satellite Symposium. Congr. Soc. Fam. Comunitaria. La Coruña, Nov. 11-13, 1993.
  • Cacabelos, R. Molecular psychopharmacology of Alzheimer's disease, New therapeutic strategies. IV Congr. Intern. Pharmacotherapy and Geriatric Nutrition, Valencia, 26-29.2.92 (1992).
  • Cacabelos, R. Molecular neurobiology of Alzheimer's disease. Therapeutic prospects. I Symposium on Psychobiology. Current Perspectives in Psychobiology Research. La Coruña, 9-13.3.92 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. GRF-induced GH response in opiate addicts. Int. Meeting. Strategies for studying CNS active compounds: Models, screens and clinical syndromes. Madrid, 26 April-2 May, 1992. Behav. Pharmacol., 3(Suppl. 1):60 (1992).
  • Fernández-Novoa, L., Pastuzko, A., Franco, A., Álvarez, X.A., Cacabelos, R. Effects of neurocatin on the release and level of serotonin in synaptosomes from the rat brain. Int. Meeting. Strategies for studying CNS active compounds: Models, screens and clinical syndromes. Madrid, 26 April-2 May, 1992. Behav. Pharmacol., 3(Suppl. 1):94 (1992).
  • Fernández-Novoa, L., Pastuszko, A., Franco, A., Álvarez, X.A., Cacabelos, R. The effects of neurocatin on serotonin metabolism in synaptosomes from the rat brain. Int. Meeting. Strategies for studying CNS active compounds: Models, screens and clinical syndromes. Madrid, 26 April-2 May, 1992. Behav. Pharmacol., 3(Suppl. 1):94-95 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Positive effects of GHRP-6 on passive avoidance behavior in a new experimental paradigm. Int. Meeting. Strategies for studying CNS active compounds: Models, screens and clinical syndromes. Madrid, 26 April-2 May, 1992. Behav. Pharmacol., 3(Suppl. 1):84-85 (1992).
  • Cacabelos, R., Fernández-Novoa, L., Franco-Maside, A., Álvarez, A. Neuroendocrine and neuroimmune modulatory effects of brain histamine: physiological responses and pathological implications in Alzheimer's disease. XXI Ann. Meeting European Histamine Research Society. Torremolinos, Málaga, 13-17 May, 1992, pp. 90 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of betahistine on locomotor activity and passive avoidance behavior in rats. XXI Ann. Meeting European Histamine Research Society. Torremolinos, Málaga, l3-17 May, pp. 95 (1992).
  • Cacabelos, R. Neuroimmune function in mental disorders: role of brain histamine as a neuroimmunomodulator in physiological and pathological conditions. XII Congr. Asoc. Latinoamer. Biol. Soc. Biol. Med. Madrid, May 25-28 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Dose- and time-dependent effects of histamine on hypothalamic levels of interleukin-1 in rats. XXI Ann. Meeting European Histamine Research Society. Torremolinos, Málaga, 13-17 May, pp. 107 (1992).
  • Cacabelos, R. Towards an etiopathogenic treatment of Alzheimer's disease: Molecular psychopharmacology. Round Table: New therapeutic alternatives in Alzheimer's disease, III Congr. Nac. Soc. Esp. Biol., Pamplona 17-20 June, pp. 63-64 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Positive effects of betahistine on scopolamine-induced learning impairment in rats. III Congr. Nac. Soc. Esp. Biol., Pamplona 17-20 June, pp. 259-260 (1992).
  • Franco, A., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Effects of treatment with citicoline on cognitive function and serum levels of interleukin-1 in senile dementia, III Congr. Nac. Soc. Esp. Biol., Pamplona 17-20 June, pp. 260-261 (1992).
  • Caamaño, J., Valle-lnclán, F., Cacabelos, R. Blood flow velocities in middle cerebral artery of patients with vascular dementia: evaluation by transcranial Doppler ultrasonography. III Congr. Nac. Soc. Esp. Biol., Pamplona 17-20 June (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Age- and sex-related serum growth hormone (GH) levels in psychiatric patients and healthy control subjects. A correlation study between GH values and cognitive performance. Proc. 18th Collegium Internationale Neuro- Psychopharmacologicum Congress. Nice, June 28-July 2, 1992. Clin. Neuropharm., 15(Suppl. 1-B);283B (1992).
  • Cacabelos, R., Franco-Maside, A., Álvarez, X.A. Therapeutic effects of CDP-Choline on cognition and cardiovascular parameters in Alzheimer's disease. Proc. 18th CINP Congress, Nice, June 28-July 2, 1992. Clin. Neuropharmacol., 15(Suppl. 1-B):474B (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of betahistine on behavior in rats. Preliminary results. Proc. 18th CINP Congress, Nice, June 28-July 2, 1992. Clin. Neuropharmacol., 15(Suppl. 1-B) :478B (1992).
  • Fernández-Novoa, L., Pastuszko, A., Franco, A., Álvarez, X.A., Cacabelos, R. Inhibition of monoamine oxidase A by neurocatin in synaptosomes from rat brain. Proc. 18th CINP Congress, Nice, June 28-July 2, 1992. Clin. Neuropharmacol., 15(Suppl. 1-B):590B (1992).
  • Cacabelos, R., Álvarez, X.A., Franco-Maside, A., Fernández-Novoa, L., Caamaño, J., Valle-lnclán, F. Influence of CDP-Choline on cognition and interleukin-1 in Alzheimer's disease (AD) and multi-infarct dementia (MID). The Third International Conference on Alzheimer's Disease and Related Disorders. Padova, July 12-17, 1992. Neurobiol. Aging 13(Suppl. 1):S134-S135 (1992).
  • Cacabelos, R., Álvarez, X.A., Franco, A., Fernández-Novoa, L., Caamaño, J., Valle-lnclán, F., Secades, J., Novell, R., Lozano, R. Therapeutic effects of CDP-Choline in Alzheimer's disease and multi-infarct dementia. International Conference on Neurodegenerative Disease. New Approaches to Treatment. London. 15-16 Sept., 1992.
  • Cacabelos, R., Álvarez, X.A., Franco, A., Fernández-Novoa, L., Caamaño, J., Valle-lnclán, F., Secades, J., Novell, R., Lozano, R. Effects of CDP-Choline in Alzheimer's disease and multi-infarct dementia: Influence on cognition, mood, and interleukin- production. 8th lnt. Meeting and Conference. Alzheimer Disease International (ADI). Brussels, Sept. 25-27 (1992).
  • Cacabelos, R., Álvarez, X.A., Franco, A., Fernández-Novoa, L., Caamaño, J., Valle-lnclán, F., Secades, J., Novell, R., Lozano, R. Therapeutic effects of CDP-Choline in Alzheimer's disease and multi-infarct dementia. Int. Conf. Neurodegenerative Disease. New Approaches to Treatment. London, Sept. 15-16 (1992).
  • Cacabelos, R. Basic mechanisms and classification of memory disorders with special reference to dementias. Workshop: Technical aids for memory and environmental control in dementia and other cognitive impairment. NORAGE '92. First Congress of the Nordic Society for Research in Brain Aging. Sheraton Copenhagen Hotel, Copenhagen, Denmark, Oct. 9-10 (1992).
  • Cacabelos, R. Therapeutic strategies in Alzheimer's disease. Advances in Alzheimer's disease and the relationship between A.F.A.F. and lines of research in Spain. 1st Meeting of the Andalusian Association of Alzheimer's Relatives and 1st Congress of the Spanish Federation of Associations of Relatives of Alzheimer's patients. Malaga, Oct. 1-2 (1992).
  • Valle-lnclán, F., Caamaño, J., Cacabelos, R. Functional relationship between blood-flow velocity in middle cerebral artery and EEG spectral analysis. Vth Congr. Congr. College Neuropsychopharmacology. Marbella, 18-21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:326 (1992).
  • Franco, A., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Betahistine attenuates learning impairment induced by scopolamine in rats. Vth Congr. Congr. College Neuropsychopharmacology. Marbella, 18-21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:354 (1992).
  • Caamaño, J., Valle-lnclán, F., Cacabelos, R. Parieto-temporal hypoperfusion in Alzheimer's disease measured by transcranial doppler ultrasonography. Vth Congr. Congr. College Neuropsychopharmacology. Marbella, 18-21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:360 (1992).
  • Fernández-Novoa, L., Pérez-Trullén, J.M., Cacabelos, R. Serum histamine in Alzheimer's disease and multi-infarct dementia. Vth Congr. Congr. College Neuropsychopharmacology, Marbella 18- 21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:360 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Central and peripheral interleukin-l in Alzheimer's disease. Vth Congr. Congr. College Neuropsychopharmacology, Marbella 18- 21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:361-362 (1992).
  • Cacabelos, R., Álvarez, X.A., Franco-Maside, A., Fernández- Novoa, L., Caamaño, J., Valle-lnclán, F. Effect of CDP-Choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Vth Congr. Congr. College Neuropsychopharmacology, Marbella 18-21 Oct. 1992. Eur. Neuropsychopharmacol., 2/3:362-363 (1992).
  • Gómez, M.J., Álvarez, X.A., Cacabelos, R. Dementia Mood Assessment Scale in elderly controls and in patients with depression and/or cognitive impairment. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov., 1992. Annals Psychiatry 8(Suppl. 1):102 (1992).
  • Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Serum growth hormone (GH) levels in psychiatric patients. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov., 1992. Annals Psychiatry, 8(Suppl.1)106 (1992).
  • Caamaño, J., Valle-lnclán, F., Cacabelos, R. Blood flow velocity in multi-infarct dementia and Alzheimer's disease: Neuropsychological correlations. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov., 1992. Annals Psychiatry, 8(Suppl.1):107-108 (1992).
  • Cacabelos, R., Álvarez, X.A., Franco, A., Gómez, M.J., Fernández-Novoa, L., Caamaño, J., Valle-lnclán, F. Influence of CDP-Choline on cognitive parameters in Alzheimer's disease and multi-infarct dementia. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov., 1992. Annals Psychiatry, 8(Suppl.1):108 (1992).
  • Cacabelos, R., Fernández-Novoa, L., Franco, A., Álvarez, X.A. Serum histamine and tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov. 1992. Annals Psychiatry, 8(Suppl.1):108 (1992).
  • Franco, A., Álvarez, X.A., Fernández-Novoa, L., Cacabelos, R. Serum interleukin-1p in control subjects and senile dementia. 6th Eur. Congr. Assoc. Eur. Psychiat., Barcelona 3-7 Nov. 1992. Annals Psychiatry, 8(Suppl.1):109 (1992).
  • Franco, A., Álvarez, X.A., Mallo, F., Díaz, E., Cacabelos, R. Learning impairment by passive avoidance in rats with retinoic acid deficient diet. X Congr. Nac. Soc. Esp. Endocrinology. Santiago de Compostela, 5-7 June, 1991. Endocrinology, 38(Suppl.2):39 (1991).
  • Álvarez, X., Franco, A., Mallo, F., Díaz, E., Cacabelos, R. Effect of growth hormone releasing hexapeptide (GHRP-6) on behaviour in rats. Xth Nat. Soc. Congr. Esp. Endocrinology. Santiago de Compostela, 5-7 June, 1991. Endocrinology, 38(Suppl.2);44-45 (1991).
  • Franco-Maside, A., Álvarez, X.A., Cacabelos, R. Atrial natriuretic peptide in Alzheimer's disease. 5th World Congr. Biol. Psychiatry, Florence, Italy, June 9-14, 1991. Biol. Psychiatry 29/11S:479S-480S (1991).
  • Álvarez, X.A., Franco-Maside, A., Cacabelos, R. GRF-induced GH response in Alzheimer's disease (AD), multi-infarct dementia (MID), and pseudodementia (PD). 5th World Congr. Biol. Psychiatry, Florence, Italy, June 9-14, 1991. Biol. Psychiatry, 29/l l S:685S (1991).
  • Cacabelos, R., Franco-Maside, A., Álvarez, X.A. Interleukin-l (IL-1) in Alzheimer's disease (AD). 5th World Congr. Biol, Psychiatry, Florence, Italy, June 9-14, 1991. Biol. Psychiatry, 29/11S:687S (1991).
  • Cacabelos, R., Barquero, M., García, P., Álvarez, X.A., Varela de Seijas, E. Cerebrospinal fluid interleukin 1 in Alzheimer's disease. XXII Congr. Intern. Soc. Psychoneuroendocrinology, Siena, Italy, June 17-20, 1991. Neuroendocr. Lett., 13 :206 (1991).
  • Franco, A., Álvarez, X.A., Cacabelos, R. Acute effects of growth hormone releasing factor (GRF) on cognitive function in aging and senile dementia. XXII Congr. intern. Soc. Psychoneuroendocrinology, Siena, Italy, June 17-20, 1991. Neuroendocr. Lett., 13:213 (1991).
  • Álvarez, X.A., Vara, E., Barquero, M., García, P., Moreno, A., Varela de Seijas, E., Cacabelos, R. Cerebrospinal fluid (CSF) insulin in Alzheimer's disease. XXII Congr. Intern. Soc. Psychoneuroendocrinology. Siena, Italy, June 17-20, 1991. Neuroendocr. Lett., 13:249 (1991).
  • Álvarez, X.A., Franco, A., Fernández, L., Caso, J., Cacabelos, R. Interleukin-l in senile dementia. Correlation with physiological and cognitive parameters. Il Eur. Congr. Gerontol., Madrid 11-14 Sept., 1991. Gerontol. Gerontol., 26 (Suppl.1):202 (1991).
  • Franco, A., Álvarez, X.A., Caso, J., Fernández, L., Cacabelos, R. Atrial natriuretic peptide in senile dementia. Il Eur. Congr. Gerontol., Madrid 11-14 Sept., 1991. Rev. Esp. Gerontol., 26 (Suppl. 1):202 (1991).
  • Álvarez, X.A., Franco, A., Caso, J., Fernández, L., Cacabelos, R. GRF-induced GH response in senile dementia. Correlation between neurophysiological and neuroendocrine parameters. II Eur. Congr. Gerontol., Madrid 11-l4 Sept., 1991. Gerontol. Gerontol., 26 (Suppl. l):203 (l99l).
  • Cacabelos, R. Brain histamine: Neuroendocrine regulator in physiological and pathological conditions. Symposium Biogenic Amines. 1st Int. Cong. Vitamins and Biofactors in Life Sciences (ICVB): Kobe, Japan, Sept. 16-20; pp. 53 (1991).
  • Cacabelos, R., Álvarez, X.A. Environmental factors, development and cognition: Influence of the somatotropinergic system (STS) on mental function and psychomotor activity. VIth Int. Congr. Auxology. Madrid, 15-19 Sept. (1991).
  • Pérez-Trullén, J.M., Vázquez-André, M.L., Álvarez, X.A., Cacabelos, R. The P300 wave as a diagnostic method in Alzheimer's disease. IV Congr. Soc. Esp. Neurosciencia. Alicante 30.9-3.10, 25.16-P (1991).
  • Álvarez, X.A., Franco, A., Mallo, F., Díaz, E., Cacabelos, R. Testosterone treatment reverses retinoic acid deficiency-induced learning impairment in rats. IV Cong. Soc. Esp. Neurosciencia, Alicante 30.9-3.10, 32-16-P (1991).
  • Álvarez, X.A., Franco, A., Cacabelos, R. Effects of GRF(1- 29)NH2 on cognitive function in senile dementia. IV Cong. Esp. Soc. Neurosciencia, Alicante 30.9-3.10, 32-17P (1991).
  • Cacabelos, R. Genetic markers in Psychiatry. XVI Reun. Nac. Soc. Esp. Biological Psychiatry, Vitoria, 7-9 Nov., (1991).
  • Franco, A., Álvarez, X.A., Gómez-Trigo, J., Caamaño, J., Cacabelos, R. Influence of GRF on mental function in senile dementia. XVI Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: 111 (1991).
  • Álvarez, X.A., Franco, A., Gómez-Trigo, J., Caamaño, J., Cacabelos, R. Central and peripheral interleukin-1 in senile dementia. XVI Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: 111 (1991).
  • Álvarez, X.A., Franco, A., Gómez-Trigo, J., Caamaño, J., Vara, E., Barquero, M., García, P., Moreno, A., Varela de Seijas, E., Cacabelos, R. Central insulin in senile dementia. XVI Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: 112 (1991).
  • Pérez-Trullén, J.M., Vázquez André, M.L., Cacabelos, R. Study of prosody in Alzheimer's disease. XVI Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: 113 (1991).
  • Pérez-Trullén, J.M., Vázquez André, M.L., Caso, J., Álvarez, X.A., Franco, A., Cacabelos, R. Language alterations in Alzheimer's disease. XV1 Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: l l3 (1991).
  • Pérez-Trullén, J.M., Vázquez-André, M.L., Modrego, A., Álvarez, X.A., Cacabelos, R. Memory disorders and P300 in Alzheimer's disease. XVI Reun. Nac. Soc. Esp. Biol., Vitoria, 7-9 Nov., 1991. Anales Psiquiatría, 7: 114 (1991),
  • Cacabelos, R. New aspects of the aetiopathogenesis of Alzheimer's disease. International Workshop. Ageing and Preventive Pharmacology. Alicante, 13-14 Dec., (1991).

Courses and Seminars

  • The alternative stock market: Why should an SME go public? Hotel InterContinental, Madrid, 31 March, 2011.
  • New perspectives in genomic medicine in the workplace. VI Seminar on Occupational Medicine. Garrigues Auditorium, Madrid, 26 October, 2011.
  • Social impact of genomics and personalised medicine. Directorate General of the Police and the Civil Guard. National Police Force. Training and Development Division. Galician Police Headquarters. Auditorium of the Caixa Galicia Foundation, Coruña, 20 April, 2010.
  • Genomic medicine and personalisation of pharmacological treatment. Fedefarma. Pharmaceutical Federation. Aula de Formación de Massanassa, Valencia, 3 June, 2010.
  • Health biotechnology. Presentation of the Agri-Food City of Tudela, Madrid, March 24 (2009).
  • Biotechnology applied to human nutrition in the fishery and aquaculture product preservation industry. Anfaco-Cecopesca Conference. Vigo, 24 June (2009).
  • Pharmacogenomics in Alzheimer's disease. University of Guadalajara, University Centre of Health Sciences, Guadalajara, Mexico. 29 Nov (2007).
  • Genomic Medicine. Autonomous University of Guadalajara. Dirección de Comunicación Universitaria, Guadalajara, Mexico. 30 Nov (2007).
  • The Health of Executives: Risks and Prevention. Spanish Association of Executives (AED). UNESA Assembly Hall, Madrid. 14th March 2006.
  • Master in Social Gerontology. 5th Ibero-American Edition, La Serena, Chile, 2005-2006. Director: Rocío Fernández-Ballesteros.
    Biology of Ageing (6 hours)
    Neurobiology of Pathological Ageing (4 hours).
  • Genomic Medicine. Course "Latest trends in the design of antiparasitic drugs and vaccines". Scientific Calculation Centre, University of the Andes, Merida, Venezuela. 5-9 June, 2006.
  • Neurological Diseases: Present and Future. Galician Association of Study and Opinion (AGEO). Hostal Reyes Católicos, Santiago de Compostela. 16th June (2006).
  • Genomic Medicine and degenerative diseases. Summer Courses 2006 Complutense University. Gene Therapy (Director: Antonio Liras). Royal Victoria Eugenia Foundation, El Escorial. 3-7 July (2006).
  • Genomic Medicine of the Future. Conferences of ENCIGA (Asociación dos Ensinantes de Ciencias de Galicia). Aula Magna da Facultade de Matemáticas de Santiago de Compostela. (27.10.2006).
  • Functional Genomics and Pharmacogenomics of Alzheimer's Disease. Karolinska Institutet, Huddinge, Stockholm. June 8, 2005.
  • Genomic Medicine: The great challenges of the future. Spanish Plan for Brain Risk Prevention and Genomic Medicine. Spanish Society of Genomic Medicine. Murcia. 28th April, 2005.
  • Opportunities and challenges of individualised and predictive medicine. Biotechnology and Health Conference. Challenges for Spanish Companies. Madrid. 24 May, 2005.
  • Course on Genomic Medicine for Occupational Medicine Specialists. Director: Ramón Cacabelos and Javier Sanz. National School of Occupational Medicine, Complutense University, Madrid. 23rd June, 2005.
  • Genomic Medicine and Freedom of the Individual. Ramazzini Club, Casino, Madrid. 23rd June, 2005.
  • Genomic Medicine: Challenges of the Future. Healthy Soria. Caja Rural Foundation, Soria. 3 Nov. 2005.
  • Biological Bases: Neurobiology of brain ageing. Master's Degree in Social Gerontology. Speciality in Gerontological Service Quality. Director: R. Fernández-Ballesteros. Faculty of Psychology. Autonomous University of Madrid. Madrid. January-December 2004.
  • Genomic Medicine: Implications for Diagnosis and Treatment. Brno Faculty Hospital. Center of Molecular Biology and Gene Therapy, Brno, Czech Republic. 3 May, 2004.
  • Pharmacogenetics in Complex Disorders. Institute of Haematology and Blood Transfusion. St. Charles University General Hospital, Prague, Czech Republic. 4 May, 2004.
  • Therapeutic strategies in pharmacogenomics and nutraceutical products. Continuing Education Programme. Federació Farmacéutica S. Coop. C.L. Valencia. May, 2004.
  • Current state of knowledge on dementias: Past and Future. Psychological and socio-health aspects of dementias: Challenges for the future. University Extension Courses. University of Oviedo. (10-14.2.2003).
  • Alzheimer's disease today. Summer courses at the University of Cantabria. IV Santander Summer Courses. Society and Alzheimer's disease: Challenges for the future. Santander. (7-11 July, 2003).
  • Alzheimer's disease and other dementias: keys to differential diagnosis. Summer courses at the University of Cantabria. IV Santander Summer Courses. Society and Alzheimer's disease: Challenges for the future. Santander. 7-11 July, 2003.
  • Towards an etiopathogenic treatment of Alzheimer's disease. Ferrer Research Centre, Barcelona. (20.2.2002).
  • Biological bases of old age: Neurobiology of brain ageing. Specialist course in social gerontology. Autonomous University of Madrid, Faculty of Psychology, and Ministry of Labour and Social Affairs. Madrid. 2002.
  • Biotechnology for human and animal health. Experts Meeting. ASEBIO. Madrid. (5.12.2002).
  • Master in Social Gerontology. 4th Iberoamerican Edition, San Luis Potosi, Mexico, 2002-2003. Ministry of Labour and Social Affairs/IMSERSO; Faculty of Psychology, Autonomous University of Madrid; Ministry of Social Development (SEDESOL); National Institute for the Elderly (INAPAM), Mexico.
    -Biology of Ageing (6 hours)
    -Neurobiology of Pathological Ageing (4 hours).
  • Biological bases of old age. Master's Degree in Social Gerontology. Autonomous University of Madrid. 2001.
  • Neurobiology of Pathological Ageing. Master's Degree in Social Gerontology. Autonomous University of Madrid. 2001.
  • Neurological diseases in adulthood. Current and future needs, care and resources. Ageing and disability: The socio-health challenge. II University Master's Degree in Direction and Management of Gerontological and Socio-Sanitary Programmes and Centres. University of Vigo and Ministry of Labour and Social Affairs. 2001.
  • Pharmacogenomics of Alzheimer's disease. EuroEspes 10th Anniversary Conference. EuroEspes Biomedical Research Centre, Bergondo, La Coruña. (19.4.2001).
  • Cows tolas and media. Concello de Porriño, Concellería de Cultura, Porriño, Pontevedra. (25.4.2001).
  • Prion diseases in cattle and sheep. Diagnosis during the life of the animal. Genetic certification of a livestock farm. Asociación Mutual Aseguradora (AMA), Madrid. (8.5.2001).
  • Alzheimer's disease today: major challenges. 61st University Extension Summer Courses. Advances in Alzheimer's disease (Cod. 1680.61). University of Oviedo, Gijón. (2-6.7.2001).
  • Current research and prospects for the treatment of Alzheimer's disease. 61st University Extension Summer Courses. Advances in Alzheimer's disease (Cod. 1680.61). University of Oviedo, Gijón. (2-6.7.2001).
  • Identification of genetic risk and pharmacogenomics of Alzheimer's disease. Advances and quality of life in Alzheimer's disease. AFA Tenerife, Tenerife. (4-5.10.2001).
  • A private initiative multidisciplinary centre. II Technical Conference ASEM Galicia. Capacity 2001. Vigo Trade Fair Institute. (2-4.11.2001).
  • Diagnostic and therapeutic protocol for ADI project patients. I Course for ADI Counsellors and IV Course for ADI Teachers. EuroEspes Medical Centre, Bergondo, La Coruña. (23.2.2000).
  • Biological bases of old age. Normal ageing. Master's Degree in Social Gerontology. Speciality in Gerontological Service Quality. Faculty of Psychology. Autonomous University of Madrid. (17.3.2000).
  • Neurobiology of pathological human ageing. Master's Degree in Social Gerontology. Speciality in Gerontological Service Quality. Faculty of Psychology. Autonomous University of Madrid. (17.3.2000).
  • Mental Health and Personal Well-being. Biological bases of neurodegenerative processes. Intelligent Holidays 2000. Lanzarote. (21-23.7.2000).
  • Alzheimer's disease: Etiology, genetics and pharmacogenomics. Cloenda Lecture. Hospital Universitari del Mar, Clinical Sessions, Barcelona. (25.5.2000).
  • Basic and clinical research in Alzheimer's disease. University Extension Summer Courses. University of Oviedo. Advances in Alzheimer's disease. Jovellanos Chair of University Extension, Gijón. (4.7.2000).
  • Neuropsychiatric disorders in Alzheimer's disease. University Extension Summer Courses. University of Oviedo. Advances in Alzheimer's disease. Jovellanos Chair of University Extension, Gijón. (4.7.2000).
  • Brain death and euthanasia. SEK Summer University: Is there life after life? The answer from science and avant-garde thought. SEK University, Segovia. (3-5.7.2000).
  • Alzheimer's disease. Causes and therapeutic future. University of the Balearic Islands. Palma de Mallorca. (15.9.2000).
  • Dementia intervention programme. Balearic Islands University, Palma de Mallorca. (16.9.2000).
  • Therapeutic strategies in Alzheimer's disease. Towards a comprehensive treatment. Hotel Bogotá Royal, Bogotá, Colombia. (28.6.2000).
  • Neurobiological bases of normal and pathological ageing. PhD Programme: Cognition and disorders. Course: Intellectual deficits and ageing. Coordinator: Prof. Dr. Rocío Fernández-Ballesteros. Autonomous University of Madrid. (12.2.1999).
  • Biological bases of old age: Neurobiology of brain ageing. Specialist Course in Social Gerontology. Director: Prof. Dr. Rocío Fernández-Ballesteros. Autonomous University of Madrid. (12.2.1999).
  • Bio-social aspects of Alzheimer's disease. First Conference on Social Gerontology. Monograph on Alzheimer's disease. Aula Magna Faculty of Psychology, University of Granada, Granada. (27.2.1999).
  • Degenerative and ischaemic brain damage: Diagnostic, therapeutic and preventive strategy. Riviera Complex, Montevideo. National Institute of Neurology, Faculty of Medicine, Montevideo, Uruguay. (14.6.1999).
  • Degenerative and ischaemic brain damage: Diagnostic, therapeutic and preventive strategy. Aconcagua Hotel, Mendoza. Chair of Neurological Clinic, Faculty of Medical Sciences, National University of Cuyo, Mendoza, Argentina. (15.6.1999).
  • Degenerative and ischaemic brain damage: Diagnostic, therapeutic and preventive strategy. Medical Association of Corrientes. Society of Psychiatry of Corrientes, College of Neuropsychopharmacology of the Northeast, Society of Neurology and Neurosurgery of Chaco, Corrientes, Argentina. (16.6.1999).
  • Degenerative and ischaemic brain damage: Diagnostic, therapeutic and preventive strategy. Metropol Hotel, Tucumán. Society of Neurology of Tucumán, Society of Gerontology and Geriatrics of Tucumán, Society of Psychiatry of Tucumán, Third Updating Course in Geriatrics and Gerontology, Tucumán, Argentina. (17.6.1999).
  • Genetics of Alzheimer's disease: Aetiopathogenic events and primary risk factors. Medical Circle of Rosario. Neurology and Neurosurgery Society of Rosario. Continuing Education Programme, 1999-2000 Cycle. Rosario, Argentina. (18.6.1999).
  • Therapeutic strategies in Alzheimer's disease. Medical Circle of Rosario, Society of Neurology and Neurosurgery of Rosario. Continuing Education Programme, 1999-2000 Cycle. Rosario, Argentina. (18.6.1999).
  • Alzheimer's disease nowadays: Evolution and clinic. Summer courses. University Extension. University of Oviedo. Society and Alzheimer's disease: challenges for the future. Jovellanos Chair, Gijón. (6.7.1999).
  • Neurodegenerative Diseases and Ageing. Scientific Dissemination Conferences. Caja Burgos Cultural Centre. Aranda de Duero. (16.11.1999).
  • Alzheimer's disease. Causes, identification of risks and care solutions. Caja Duero, Béjar. (26.10.1999).
  • New contributions in the aetiopathogenesis of Alzheimer's disease. I Course on Geriatrics and Gerontology in Primary Care. Faculty of Medicine, University of Valladolid. (10.12.1999).
  • Neurobiological bases of pathological ageing. Master in Social Gerontology. 3rd Iberoamerican Edition. Brasilia, Brazil. (Oct. 1999).
  • Alzheimer's disease: New horizons and social and health care support. Association of relatives of Alzheimer's patients in La Ribera. Aranda de Duero, Burgos. (30.3.1998).
  • Therapeutic approach to Alzheimer's disease. International symposium on Alzheimer's disease. Mexico DF. (28.2.1998).
  • Therapeutic approach to Alzheimer's disease. Guadalajara, Mexico. (2.3.1998).
  • Therapeutic approach to Alzheimer's disease. Tijuana, Mexico. (4.3.1998).
  • Therapeutic approach to Alzheimer's disease. Monterrey, Mexico. (6.3.1998).
  • Alzheimer's disease today. Health Month. Caja Rural Foundation. Zamora. (11.5.1998).
  • Brain Ageing in an Elderly Society. Casado del Alisal Summer University. Palencia. (6.7.1998).
  • Alzheimer's disease today: challenges for the future. Summer Courses/University Extension. University of Oviedo. Jovellanos Chair, Gijón. (9.7.1998).
  • Comprehensive model in the treatment of Alzheimer's disease. Summer courses. Jovellanos Chair, Gijón. (9.9.1998).
  • Current needs and future approach to Alzheimer's disease. Summer courses. Jovellanos Chair, Gijón. (9.7.1998).
  • Bioethics of care for the elderly with degenerative diseases. Genetic prevention of dementia. VI National Bioethics Conference. Granada. (25-26.9.1998).
  • Alzheimer's disease today: challenges for the future. Asturian Gerontological Forum. Oviedo. (8. 10. 1998).
  • Advances in the comprehensive treatment of Alzheimer's disease. II International Symposium on Alzheimer's disease. Mexico DF, Mexico. (20. l0.1998).
  • Advances in the comprehensive treatment of Alzheimer's disease. Guadalajara, Mexico. (21.10. 1998).
  • Advances in the comprehensive treatment of Alzheimer's disease. Monterrey. Monterrey, Mexico. (22.10.1998).
  • Scientific news in genetics, molecular biology and the social impact of neurosciences: Scientific advances. Gersalud, Cuenca. Cuenca. (6.11.1998).
  • Neurodegenerative diseases and ageing. Scientific and socio-health challenges in advanced economies. VII Cycle of scientific dissemination conferences. Caja de Burgos, Burgos. (17.11.1998).
  • Alzheimer's disease and related disorders. Rosario, Argentina. (3.6.1998).
  • The latest medical advances on Alzheimer's disease. Third International Meeting Alzheimer Monterrey '98. Hospital San José, Monterrey, Mexico. (24.10.1998).
  • Aetiopathogenesis of Alzheimer's disease. Course on Geriatric Psychiatry. Institute of Medical Sciences. University of Valladolid. Faculty of Medicine. Director: J.A. Macías. (16.12.1998).
  • Diagnosis of Alzheimer's disease. Course on Geriatric Psychiatry. Institute of Medical Sciences. University of Valladolid. Faculty of Medicine. Director: J.A. Macías. (16.12.1998).
  • Plans for future prevention and psychosocial support for Alzheimer's disease. Caja de Ahorros de Salamanca y Soria. Alzheimer's Family Association, Salamanca. (17.3.1997).
  • Alzheimer's, the great socio-health problem for Spain in the year 2000. Cycle "Spanish Health Facing the Challenge of the 21st Century". Badajoz. (11.3.1997).
  • Non-cognitive symptoms in dementias. I Refresher Course in Psychiatry and Mental Health. Mental Health Services. Principality of Asturias. (5.3.1997).
  • Research into natural products applied to the development of new medicines. CIBE. EuroEspes Foundation, La Coruña. (10.3.1997).
  • Alzheimer's disease. AFAIC. Foundation and Presentation of the Association of Relatives of Alzheimer's Patients of Inca and Region. Inca, Balearic Islands. (3.2.1997).
  • Health aspects of life: Ageing. Melilla Conference and Exhibition Centre. Ministry of Labour and Social Affairs. V Centenary of Melilla. Conference: Life after sixty. (22.4.1997).
  • Challenges facing young people in the 21st century. Colegio de Fomento Peñarredonda. Conference Centre. La Coruña. (10.5.1997).
  • Master's Degree in Social Gerontology. University of Granada and INSERSO/Ministry of Labour and Social Affairs. Module 6.6. Neurogerontology. (9.5.1997).
  • Alzheimer's disease: scientific progress and social and health care. Week of the elderly in the region of Murcia. Caja Murcia and University of Murcia. (13.5.1997).
  • Cognitive impairment in the elderly. Diagnostic and therapeutic keys. Training Course in Geriatric Care for Primary Care and Resident Doctors. Internal Medicine Service. Hospital Clínico Universitario Virgen de la Victoria, Malaga. (3.6.1997).
  • Alzheimer's disease. Causes, treatment and prevention. Las Palmas Casino. Hotel Sta. Catalina. Rotary Club. Las Palmas. (17.6.1997).
  • Scientific advances and social and health care in Alzheimer's disease. II Conference on Alzheimer's disease. Tenerife Association of Relatives of Alzheimer's Patients. (17-18.6.1997).
  • Seminar. Diseases with social impact. Degenerative pathologies and senile dementia. Alzheimer's disease. UIMP. Santander. (30.6.1997).
  • Seminar. Diseases with social impact. Degenerative pathologies and senile dementia. Psychiatric disorders in old age. UIMP. Santander. (3.7.1997).
  • Seminar. Diseases with social impact. Degenerative pathologies and senile dementia. Genetic prevention plans in diseases of the nervous system. UIMP. Santander. (4.7.1997).
  • Cerebrolysin: Basic and Clinical Studies in CNS Disorders. CIBE. EuroEspes Foundation, La Coruña. (9.7.1997).
  • Current state of Alzheimer's disease. Summer Courses. University of Oviedo. Jovellanos Chair. Gijón. July 1997.
  • Future care and treatment of Alzheimer's disease. Challenges in the year 2000. Summer Courses. University of Oviedo. Jovellanos Chair. Gijón. July 1997.
  • ESTREIA Project. Working Group: Approach and commitment of the Galician financial system to business innovation. Panel of Business Experiences in Financing Innovation. Galician Confederation of Entrepreneurs. Santiago de Compostela. (8.7.1997).
  • Doctorate Course. University of Santiago de Compostela and the Official College of Doctors of La Coruña. Brain ageing. Programme: Advances in physiopathology and medical therapeutics as a basis for medical research. Course 96-97.
  • Alzheimer's disease: Social and health care planning and therapeutic intervention. Association of Relatives of Alzheimer Patients (AFABUR): Burgos. (15.9.1997).
  • Treatment and prevention of Alzheimer's disease. Association of relatives of Alzheimer's patients. Soria. (16.9.1997).
  • Urological pathology in geriatrics and disorders of the central nervous system. CIBE. EuroEspes Foundation, La Coruña. (25.9.1997).
  • Update on Alzheimer's disease. Aetiopathogenesis and diagnosis. La Arruzafa National Parador. Cordoba. (20.9.1997).
  • Medical training priorities at the level of hospital managers. International forum. Postgraduate medical education: Towards improving health care quality and costs. College of Physicians. Madrid. (12.12.1997).
  • Degenerative diseases. Course on Psychogerontology. Autonomous University of Madrid. Faculty of Psychology. Madrid. (11.12.1997).
  • Biological bases of old age: Neurobiology of brain ageing. Specialist course in social gerontology. Autonomous University of Madrid, Faculty of Psychology, and Ministry of Labour and Social Affairs. Madrid. (12.12.1997).
  • International Distance Learning Master's Degree in Management of Research Institutes. International School of Hospital Management, Madrid. (1997-1998).
  • Course in Neuroscience. International School of Hospital Management. Madrid. (1997-1998).
  • Course on Neuropsychiatry in Primary Care. International School of Hospital Management. Madrid. (1997-1998).
  • Specialisation course in Neurogerontology and Neurogeriatrics. International School of Hospital Management. Madrid. (1997-1998).
  • Specialisation Course in Dementias and Alzheimer's Disease. International School of Hospital Management. Madrid. (1997-1998).
  • Sleep/Wake disorders in Alzheimer's disease. S-20098/Phase IIb-Alzheimer's disease. European Coordinators Meeting (2), IRIS, Paris. (3.1.1996).
  • Alzheimer's disease. Towards molecular diagnosis and new therapeutic strategies I.M.Q. Scientific Programme. San Rafael, La Coruña. (30.1.1996).
  • Spanish Anti-Dementia Plan:
    PEAD Presentation.
    Etiopathogenesis and diagnostic markers of senile dementia.
    Diagnostic protocol in neurogeriatrics.
    Therapeutic strategies in dementia.
    PEAD-National Health Network Protocol.
    I Meeting of the Spanish Anti-Dementia Plan, CIBE, La Coruña. (3.2.1996).
  • Genetic studies on Alzheimer's disease at present. Faculty of Psychology, University of Granada. (16.2.1996).
  • Neurobiology of brain ageing. Master's Degree in Social Gerontology, Inserso. University of Granada. (16.2.1996).
  • Current state of Alzheimer's disease. Club Prensa Asturiana, La Nueva España, Oviedo. (26.2.1996).
  • Treatment of dementias. Diploma in Mental Health. Faculty of Medicine, Oviedo. (26.2.1996).
  • Presentation Inaugural Conference Last Minute Club. Alzheimer's disease. B. Winblad. Palma de Mallorca. (28.2.1996).
  • Senile dementia. Housewives' Association, La Coruña. (12.3.1996).
  • Alzheimer's disease: Prevention plans and genetic identification in high-risk population. Alzheimer-Zamora Association of Relatives and Friends. (13.5.1996).
  • Advances in the prevention of Alzheimer's disease. Course on care for patients with dementia syndromes. Association of Relatives of Alzheimer's patients. Andalusia, Malaga. Parque San Antonio Clinic, University of Malaga, Malaga. (14.5.1996).
  • Japanese social and health care system and problems related to the ageing population. II Japanese Cultural Conference. University of Alcalá de Henares, Madrid. (29.5.1996).
  • Alzheimer Today: Latest news. Lifelong Learning Programme. Pharmaceutical Federation, Valencia. (6.6.1996).
  • Doppler Sonography. Postgraduate Course on Alzheimer's disease. The summer university of Southern Stockholm, Novum and Huddinge University Hospital, Karolinska Institutet, Stockholm. June 24-28, 1996.
  • Drug Trials. Postgraduate Course on Alzheimer's disease. The summer university of Southern Stockholm. Novum and Huddinge University Hospital, Karolinska Institutet, Stockholm. June 24-28, 1996.
  • Treatments and causes of mental disorders: Towards new concepts of mental health. Conference on mental illness, marginalisation and human suffering. Las Palmas de Gran Canaria. 18-22 April, 1996.
  • Alzheimer's, a well-known disease. Alzheimer's disease in Castilla y León. Benito Menni Hospital Centre, Valladolid. 29.3.1996.
  • Biology of Ageing (8 Hours):
    Biological bases of ageing.
    Physiology and Physiopathology of ageing.
    Principles of neurogerontology.
    Neurobiological bases of memory and learning.
    Prevalent pathologies.
    Research methods.
  • Master's Degree in Social Gerontology. 2nd Iberoamerican Edition. Santiago de Chile, Chile. 1996-1997 (7-11 Oct., 1996).
  • Bio-Psycho-Social Programmes in Dementias (I) (2 Hours):
    Senile Dementia.
  • Master's Degree in Social Gerontology. 2nd Iberoamerican Edition. Santiago de Chile, Chile. 1996-1997 (7-11 Oct., 1996).
  • Japan: Lessons from a culture of public health and social welfare. INSERSO, Madrid. (5.11.1996).
  • Course: Advances in dementia. Mental health and psychiatry on the threshold of the new millennium. I Caribbean and Bolivarian Countries Regional Meeting "Carlos Alberto Seguín". XIV National Congress of Psychiatry "Honorio Delgado". Lima. (28.11-1. 12.1996).
  • Doppler sonography in Alzheimer disease. Postgraduate Course in Alzheimer disease. Novum and Huddinge Hospital, Stockholm. (24-28.6.1996).
  • Drug trials in Alzheimer disease. Postgraduate Course in Alzheimer disease. Novum and Huddinge Hospital, Stockholm. (24-28.6.1996),
  • Alzheimer's disease. Aetiopathogenic factors and genetic evaluation. Lifelong Learning Programme. Pharmaceutical Federation. Valencia. Jun. 96.
  • Scientific and Social and Health Update on Alzheimer's disease. Scientific Conference. Ramón Areces Foundation, Madrid. (10.6.1996).
  • Alzheimer's disease. Plans for prevention and socio-sanitary support. Alzheimer's Family Association, La Coruña. (29.10.1996).
  • Biological bases of old age. Neurology of cerebral ageing (3 hours). Specialist in Social Gerontology. Academic year 1996-97. Autonomous University of Madrid, Madrid. Dec. 96.
  • Mental Retardation and Brain Neurodegeneration. Ave Maria Foundation, Sitges, Saló d'Or. (16.1.1995).
  • Current situation and perspectives in the treatment of Alzheimer's disease. Liceo Recreo Orensano, Orense. (6.2.1995).
  • Alzheimer's disease. Current perspectives in medicine. Institut D'Estudis Ilerdencs. Diputació de Lleida, Lleida. (31.1.1995).
  • Neurogerontology of ageing. Master's Degree in Social Gerontology. University of Granada, Ministry of Social Affairs, INSERSO, Granada. (10.2.1995).
  • Genetics and neuroimmune function in Alzheimer's disease. Seminar. Neuroscience. Faculty of Medicine, Lleida. (31.2.1995).
  • Biological aspects of old age. Ageing and the central nervous system. Master's Degree in Social Gerontology, Promotion 1994-1996. Faculty of Psychology, Autonomous University, Ministry of Social Affairs, INSERSO, Madrid.
  • Recent advances in Alzheimer's disease: New perspectives and treatment. Menéndez Pelayo International University, Seminars '95. Actualidad Clínica en Geriatría, Sta. Cruz de Tenerife. (3-7.4.1995).
  • Senile dementia: Health and residential policy. Ballesol Residence, Madrid. (25.4.1995).
  • Alzheimer's disease: Diagnosis and therapy. Association of Alzheimer's Relatives, León. (3.5.1995).
  • Alzheimer's disease: Genotyping and new treatments. Osaka University Medical School. Osaka, Japan. (22.5.1995).
  • Alzheimer's disease. Aula Tercera Edad, Oviedo City Council, Oviedo. (20.6.1995).
  • Senile dementia: Causes and health care. Bergondo Town Council, Bergondo, La Coruña. (3.6.1995).
  • Current state of Alzheimer's disease. Summer courses. Social and Health Care Needs of the Elderly: Debate and Future Prospects. University of Oviedo. Jovellanos Chair, Gijón. (3-7.7.1995).
  • Future prospects and social and healthcare needs in Alzheimer's disease. Summer Courses. Socio-sanitary needs of the elderly: Debate and future perspectives. University of Oviedo, Jovellanos Chair, Gijón. (3-7.7.1995).
  • Demencia senil: A epidemic of the XXI. Demanda socio-sanitaria de coidados xeriátricos, do diagnóstico a atención integral. University of Vigo. Summer Courses. Xeriatrics: Social and health problems and public services. A integración coordinada dos recursos. Vigo. (11.7.1995).
  • Genetic identification programmes in Alzheimer's disease. Talk-Colloquium on Alzheimer's Dementia. Alzheimer's Family Association. Salamanca. 2 Oct. 1995.
  • Dementias: Diagnostic review and advances in treatment. LATU, Montevideo. 13 Sept. 1995.
  • News and latest therapeutic concepts on citicoline. Current relevance in the treatment of brain ageing, Alzheimer's disease and stroke. Baliarda Laboratories, Buenos Aires. 14 Sept. 1995
  • Neurological and neurochemical basis of Alzheimer's disease. II Conference on Senile Dementia of the Alzheimer's Type. Alzheimer's Association "Sta. Elena". Seville. 20-22 Oct. 1995.
  • Alzheimer's disease. 7th "City of San Sebastian" Geriatrics Course, San Sebastian. 16 Nov. 1995.
  • Alzheimer's disease. San Francisco Clinic, León. 20 Nov. 1995.
  • Preclinical and clinical strategies for the pharmacological evaluation of candidate drugs in Alzheimer's disease. Janssen Pharmaceutica, Beerse, Belgium. 23 Nov. 1995.
  • Advances in genetics and molecular biology in schizophrenia. Specialised Training Programme in Comprehensive Psychosocial Rehabilitation in the Community. Associació A.R.A.P.P.D.I.S., Barcelona. 24 Nov. 1995.
  • Socio-family problems and treatment of Alzheimer's disease. Alzheimer-Canarias Association. Las Palmas de Gran Canaria. 30 Oct. 1995.
  • Pharmacological treatment of dementia. Course Psychiatric disorders in the elderly. Institute of Medical Sciences. University of Valladolid, Valladolid. 12 Dec. 1995.
  • Alzheimer's disease: Aetiopathogenic factors, diagnostic criteria and therapeutic guidelines. Lifelong Learning Programme. Pharmaceutical Federation, Valencia. (13.1.1994).
  • Alzheimer's disease: Aetiopathogenic factors, diagnostic criteria and therapeutic guidelines. Lifelong Learning Programme. Federació Farmacéutica Technical Department. Valencia. (13.1.1994).
  • Advances in Alzheimer's disease. Summer Courses 1994. Gijón. Psychogeriatrics in the present day. Jovellanos Chair. Gijón. July 4-8, 1994.
  • Cognitive alterations in old age: senile dementia and Alzheimer's disease. Summer Courses. University of Vigo. Análise Xerontolóxico da realidade presente e o futuro das persoas maiores na comunidade. Vigo, Course Nº 79. 11-12 July, 1994.
  • Biology of ageing. Master's Degree in Social Gerontology. PAMI-INSERSO. Buenos Aires, Argentina. Oct-Nov. 1994.
  • Alzheimer's disease. Etiopathogenic factors and treatment. Russian Academy of Medical Sciences. National Mental Health Research Center. Moscow, Russia. 15 Oct. 1994.
  • Diagnosis of Alzheimer's disease. Definition of AD genotype/phenotype. The Karolinska Institutet Postgraduate Education Series. Stockholm, Sweden. 19-20 Nov. 1994.
  • Aetiopathogenesis of Alzheimer's disease. PhD course. Univ. Zaragoza. Medical College. Zaragoza. 28 Nov. 1994.
  • Alzheimer's Disease: Therapeutic Predictors. Presentation ANNALS OF PSYCHIATRY Vol. 4. Alzheimer's Disease. Hotel Castellana-lntercontinental, Madrid. 20 Nov. 1994.
  • Alzheimer's disease genotypes and therapeutic strategies. Presentation ANNALS OF PSYCHIATRY Vol. 4. Alzheimer's Disease. Hotel Condes de Barcelona, Barcelona. 14 Dec. 1994.
  • Senile dementia: Medical and social responsibility. Cáritas Diocesana, Riveira, La Coruña. 17 Dec. 1994.
  • Experimental Psychoneuroendocrinology. Doctorate Course, Faculty of Medicine, Complutense University, Madrid. Course 1994-1995.
  • Alzheimer's disease: Perspectives for a decade. Hotel Majestic, Barcelona. (26.1.1993).
  • The biological process of ageing. Biannual Training Plan in Social Services. C.O.P.-INSERSO. Official College of Psychologists. Madrid. (26.2.1993).
  • Advances in the knowledge of dementia syndromes. Current status of therapy with cerebral vasoregulators. Postgraduate course. Advances in Applied Psychopharmacology. Directors: J. Bobes, M. Bousoño. Faculty of Medicine, Oviedo. (20.4.1993).
  • Dementia. Current status. Psychiatric disorders in dementia. Joan March Research Centre. University of the Balearic Islands, Palma de Mallorca. (23.4.1993).
  • New contributions in Alzheimer's disease. I Geriatrics and Gerontology Course. Postgraduate Training Secretariat. Faculty of Medicine. University of Valladolid. Valladolid. (4.6.1993).
  • Alzheimer's disease: The challenge of the future. Alzheimer's disease and other dementias. INSERSO, Madrid. (23.6.1993).
  • Treatment of dementias. Seminar on Psychopharmacology Update. ARPYA, Valencia. (29.6.1993).
  • Neuroimmune function of brain histamine: Etiopathogenic and therapeutic implications in Alzheimer's disease. Kursraum des Instituts für Pharmakologie und Toxikologie, Leopold- Franzens-Universitat Innsbruck, Austria. (23.11.1993).
  • The future of Biological Psychiatry. Gallery Hotel, Barcelona. (3.2.1992).
  • Neurotransmitters and ageing. V Geriatric Refresher Course. Faculty of Medicine. University of Salamanca. Society of Geriatrics and Gerontology of Castilla y León. (22.2.1992).
  • Aetiopathogenesis of Alzheimer's disease: Diagnostic and therapeutic prospects. Barcelona College of Physicians. (19.3.1992).
  • Aetiopathogenesis and biological diagnosis of Alzheimer's disease. Course: Alzheimer's disease and related disorders. University School of Nursing. Faculty of Medicine. Complutense University. Madrid. (22.4.1992).
  • Therapeutic strategy in Alzheimer's disease. Course: Alzheimer's disease and related disorders. University School of Nursing. Faculty of Medicine. Complutense University of Madrid. (22.4.1992).
  • Molecular neuropathology of Alzheimer's disease: Bases for an etiopathogenic treatment. College of Physicians. La Coruña. (23.4.1992).
  • I EuroEspes Biomedical Training Day. Senile Dementia-I: Clinical utility of calcium antagonists. College of Physicians. Pontevedra. (28.5.1992).
  • II EuroEspes Biomedical Training Day. Senile Dementia- II: Neuronal membrane repair treatment. College of Physicians. Valladolid. (12.6.1992).
  • Molecular genetics and neurochemistry of schizophrenia. Faculty of Psychology. University of Barcelona. (29.9.1992).
  • Involvement of free radicals in various pathologies. Critical Care Forum. Free radicals and human pathologies. Torrequebrada Hotel. Benalmádena, Málaga. (10.11.1992).
  • Biological aspects of old age. Master's Degree in Social Gerontology. Faculty of Psychology. Autonomous University. Madrid. (20.11.1992).
  • Alzheimer's disease: Future prospects. Medical Association of Tenerife. Santa Cruz de Tenerife. (9.12.1992).
  • Neurochemical perspectives on Alzheimer's disease. Centre for Molecular Biology, Autonomous University of Madrid. Faculty of Science, Madrid. (13.3.1991).
  • PhD Course: Psychoneuroendocrinology. Faculty of Medicine, Complutense University, Madrid. (1.3-30.6-1991).
  • Therapeutic perspectives in Alzheimer's disease. Institut de Recherches Internationales Servier (I.R.I.S.), Paris, France. (17.3.1991).
  • Lazaroides. Upjohn Convention. Hotel Meliá-Castilla, Madrid. (10.1.1991).
  • Therapeutic perspectives on Alzheimer's disease. IV Course on Geriatrics. Official College of Doctors of León. Castilian-Leonese Society of Geriatrics. León. (9.2.1991).
  • Brain histaminergic system: Neurobiology and alterations in Alzheimer's disease. Seminars in Neuroscience. Department of Morphology. Faculty of Medicine, Autonomous University of Madrid. Madrid. (3.5.1991).
  • Influence of the somatotropinergic system on cognitive functions. PhD course (1991). Biochemistry of Gastrointestinal Peptides. Directors: J.C. Prieto and E. Arilla. Department of Biochemistry and Molecular Biology. Faculty of Medicine, University of Alcalá de Henares. Alcalá de Henares. (13.5.1991).
  • Physiology of sleep in the elderly. Biochemical and EEG changes. The elderly and sleep. Knoll Convention, Hotel Palace, Madrid. (23.5.1991).
  • Physiopathology of memory and ageing. Round Table: Memory and ageing. Hotel Meliá-Madrid, Madrid. (24.5.1991).
  • Neuroimmune function in mental disorders. PhD course. Cajal Institute, CSIC, Madrid. (27.5.1991).
  • Molecular psychopharmacology in child psychiatry. Conference on neurobiology and psychopharmacology in child and adolescent psychiatry. Academy of Medical Sciences of Catalonia and the Balearic Islands, Barcelona. (31.5.1991).
  • Legislative planning in psychogeriatrics. Scientific conference. Psychiatry and Law, Orense. (8.6. 1991).
  • Quality of life in old age: Social impact of Alzheimer's disease and other dementias. Course on mental health and quality of life. Jovellanos Chair, Gijón. (11.7.1991).
  • Neuroimmune factors and neuropeptidergic treatment in Alzheimer's disease. Department of Neuropsychiatry, Osaka University Medical School, Osaka, Japan. (24.9.1991).
  • Neuroimmune function in Alzheimer's disease: Involvement of brain histamine in the pathogenesis of senile dementia. Department of Pharmacology II, Osaka University Medical School, Osaka, Japan. (26.9.1991).
  • New perspectives on Alzheimer's disease. Faculty of Medicine. University of Salamanca. (21.11.1991).
  • Alzheimer's disease: Aetiopathogenic treatment. Sta. Teresa Sanatorium. Arevalo, Avila. (22.11.1991).
  • New trends in the etiopathogenetic treatment of Alzheimer's disease. Tampere University, Tampere, Finland. (19.12.1991).
X

Leave us your contact information and we will contact you.